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INTRODUCTION 
Myotonic dystrophy (MyD) has been recognized as a disease entity for 
approximately a century. In the same year Batten and Gibb (1909) and Steinert 
(1909) independently reported a series of patients with progressive muscular 
atrophy and weakness of facial and distal limb muscles, who were unable to 
relax the hand muscles after a forceful contraction (myotonia). During the 
following decennia, the involvement of multiple organ-systems was defined: 
cardiac conduction defects, smooth muscle involvement, hypersomnia, reduced 
intelligence and a lack of initiative in the early onset cases. These were 
accompanied by cataracts, abnormal glucose response, increased anaesthetic 
risk and in males, typical premature baldness and testicular atrophy (Harper, 
1989). Since 1992, a diagnostic accuracy nearing 100% can be reached by a 
combination of clinical examination and DNA techniques (Reardon et al., 1992; 
Mahadevan et al., 1992; Brunner, thesis, 1993; Wieringa, 1994). At present, 
despite significant effort, there remains no treatment that will alter the natural 
history of muscular dystrophy (Harper, 1989). 
The early contributions by Fleischer (1918) and Vogt (1921) described in 
detail the inheritance pattern, using the typical multi-coloured cataract as a 
marker for MyD. Fleischer (1918) suggested that MyD is a hereditary illness, 
the severity of which depends on the age of onset and increases in successive 
generations. The disease may be transmitted for many generations without 
obvious symptoms, with the possible exception of cataract. This peculiar 
autosomal dominant inheritance pattern was confirmed by others in several 
other countries (Thomasen, 1948; Bell, 1947; Klein, 1958; Höweler, 1986, 1989). 
In Bell's review (1947), most studies revealed a remarkable trait: the disease 
presented earlier with increasing severity in subsequent generations (antici-
pation). This assumption was ignored by Penrose (1948) but confirmed by 
Klein (1985) and finally led to a reluctant acceptance of the anticipation theory 
by Höweler and associates, as shown in their work (1986, 1989). 
Three main clinical forms of MyD were recognized by Dyken (1969) and 
Dyken and Harper (1973): a 'congenital' adult and late onset form. This 
clinical classification was expanded by Höweler (1986) and more recently by 
Koch (1991), who divided their adult onset cases into two subgroups, these 
are, early adult and late adult (see Table 1). The late onset form of MyD is 
characterized by a very mild symptomatology: cataract is commonly the only 
feature, but in some cases a mild facial weakness and myotonia may be 
present. The 'congenital' form is the most severe, with at birth severe 
hypotonia, insufficient respiration and impaired swallowing (Harper, 1975; 
Hageman, 1993). Some of the cases may have talipes or arthrogryposis. Those 
surviving the neonatal period show mild to moderate mental retardation and 
later, develop the same pattern of muscular weakness as the adult onset form. 
This form, also termed the classical form of MyD has its onset in adolescence 
or in early or later adulthood. The majority of patients show the classical trait 
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Table la. Clinical division ofMyD in subgroups 
type 
childhood 
MyD 
onset 
congenital 
1-12 yrs 
12-50 yrs 
adult onset or 
classical form 
MyD 1 2 ~ 2 0 У" 
late onset or 
mild MyD 
> 50 yrs 
initial symptoms 
neonatal diffuse hypo­
tonic paresis, respira­
tory insufficiency, 
clumbfeet. Maternal 
inheretance. Incomplete 
recovery. 
mental retardation, 
neonatal symptoms 
absent. 
myotonia with typical 
weakness: face, 
pharynx, distal limbs. 
as well testis-atrophy, 
infertility, sometimes 
social isolation. 
cataract 
late symptoms 
mental retardation. 
After 10 yrs of age 
progressive weakness, 
cataract, GI motility 
disorders. 
multi-organ signs 
slow prog, weakness, 
finally proximal. 
Wheelchair: 5%, mental 
slowness, apathy, 
hypersomnolence. 
variable organ involve­
ment: cataract, conduc­
tion cor, complications 
by partus and anaesthe­
sia. 
myotonia, mild muscle-
dystrophy. 
CTG* 
>600 
about 100 to 
about 1300 
50 to about 
100 
adapted from Hòweler et al., 1986; Koch et al., 1991; Harley et al., 1993 
*: approximation of CTG repeat-length 
of myotonia, muscle weakness and in later stages cataract, in combination with 
some other organ-specific signs. 
After the discovery of the genetic abnormality in 1992 it became clear that 
the distinct clinical subtypes must have a genetic basis. Simultaneously, 
Aslanides et al. (1992), Brook et al. (1992), Buxton et al. (1992), Fu et al. (1992), 
Harley et al., (1992), Jansen et al. (1992) published the discovery of the genetic 
abnormality. They showed that a polymorphic CTG repeat (Cytosin-Thymidin-
Guanin) in the 3' untranslated region, located at the ql3.3 band of chromo-
some 19 was the major defect. 
While the normal gene has between 5 and 30 CTG repeats, the MyD alleles 
vary from 50 to several thousands (Brunner et al., 1992; Harley et al., 1993). 
Using DNA techniques, the aforementioned clinical subgroups, depending on 
age of onset, are broadly correlated with the CTG repeat expansion (Harley 
et al., 1993; see Table 1). 
The clinical expression of MyD is variable, even within the same family, 
although the disease is genetically homogenous (Harper, 1989). The latter 
author stated that clinical variability in fact is a hallmark of MyD. It is true 
that the variability correlates with the size of the repeat expansion. Some 
incomplete correlation between genotype and phenotype can be defined: an 
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earlier onset and a greater severity broadly correlates with a longer CTG 
repeat (Hunter et al., 1992; Tsilfidis et al., 1992, Harley et al., 1993). The 
strongest correlation was apparent between CTG repeat length and muscle 
involvement and to a lesser degree with heart and brain (Pizzuti et al., 1993 
а.о.). However, the correlation is neither linear nor absolute. For instance, 
some infants who are severely affected with congenital MyD have small 
expansions (Tsilfidis et al., 1992). Patients with MyD occasionally show a 
marked somatic mosaicism of the CTG repeat length (Ashizawa et al., 1993; 
Anvret et al., 1993; Thornton et al., 1994; Janssen et al. 1994). In one investiga­
tion skeletal muscle DNA from 8 adult patients with the mild to moderate 
type of MyD showed a repeat of more than 1500, while in 5 of them, the 
repeat size was substantially shorter in leucocytes DNA (Ashizawa et al., 
1993). Moreover, in sperm the (CTG)n repeat excess was often longer in adult 
cases than the repeat in leucocytes in the same patient (Janssen et al., 1994). 
At the time of preparing this document, the effects of the gene products on 
the separate organ systems remain uncertain (Ptacek et al., 1993; Wieringa, 
1994). Because the gene product is a myotonin-proteinkinase, one may expect 
an influence on the phosphorylation processes (Fu et al., 1992) in the several 
membranes, with consequences for the ion transport and finally intracellular 
damage (Griggs et al., 1990; Benders et al., 1993 а.о.). 
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AIM AND OUTLINE OF THE STUDY 
Recent investigations have demonstrated that MyD patients differ from one 
another not only in clinical features but also regarding genetic defects. In 
addition, the length of the (CTG)n excess broadly correlates with the four 
clinical types. A review of the literature demonstrated that most of the 
previous investigations usually included all the various clinical subtypes. 
Therefore, it appears that clinical studies should be performed for selected 
groups of MyD patients. 
The leading questions of this thesis were as follows: 
1. What is the additional diagnostic value of sensitive quantitative measure-
ments? 
2. What is the pattern of early expression in some organ systems? 
3. How does the spectrum of organ-system involvement clinically present 
itself in an adult onset group of MyD patients? 
Based on clusters of clinical features, several authors divided the MyD 
population into 4 or 5 clinical subgroups (Dyken, 1969; Dyken and Harper, 
1973; Höweler, 1986; Koch, 1991). In this series of clinical studies we confined 
ourselves to the adult onset group only. 
Prior to the detection of the gene defect, our goal was to give particular 
attention to increasing diagnostic accuracy by special quantitative clinical 
investigation methods. At a later stage, when adequate genetic markers 
became available, the focus of our studies shifted to early expression related 
clinical issues in an adult onset group of MyD patients of mild severity. 
Aim and design of the studies 
As far as possible, a choice was made to confine the study to the adult onset 
or classical form, this being the most numerous (> 50%) group. Only common 
MyD related signs were included. In the later studies we focused on a rather 
early phase of the disease. Another choice, was to use quantitative methods, 
which reflect the course of the slow progressive nature of the illness in a more 
efficient manner. For practical reasons the above mentioned method was 
chosen to study some unknown aspects of common organ involvement in 
MyD. Thus, we performed studies concerning neuro-ophthalmology, neuro-
otology, bulbar weakness, speech and neuro-psychology. 
A selective review of the literature, limited to these selected topics, will be 
given in chapter 1. 
In chapter 2, the results of the study of eye movement disorders, retinopathy 
and opticopathy, mainly for an adult onset group are described with regards 
to pattern, pathophysiological mechanism, expression mode and course. 
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Aim and outline of the study 
In chapter 3, the findings of several neuro-otologic investigations for an 
adult onset group are presented. 
In chapter 4.1, an easy bedside method to detect the swallowing abnorma-
lities for an adult onset group is documented. 
In chapter 4.2, the results of a computerized speech analysis in a mildly 
affected adult onset group are documented. 
In chapter 5, the neuro-psychological pattern is presented for a mildly 
affected adult onset group. 
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Review of Literature 
1. MYOTONIC DYSTROPHY 
1.1. Neuro-ophthalmology 
2.2.3. Historical perspective 
The early studies of several ophthalmologists were major contributions to the 
knowledge of myotonic dystrophy (MyD). Although it is impossible to discuss 
them all, a short historical review will be given. Greenfield (1911) was the first 
to stress the importance of cataracts as a feature of MyD. It was Fleisher (1918) 
who noted the relationship of clinical symptology and the age of onset and 
outlined the crude lines of the inheritance pattern, including anticipation (the 
severity of the disease increases during successive generations). Furthermore, 
a part of his contribution was a description of the second phase of develop-
ment of cataracts. Shortly after the discovery of the slitlamp in 1920, lens 
inclusions were recognized as a characteristic of MyD after the publication of 
Vogt (1921), who also reported the chronological sequence of development of 
these (multicoloured) cataracts. The first person to perform a large scale 
population study was Klein (1958), who gathered the largest family study to 
date in Switzerland. With regards to The Netherlands, Vos's (1938) thesis, 
entitled 'Cataracta myotonica' should be mentioned. 'Because this dissertation 
was written in Dutch it did not receive the international publicity it deserved', 
wrote the Dutch ophthalmologist Junge (1966). The thesis of the latter Ocular 
changes in dystrophia myotonia, paramyotonia and myotonia congenita' 
carefully documents the different ophthalmologic abnormalities for the period 
up to 1967 in MyD, which comprises amongst other topics detailed descrip-
tions of cataracts, retinopathy and histology. In the same year Burian and 
Burns (1967) reported in an excellent article regarding the eye in MyD. The 
remaining literature up until 1989 has been summarized by Harper in his 
monography about MyD. Recently, Ashizawa et al. (1992) described the 
diagnostic value of separate ophthalmological findings in a group of patients 
in whom accuracy of the diagnosis was confirmed for the first time by 
haplotype-analysis. 
In the following paragraphs, the literature regarding neuro-ophthalmological 
topics in MyD will be summarized. 
3.3.2. Lens opacities 
Vogt (1921,1931) documented the successive phases of lens inclusion in MyD. 
The following features were listed by Vogt (1931) as characteristic of MyD: 
white opacities interspersed with coloured opacities, a sufficient number of 
such opacities and no opacities in the anterior or posterior zones of disconti-
nuity. 
There are 4 stages of development (Table 2). The first or Vogt stage is 
characterized by a bi-lateral appearance of dust-like irregular shaped white 
opacities intermingled with iridescent crystals of varying red and green (less 
frequently yellow and blue) immediately beneath the anterior and posterior 
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Table 2. Slitlamp findings m MyD 
phase 1 no visual symptoms; some dust-like white and multi-coloured opacities in the 
anterior and posterior cortex. Pos. predictive value or: PPV: 100%*. 
phase 2 usually no visual symptoms; the opacities increase in density along the lens 
sutures (star shaped). PPV: 100%* 
phase 3 diminution of visual acuity; subcapsular vacuoles and waterclefts occur, 
lenticular sclerosis exacerbates while coloured opacities become less suspicious. 
PPV: uncertain. 
phase 4 impaired vision; mature cataract. PPV: 0%. 
Vogt, 1921, 1931 
*Ashizawa et al., 1992 
capsules of the lens-cortex. Visual symptoms are usually absent. In the second 
or Fleisher stage (1918), the opacities become more diffuse, they increase after 
years in density and develop a stellate shape. 
This may sometimes result in slightly reduced vision. In the third and final 
stage water clefts, vacuoles and lamellar separations develop, resulting in 
complete opacity with definite impaired vision. The fourth phase of mature 
cataract cannot usually be recognized as myotonic cataract since the multi-
coloured crystals have disappeared (Vogt, 1921,1931; Junge, 1966; Duke Elder, 
1969). 
The differential diagnosis for iridescent lucencies (IRL, previously: 
multicoloured crystals) is rather diverse. Sporadic IRL may occur in several 
diseases: hypothyroid disease, hypocalcaemia, juvenile diabetic mellitus, 
mongoloid idiocy, autosomal dominant cataract, idiopathic IRL (especially in 
young females) and due to the effects of various drugs (neuroleptic drugs, 
silver and gold-compounds) (Junge, 1966; Roy, 1989). 
Electronmicroscopy of lenses with cataracts removed from patients with 
MyD revealed a number of unusual features such as lipid droplets, vacuoles 
containing whorled material and protein crystalloid deposits (Dark and 
Streeten, 1977). The most remarkable finding is that the IRL are probably 
whorls of plasma membranes and no real crystals (Eshagian et al., 1978). 
Regarding the prevalence and age related occurrence of lens opacities, Klein 
(1958) in his population study, found lens opacities in 237 of the 242 patients 
(97.9%). The youngest patient with definite myotonic cataract was reported by 
Klein (1958) being 10 years of age, although sporadic and non-specific lens 
opacities can be found at a younger age (Harper, 1972, 1973). Cataracts may 
be the only manifestation of the disease in about 5-10% of the MyD popula-
tion (Bundey and Carter, 1970; Polgar et al., 1972) and in late onset, form lens 
opacities may be the sole manifestation for many years (Harley et al., 1993). 
Höweler (1986) separated the occurrence of the typical myotonic cataract 
(IRL) into several age groups: 0% < 10 yrs, 46% 10-29 yrs, 67% 3 0 ^ 9 yrs and 
87% above 50 yrs of age. Similar results were discovered by others (Klein, 
1958; Junge, 1966 and Harper, 1989). Therefore the typical myotonic cataract 
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probably does not occur below 10 years of age and the frequency of lens 
opacities increases with age. No certain data is available regarding the speed 
of progression, simply because no longitudinal investigations have been 
reported to date. 
How is the frequency of occurrence of cataract in the several sub-groups, 
dependant upon the age of onset? In the childhood group 4/16 (25%) showed 
myotonic cataract (only after the first decade of the disease), in the early adult 
onset group 22/50 (44%), in the late adult onset group 11/15 (73%) and in the 
senile onset group all 21 (100%) patients (Höweler, 1989). Cataracts are for the 
congenital group extremely rare, but may occur in the later stages (Harper, 
1972). 
What are the practical uses and misuses of slitlamp investigation for genetic 
research? Polgar (1972) studied the value of lens-inclusions and EMG for 'early 
detection'. It was concluded that EMG and slitlamp studies were useful 
methods to discover some clinically asymptomatic gene carriers in family 
studies. The question of how many asymptomatic first degree relatives were 
affected was answered by Harper (1973), who found 17.6% of them definitely 
affected and 13.7% suspicious but not diagnostic. Although Harper (1973) 
suggested that nearly all heterozygotes may be detected by the age of 14 
years, Bundey et al. (1970, 1974) demonstrated that this statement might be 
true, but not before 40 years of age. Finally, Brunner (1991) demonstrated for 
a group of DNA proven MyD patients, that approximately 8% of the patients 
remained undiagnosed, regardless of neurological investigation, EMG and 
slitlamp-investigation. The same author (1991) stated that in particular, 
aspecific unilateral or sporadic IRL are often false positive and induce 
unnecessary DNA studies. Using the guidelines of Ashizawa (see further), this 
number can certainly be reduced. The use of DNA markers as a golden 
standard, enabled Ashizawa (1992) to solve some long standing uncertainties 
regarding lens-inclusions and define the sensitivity and specificity of the other 
lens-opacities other than IRL. 
For a group of definite MyD gene carriers, Ashizawa (1992) discovered in 
18/30 patients IRL, bilaterally in 14/18 and in the remaining 4 patients 
unilaterally. The number of IRL was less than 10 in 13/28 eyes, 10 or more in 
9 eyes and disregarded in 6 eyes of the 14 MyD patients with bilateral IRL. 
Ashizawa compared these findings with a group of 'non-MyD patients'. None 
of the 49 'non-MyD patients' showed bilateral IRL but four of them exhibited 
unilateral IRL, totalling 4 IRL. Ashizawa suggested some rules to increase the 
specificity of slitlamp investigation for MyD. Firstly, a population of MyD 
must be taken which raises the apriori change 10.000 times compared with the 
normal population. Other recommendations are: lens inclusions should be 
investigated by an ophthalmologist experienced in identifying more subtle lens 
opacities of MyD, using a stationary slitlamp, and only if IRL are found 
bilaterally and outnumbering 10 (?) per eye, can they be regarded as 
pathognomonic (Ashizawa et al., 1992). Furthermore, one may include the 
posterior cortical cataract (PCC), but firstly it must be distinguished on 
5 
Chapter 1 
morphological grounds from the other types of co-existing posterior cortical 
and posterior subcortical capsular opacities (age-related, steroid-related and 
congenital). Ashizawa and allies (1992) also warned about excluding the 
diagnosis of MyD merely based on slitlamp findings (neg. predictive value of 
92% for combining IRL and PCC (Ashizawa et al., 1992). Genetic counselling 
with regard to lens-opacities for 'asymptomatic' gene-carriers has shown that 
it is quite reliable (true-positive results in 18/20 patients) (Longstaff et al., 
1991). Harley found that for asymptomatic groups with a CTG repeat of less 
than 100 the lens inclusions may occur as sole manifestation (Harley et al., 
1993). 
1.1.3. Retinopathy 
Since the reports of Verwey and Le Gras (1933) and Gotfredsen (1949) macular 
degeneration and tapetoretinal degeneration are recognized as features of 
MyD. 
In the initial phase, the retinopathy is clinically undetectable or may give 
atypical blurred vision with sometimes moderately (20-35 deg.) bilateral 
constricted visual fields (Burian and Burns, 1967). In such cases, the retino-
pathy was diagnosed based on fundoscopy or electrophysiological tests in 
population studies (Table 3). For criteria concerning retinopathy see the 
separate textbooks (e.g. Walsh and Hoyt, fourth edition). Colour vision is 
normal and night blindness is absent, but the dark-adaptation threshold is 
usually diminished (Table 3). In the series of Junge (1966) and Burian and 
Burns (1967) the majority of patients had a visual acuity above 0.6. Sometimes 
the visual acuity is severely reduced, due to maculopathy, cataract or a 
combination of both. 
It is difficult to gain a clear picture of the retinopathy as seen by ophthalmo-
scope. The findings are variable with some findings being included by chance 
due to a sample error in the small series (N=15-52) and lens opacities 
sometimes obscure the retinal abnormalities. Most reported abnormalities are 
located in the peripheral retina (12-53%) (Burian and Burns, 1967; Junge, 1966; 
Hayasaka et al., 1984). According to the latter these lesions are presumably at 
the level of the deep retinal layer and do not substantially alter the visual 
functions. The major abnormality in the retinal periphery are the gross clumpy 
pigmentations (Burian and Burns, 1967; Junge, 1966), sometimes in com-
bination with rather unique yellow peripheral flecks (20%) (Hayasaka et al., 
1984). In up to 20% of the patients the retina is diffusely involved so that a so 
called butterfly dystrophy or a reticular dystrophy may be observed 
(Deutman, 1974; Hayasaka et al., 1984). In the macular region, a minority of 
patients (4—20%) have aspecific streak-like or pigmented macular lesions 
(Burian and Burns, 1967; Junge, 1966; Meyer et al., 1980). Some authors also 
suggest a dysfunction of the photoreceptors (Junge, 1966; Burians and Burns, 
1967). Another remarkable finding was the narrowing of the retinal arterioles 
in relatively young patients (Burian and Burns, 1967). 
Most evidence for a retinopathy comes from the electrophysiological studies. 
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About 60-83% of the electrophysiological retinal studies were bilaterally 
grossly abnormal regardless of ocular symptoms or the appearance of visible 
fundus abnormalities (Junge, 1966; Kirkham and Coupland, 1981; Sandrini et 
al, 1986; Pinto et al., 1987; Kerry and Ganes, 1989). A common but aspecific 
finding was the bilateral reduction of b-wave amplitude in the ERG, both in 
scotopic and photopic conditions, with rarely a prolonged implicit time factor, 
(Burian and Burns, 1966; Stanescu and Wawernia, 1970; Stanescu and Michels, 
1975). Although the ERG abnormalities are partly influenced by the under 
exposing of the retina by cataracts, the rods in the retina seem diffusely 
involved in MyD. Pinto et al. (1987) recorded pattern-ERG's which were either 
absent or of low amplitude indicating a bipolar-ganglion cell layer dys-
function. The same author also found subnormal electro-oculography (EOG) 
indices using the dark trough method, indicating that the pigment epithelium 
must be somehow involved. EOG changes (36%) are probably less frequent 
than ERG changes (83%) in electrophysiological tests (Junge, 1966). To 
summarize, one may assume a pathological process that invariably affects both 
the retina (pigment-epithelium, bipolar-ganglion cell layer and rods in the 
peripheral retina), the photoreceptors and macula. 
Relevant histo-pathological studies are usually autopsy studies and do not 
exceed 3 patients each, (Manschot et al., 1968; Burns, 1969; Houber and Babel, 
1970; Betten 1971; Ginsberg, et al. 1978; Meyer et al., 1980), except the study 
of Sarks et al. (N=5) (1985). The reported findings are too variable and 
insufficient to give a consistent pattern of retinopathy. The common main 
changes are disorganization of the peripheral retina: scattered drusen, colloid 
deposits within a slightly thickened Bruch's membrane (Ginsberg et al., 1978) 
and cystic changes (Betten, 1971). In addition, diffuse variable atrophy of all 
retinal layers, pigment increase and hypertrophic pigment epithelium (Manschot, 
1968; Houber and Babel, 1970; Meyer et al., 1980) and variable loss of 
Table 3. Retinopathy and opticopathy m Myotome Dystrophy 
Abnormal.in. 
Concentric vis. fields 
Dark adaptation 
Fundoscopy 
- macula 
- retina 
ERG 
- photopic 
- scotopic 
EOG 
pVER 
Junge 
N = 52 
2/52 
31/36 
3/52 
6/52 
30/86# 
71/86# 
28/78# 
np 
Bunan-Burns 
N = 25 
7/22 
24/24 
6/14 
4/12 
? 
low b-2 
np 
np 
Pinto 
N = 14 
10/14 
np 
? 
? 
9/14 
3/14 
6/14 
11/12 
Hayasaka 
N = 15 
0/6 
0/6 
2/8 
8/15 
0/8 
1/8 
0/8 
np 
#: eyes 
np: not performed 
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photoreceptors were reported (Betten et al., 1971; Houber and Babel, 1970, 
Sarks et al., 1985). Perhaps this is specific for MyD when taking into account 
that hypertrophy of the pigment epithelium is peculiar for most other 
tapetoretinal degenerations (Houber and Babel, 1970). The study of Sarks et al. 
(1985) is the only study reporting EM findings of the retina. The main finding 
was an accumulation in the macular region of lipofucsin in large hyper-
pigmented cells in all 5 investigated MyD patients. 
The relationship to age or group, depending on the age of onset, is to be 
questioned. Only one longitudinal study has been reported, indicating that the 
retinopathy is progressive (Yoshihiro et al. 1993). The youngest patient de-
scribed with retinopathy was 10 years of age (Burian and Burns, 1967), while 
in larger series nearly all investigated individuals with MyD showed abnormal 
results. This opinion is shared by Harper (1989), who mentioned ERG as a po-
tential screening test. No correlation however can be found with age. To date 
no data exists for the retinal dysfunction in the separate age onset groups. 
2.2.4. Opttcal nerve neuropathy and the visual cortex 
Six early studies reported pallor of the discs by fundoscopy in MyD (Ortleb, 
1912; Hauptmann, 1918; Heine, 1925; Lohlein, 1914; Franchetti, 1963; Junge, 
1966). Junge (1966) concluded that clinical evidence for an optic neuropathy 
was exceptional (3/52). Furthermore, other signs suggesting an optical nerve 
neuropathy were negative. The visual fields were within the normal range, 
without central scotoma. Colour vision is usually normal, except for 
supersensitive tests like lOOHue, which are more related to retinal connections 
than optical dysfunction (Babel, 1981). In addition, the subclinical or sluggish 
pupil reactions may probably indicate a sphincter pupillae dysfunction rather 
than an optic nerve lesion (Thompson, 1964; Spaide et al.,1984; den Heyer et 
al.,1991). Therefore, clear clinical evidence of an optical nerve dysfunction or 
a lesion anywhere else in the visual pathways is lacking (Harper, 1989). 
Visual evoked potential studies (VEP), which are considered to be near field 
potentials of the visual cortex (Celesia, 1982, 1985), repeatedly revealed 
abnormalities. 
In approximately 60-92%, VEP recording in MyD showed a symmetrical 
prolongation of PlOO-latency or a decrease of amplitude, both of flash VEP 
(Kirkham et al., 1981) and pattern reversal VEP (Gott et al., 1983; Pinto et al., 
1987; Kerty and Ganes, 1989). This finding alone is aspecific, but suggests a 
disturbance of axones and myelin in the visual pathways. 
The VEP findings may indicate a bilateral prechiasmal abnormality of the 
visual pathways of unknown exact localization (Gott et al., 1983), but others 
suggested an abnormal functioning of the visual cortex (Kerty and Ganes, 
1989). An abnormality of the visual cortex is unlikely because no other 
arguments can be listed (Harper, 1989) and MRI studies show a normal 
morphology of the visual cortex (Damián et al., 1992). Junge (1966) suggested 
that optical nerve involvement might be interpreted as secondary atrophy of 
the optic nerves as a consequence of primary retinal degeneration. To date, no 
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certain relationship between ERG and VEP has been reported, except in one 
study by Sandrini (1986), who reported an inverse relationship of VEP latency 
and ERG b-wave amplitude. 
Pinto (1987) tried to clarify the question of prechiasmal or postchiasmal 
retinal dysfunction. He studied simultaneous recordings of pattern-ERG 
(pERG) and pattern reversal VEP (pVEP) and also found evidence of a 
dysfunction of the postretinal pathways (Pinto et al., 1987). 
Pathological abnormalities of optical nerves or visual cortex are not reported 
separately to be abnormal (Coers, 1952; Berthold, 1958; Bethlem, 1958; Refsum 
1966; Harper, 1989), except in cases with mental retardation, in which the 
gyral architecture may show minor abnormalities (Rosman and Kakulas, 1966). 
Is optical neuropathy related to age or the age of onset? VEP alterations may 
occur in mildly affected MyD patients (Gott et al., 1983). The youngest patient 
with a definite abnormal VEP was 27 years of age (Gott et al., 1983), whilst in 
some series (Kerty and Ganes, 1989) the percentage of abnormalities shows a 
trend towards an increase with age. The course of VEP changes are unknown. 
No specific studies for the age of onset groups are reported prior to the 
compilation of this document (1994). 
1.1.5. Low intraocular pressure 
Although in 1932 Granstrom had already suggested that ocular hypotonia 
(OH) may occur in MyD, the studies of Junge (1966) and Burian and Burns 
(1967) made it clear that the intraocular pressure is consistently low with 
minimal diurnal fluctuation. The latter authors found intraocular hypotension 
in nearly all· investigated (N=51 and 23) patients (84-100%). Junge (1966) 
found mean values approximating 8.8 mmHg (SD: 3) with a range of 2-15 
mmHg. Burian and Burns (1967) reported a mean ocular pressure of 10 mmHg 
(SD: 9). However, the broad overlap with the normal population (mean: 15.5, 
SD 2.5; 99% interval 10.5-21 mmHg) (Goldmann and Schmidt, 1958) appeared 
to limit the value of OH (pressure below 11 mmHg) as a sensitive sign for 
(early) diagnosis. 
Degeneration of the ciliary muscle in association with reduced aquaous 
secretion in the ciliary epithelium seems to be the likeliest cause for this 
phenomenon (Walker et al., 1982; Blanksma et al., 1983). 
In 1992 Ashizawa published the results of OH in asymptomatic gene 
carriers, mildly affected MyD patients (N=32) and 51 controls. An intra-ocular 
pressure of 11 mmHg or less was found in 35 eyes of 19 patients and 5 eyes 
of 3 'non-MyD patients'. In his study, OH was a rather indefinite (0.59) but 
highly specific (0.94) sign for MyD. 
What is the relationship between age and specific subgroups? The youngest 
patient reported with OH, was 11 years of age (Junge, 1966). Although data 
of longitudinal studies are lacking, the course seems progressive as may be 
concluded from the positive relation with age (Burian and Burns, 1967). 
Unfortunately Junge (1966) could not confirm this relationship. The course 
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itself is unknown. Particular studies for the separate age dependent subgroups 
have not been performed to date. 
1.1.6. Extra-ocular muscle dysfunction 
Patients with MyD seldom complain about diplopia and clinical neuro-
ophthalmological investigations rarely reveal abnormalities of eye movements 
except some degree of ptosis. Clinical studies (Burian and Burns, 1967; Dyken, 
1967; Ashizawa et al., 1992) mentioned some restriction of gaze in up to 50% 
of patients. Lessell et al. (1971) mentioned a single patient with external 
ophthalmoplegia. Nowadays the eye movements can be investigated more 
precisely by electro-oculography (EOG) or infra-red or magnetic coil studies. 
Extra-ocular myotonia was seldom noticed in EMG studies of the extra-ocular 
muscles (Davidson, 1961; Zauberman, 1969). 
Decreased maximum velocity of small and large amplitude saccades has 
been reported in a limited (N=3-10) series of patients (von Noorden, 1964; 
Baloh et al., 1975; Oohira et al., 1985), sometimes more pronounced for 
horizontal than for vertical eye movement (Emre and Henn, 1985). Other 
oculomotor changes include hypometric saccades and disturbances of smooth 
pursuit (von Noorden, 1964; Bollen et al., 1990, 1992). 
Electro-oculographic studies of eye movements in MyD have so far yielded 
conflicting interpretations as to the underlying pathophysiological mechanism. 
Some authors have suggested a central origin for the eye movement disorders 
(von Noorden, 1964; Burian and Burns, 1967; Lessell et al., 1971; Bollen et al., 
1991, 1992), while others have considered that they are caused by a more 
peripheral mechanism (Junge, 1966; Oohira et al., 1985). 
The extra-ocular muscles are histologically quite distinct from limb muscles. 
A small number of light-microscopic studies have been reported each 
involving less than 8 patients (de Jong, 1955; Bethlem, 1955; Davidson, 1961; 
Pendefunda et al., 1964; Junge, 1966; Houber and Babel, 1970; Ketelsen et al., 
1972). The common pattern was slightly atrophic muscle fibres, a mild diffuse 
increase in connective tissue and a diffuse increase in nuclei in the sarco-
lemma. The nuclei were seldom arranged in rows. One electron-microscopic 
study (Kuwabara and Lessell, 1976) revealed aspecific alterations similar to the 
changes of the peripheral muscles (Harper, 1989). Hoogenraad performed 
enzyme histochemical studies on one MyD patient. He found no abnormal 
results (Hoogenraad et al., 1979, 1982). Although the content of ragged red 
fibres is high in extra-ocular muscles, one author reported an excess of 20% 
(Isashiki et al., 1989). A reduced cytochrome-c-oxidase activity in both extra-
ocular muscles as well as skeletal muscles in 0.4-20% was found using enzyme 
histochemical techniques (Isahishi et al., 1989; Ono et al., 1986; Yamamoto et 
al., 1989). 
No relationship between eye movement disorders and age, duration of the 
disease or neuromuscular deficit, has been reported so far. The studies are too 
small and heterogenic to appoint the youngest patient with a certain 
oculomotor dysfunction. One may expect an early onset, based on frequent 
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strabismus found in children with MyD (Harper, 1989). No studies are 
confined to the age of onset related subgroups. 
2.1.7. Peri-ocular muscle dysfunction 
Bilateral ptosis is already recognized as a characteristic aspect of MyD and this 
was first published by Steinert (1909) and Batten and Gibb (1909). Its 
frequency is high (> 60%) (Burian and Burns, 1967; Harper, 1989; Ashizawa et 
al., 1992). The weakness of the vulnerably thin levator palpebrae muscle lies 
in the morphological substrate (de Jong, 1955). Even in infants, this sign may 
be positive and therefore is regarded as an 'early sign' (Junge, 1966). As to be 
expected, even in minimally affected patients, some degree of ptosis is present 
(Mathieu et al., 1992; Ashizawa et al., 1992). The course of ptosis is definitely 
progressive (Harper, 1989) and positively related to age. The ptosis can be 
corrected by lid elevating spectacles or surgical treatment. 
Weakness of the orbicular ocular muscles sometimes accompanied by 
myotonia, appears more frequently (Steinert, 1909; Ashizawa et al., 1992). The 
consequences of atrophy of the orbicularis oculi muscles include lagophthal-
mos, ectropion, eversion of the puncta lacrimalis, blepharoconjunctivitis and 
epiphora (Junge, 1966). Likewise, peri-ocular myotonia is early in onset, and 
has a low sensitivity (0.03) and high specificity (1.0) (Ashizawa, 1992). When 
testing weakness of the orbicularis oculi muscles in gene carriers and mildly 
affected patients manually, the same author found somewhat different 
numbers: sensitivity 0.61 and specificity 0.98. The course is definitely 
progressive, correlating with age (Harper, 1989). To date, no studies with 
regards to the peri-orbicular muscles and specific age dependent subgroups 
have been presented. 
1.1.8. Miscellaneous (other ophthalmological signs) 
Stern (1978) reported in 9/18 MyD patients focal and generalized abnorma-
lities of the iris vascular pattern on fluorescence angiography. Corneal lesions like 
keratoconjunctivitis sicca or corneal ulcers were described by Burian and 
Burns (1967) in 8/25 cases and by Junge (1966) in 6/52 patients. Furthermore, 
enophthalmus (18-50%) (Klein, 1958; Junge, 1966) may occur in MyD. The 18% 
of Junge is more probably due to the fact that he used an objective measure-
ment criterion (< 10.2 mm, Hertel value). Remaining ocular phenomena were 
lagophthalmus (2/52, Junge, 1966), ectropion (1/52, Junge, 1952) and frequent 
excessive lacrimation, which is perhaps a secondary phenomenon (Junge, 1966). 
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1.2. Neuro-otologie system 
Impairment of hearing is not a conspicuous complaint in patients with MyD 
and is not largely appreciated (Harper, 1989). In 1966, Kuhn and Eye first 
reported hearing loss with definite audiogram abnormalities as a frequent sign 
in affected adults. The frequency of hearing loss is approximately 25-35% 
(Kuhn and Eye, 1966; Wright et al., 1988). Usually the audiogram reveals a 
progressive loss in high and medium frequency hearing both in children 
(O'Brien and Harper, 1984) and in adults (Wright et al., 1988). The study of 
Wright et al. (1988), is the most complete, demonstrating that in 17 out of 25 
adults, a mostly bilateral (13/17) sensorineural (14/17) hearing loss, was 
profound in ten cases. The absence of complaints in patients was remarkable, 
indicating a gradual onset. Wright (1988) also performed brain auditive 
evoked potentials (BAEP) studies and MRI studies of the 8th nerve. BAEP 
results were abnormal in 3 out of 5 cases, (two were normal, two displayed 
severe peripheral hearing loss and the last one showed bilateral delayed peak 
V latency). MRI failed to reveal any acoustic nerve abnormalities. Wright 
states that in particular adult MyD patients have a much greater chance of 
developing a serious hearing loss. Unfortunately no correlations to the onset 
and severity of muscular symptoms were reported. In the same study 
tympanic membrane mobility was also found to be reduced in about 30% of 
the patients (Wright et al., 1988). 
Two explanations can be given for hearing loss in MyD. In the congenital 
group Harper and O'Brien (1984) discovered hearing loss in 10 out of 46 
patients as a consequence of otitis media. The high frequency of otitis media 
in childhood cases is probably causally related to the presence of weakness of 
the facial and palatal muscles and secondary bony deformation of the skull 
(O'Brien and Harper, 1984). Secondly a dysfunction of the cochlea or cochlear 
nerve - not visualized on MRI -, as a result of the underlying membrane 
dysfunction in MyD, is likely in the adult onset group (Kuhn and Ey, 1966; 
Wright, 1988). 
Vertigo is an exceptional symptom in MyD and probably unrelated to 
processes causing hearing loss. BAEP abnormalities are common (30-53%) 
(Thompson, 1983; Ragazzoni et al., 1991), also indicating that the auditory 
pathways must be frequently involved. The BAEP findings are heterogenic 
with variable peak I, III and V latencies and sometimes show prolonged 
central conduction, represented by prolongation of III-V interpeak latencies. 
Functional abnormalities in the central acoustic pathways have been reported 
in small studies of adult cases. This may be concluded both from BAEP results 
(Zakrisson and Blom, 1982, Yamane and Nomura, 1984; Thompson, 1983; 
Zeithofer et al., 1986; Wright et al., 1988; Ragazzoni et al., 1991) and from 
delayed stapedius relaxation (Kuhn, 1966). In addition, the acoustic processing 
of (long latency) BAEP is also deranged (Perini et al., 1989; Ragazzoni et al., 
1991). 
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When summarizing, one may assume that sensorineural hearing loss appears 
to be caused simultaneously on a peripheral and central level, although rarely 
giving rise to symptoms. 
Morphological studies (Bethlem, 1958; Harper, 1989), pay no specific 
attention to changes of the acoustic/vestibular apparatus. Brainstem 
morphological studies did not reveal abnormalities (Coers, 1952; Berthold, 
1958; Rosman and Kalukas, 1966, Refsum, 1966). 
Except in the studies of O'Brien (1984) - concerning congenital onset patients 
- and Wright (1987) - concerning adult onset patients, no other correlations 
are known with regards to the relationship to the age of onset or age 
dependent subgroups. 
1.3. Peri-oral and bulbar weakness 
1.3.1. Peri-oral muscles 
Facial weakness (levator palpebrae, orbicularis oculi and mimic muscles in 
cheeks, chin and perioral region) has been recognized as a common feature 
since the earliest descriptions of MyD (Batten and Gibb, 1909; Steinert, 1909). 
In earlier stages of the disease, myotonic symptoms predominantly in the 
facial muscles, may cause eyelid spasm, stiffness or slowness of the tongue 
and jaw muscles (dysphagia, dysarthria) (Harper, 1989). More frequently, 
subclinical facial myotonia verified by EMG occurs (Polgar et al., 1972, Bundy 
et al., 1972, 1974; Streib et al., 1987; Mettler et al., 1990). The distribution of 
facial myotonia was studied by EMG by Streib (1983). In particular, he found 
myotonic discharges in the orbicularis oris (95% abnormal results found in 25 
MyD patients) but less frequently in the masseter muscles (52%) or sterno-
cleisomastoids (50%). Myotonia correlated positively (R=0.62) with the severity 
of muscle weakness (Streib et al., 1983). At a later stage a progressive 
weakness and atrophy of facial muscles occurs. To illustrate this, Harper 
(1989) presented four successive pictures of the same patient at the ages of 17, 
30, 44 and 56 years. The pattern of facial muscle weakness in MyD is 
characteristic, imparting a peculiar appearance of the individuals affected. 
Terms such as 'facies myopathica', 'hatched face', 'lugubrious', and 'hollowed 
out' have all been used to describe the facial appearance in MyD. 
In the initial stage of the adult type disease, the facial abnormalities are mild 
and not as marked as in facio-scapulo-humeral (FSH) dystrophy or in 
neurogenic facial palsies. In the congenital form (Harper, 1989), facial 
weakness is more pronounced and as a result of the weakness and mal-
development of the jaws and a triangular deformation of the mouth or 'shark' 
mouth is nearly pathognomonic. 
Quantitative assessments of facial function have rarely been reported. Only 
Pryse Philips et al. (1982) clinometrically studied the rest position of the facial 
muscles, including the perioral, using photographs. 
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Morphological investigation of the perioral muscles revealed similar chronic 
myopathic abnormalities as did the limb muscles (Thomasen, 1948). 
The rather typical myopathic facies with gaping expression can be recog-
nized from early adulthood onwards (Steinert, 1909; Thomasen, 1948). A 
positive relationship with age must be presumed, although longitudinal 
studies fail (Harper, 1989). No studies involving peri-oral muscles in the age 
of onset dependent subgroups are reported. 
1.3.2. Swallowing 
Upper gastro-intestinal motility disturbances are most common and cause 
considerable morbidity in MyD (Chiù et al.,1962). Swallowing difficulties are 
almost a constant feature of MyD (prevalence: 60-80%) (Harper, 1989). In 
general, dysphagia is more pronounced in solids than in liquids (Horowitz et 
al.,1987b). It is peculiar why major swallowing abnormalities occur whilst 
there is a complete absence of complaints (Swick et al.,1981; Horowitz et 
al.,1987b). Whilst in moderate phases, dysphagia may already be present 
(Bosma and Brodie, 1969), in many cases, a life threatening aspiration is the 
first presentation of the swallowing disorder. 
Barium-contrast and manometry studies showed evidence of a variable 
weakness of oesophageal contractions and diminished upper oesophageal 
sphincter pressure, with normal sphincter relaxation (Swick et al., 1981; 
Eckhart et al., 1986; Siciliano et al., 1990). In addition, stomach emptying is 
delayed (Horowitz, 1987b) and small intestine motility is reduced (Nowak et 
al., 1984). Harper (1989) considered retention of food in the pharynx and 
pooling in the vallicula as the most constant finding. Motility of gastric 
emptying can be ameliorated by drugs (Horowitz et al., 1987 a,b). 
In moderate phases, it is probably myotonia and in more severe phases 
oesophageal weakness that are mainly responsible for dysphagia (Bosma and 
Brodie, 1969). One quantitative assessment of swallowing has been reported 
using a videofluoroscopy (VDF) Barium technique (Johnson and McKenzie, 
1993). These authors recorded in 12 MyD patients (aged 16-36 years) the 
kinematic pharyngeal transit times. The results of VDF do not completely 
reflect the severity of the swallowing problem in MyD patients, especially in 
MyD patients with a longer disease duration (more than 15 years). In 4 
patients, the VDF underestimated for unknown reasons the swallowing 
disorder. 
Morphology is not essentially different from the limb muscles (Pruzanski et 
al., 1967; Nowak et al., 1982). As regards dysphagia, the striated muscles in the 
upper one third of the oesophagus are more involved in the disease process 
than the smooth muscles (Eckhart et al, 1986). 
The relationship of swallowing with age, limb muscle weakness or the age 
of onset dependent subgroups is uncertain. No clear relationship has ever 
been reported with age. From adulthood onwards, dysphagia may occur 
(Pettengell, 1985). The course is assumed to be progressive but longitudinal 
studies have not been reported. The lack of correlation between subjective and 
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objective dysphagia makes historical comparisons unreliable (Swick et al, 
1981). The assessments of severity of dysphagia seem unrelated to the severity 
of limb muscle weakness (Horowitz et al, 1987a). No selective studies have 
been reported which were restricted to the age of onset groups. 
Thus, sudden aspiration or postoperative aspiration remains an unpredic-
table and serious complication during the course of the disease, which may 
even occur in moderately affected patients (Bosma and Brodie, 1969). 
1.3.3. Speech 
The speech disorder present in the majority of patients is rather specific. 
Steinert (1909) and Batten and Gibb (1909) were the first to notice a speech 
abnormality in MyD. Thomasen (1948) described it as follows: 'the speech 
disorder is characteristic; in almost all cases it is very rapid, not to say 
gabbling; the voice is monotonous, sometimes hoarse, weak and nasal'. 
The sporadic studies regarding speech in MyD are anecdotal, small, 
qualitative and usually lack control groups (Nonne, 1905; Siemerling, 1905; 
Batten and Gibb, 1909; Steinert, 1909; Thomasen, 1948; Rouques, 1931; 
Thomasen, 1948; Caughy and Myranthopoulos, 1963; Maniecka, 1969; Calvet 
et al., 1970). As a consequence of the facio-bulbar weakness, these studies 
commonly report a pattern of flaccid dysarthria. No circumscript speech 
dysfunction can be derived from these reports. In any case, from the literature 
it is unclear which physiological mechanisms are underlying. Also the clinical 
descriptions do not assess a concomitant disorder of speech programming 
(apraxia of speech). 
Only two studies are quantitative, showing some phonatory instability. 
Calvet (1970) reported quantitative findings about the voices of 2 MyD 
patients. He requested that the patients produce a sustained vowel / a / . The 
only abnormal finding was a 'higher voice fundamental frequency' (the 
number of vocal folds vibratory cycles per second) in both patients. Ramig's 
(1988) quantitative study is the most extensive. He studied 6 patients with 
MyD. Their voices were recorded on tape and analyzed. This author also 
studied the 'maximum sound prolongation' (MSP) of the vowels / a / , / i / and 
/ u / . The major quantitative result was that the MyD patients had a cycle to 
cycle variation ('jitter'), three times greater in the period of the acoustic output 
pressure during MSP than controls. 
Ramig suggested that the myopathic or myotonic changes of the laryngeal 
muscles are responsible for these periodic variations of speech. The cor-
relations between speech and bulbar muscle-groups or a possible coexistent 
dyspraxia of speech remain to be established. 
Dystrophic morphological changes in the pharynx, larynx, velum palatinum 
are reported which do not essentially differ from the chronic myopathic 
changes in the limb muscles (Albrecht, 1920; Thomasen, 1948). Morphological 
investigations of the brainstem did not reveal any major abnormalities (see 
chapter on neuro-otology) and the primary speech areas are usually spared on 
MRI (Huber et al., 1989; Damián et al, 1992). 
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Up to the time of this writing (1994), no certain correlation between speech 
and age has been demonstrated. From early adulthood onwards, a nasal or 
slurred speech may occur (Steinert, 1909; Maniecka, 1969; Ramig, 1980). 
Although longitudinal studies are lacking, most authors agree that the flaccid 
dysarthric speech becomes progressively worse (Thomasen, 1948; Myrantho-
poulos and Caughy, 1963; Harper, 1989). To our knowledge specific studies 
dividing the population into age of onset subgroups have not been performed. 
1.6. Mental impairment 
2.6.1. Historical perspective 
Abnormalities in the intellectual functions in adults with MyD have been 
recognized since the early publications regarding MyD (Bramwell and Addis, 
1913; Adie and Greenfield, 1923; Maas and Paterson, 1937). High percentages 
(35-65%) of intellectual dysfunction were noted in large survey studies 
(Thomasen, 1948; de Jong, 1955; Klein, 1955; Höweler, 1986). In his study of 
101 cases, Thomasen (1948) found 36% of his population had a 'considerable 
degree' of intellectual involvement, 41% were 'somewhat' impaired and only 
24% were considered to be clinically normal. 
It is difficult to define this mental impairment in clinical terms. Additionally, 
in the majority of the early clinical studies regarding cerebral involvement, 
intellectual, personality and psychiatric symptoms, these were intermingled. 
Caughy (1963) reviewed the changes in mental state and described, in 
agreement with Thomasen (1948), three different types: more or less 
pronounced intellectual deterioration, considerably reduced initiative and a 
carefree temperament. In his series, fatigue and adynamia are prominent 
symptoms. Daytime somnolence is often present and gives the impression of 
apathy. Furthermore social deterioration is a feature in families afflicted by 
this disorder (Thomasen, 1948). In spite of the physical and mental disability, 
patients exhibit a carefree temperament as illustrated by Maas and Paterson 
(1937): 'they are generally satisfied and cheerful and do not easily get angry.' 
This point of view has been shared by many others, including Harper (1979, 
1989). 
In order to clarify the spectrum of intellectual dysfunction several stan-
dardized neuro-psychological studies have been performed since 1980 (see 
further on). Apart from the great variability of methods and results, most 
studies had visuo-spatial and visuo-constructive dysfunction in common. 
Unfortunately, to date, no close matching with the clinical type has been 
reached but in general the earlier the onset, the more severe the neuro-
psychological abnormality (Thomasen, 1948; Dyken and Harper, 1973). In 
recent years, correlative studies with advanced imaging methods (MRI, 
SPECT, PET) have been performed. So far neuro-psychological studies in 
relation to genetically defined patients groups have not been performed. 
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2.6.2. Clinical description 
The clinical presentation of intellectual involvement is quite variable and is 
difficult to interpret. Thomasen's (1948) description is perhaps most accurate 
but concerned the picture of a full blown mental impairment: 'the reduced 
initiative is often misinterpreted as laziness and disinterest; they are easily 
overcome by sleep and the reduced initiative is parallel with intellectual 
deterioration; a remarkable indolence, carelessness and contentness which 
glaringly contrasted with the physical incapacity; they think they manage 
excellently which causes conflicts with healthy family members'. This 
description however, rather outlines a patient with longstanding disease than 
the average patient. 
Caughey's impression (1963) may illustrate this attitude: 'While in the 
country in search of a certain "myotonic" home, it was often possible to 
identify a residence by its neglected appearance, the obvious need of repairs, 
the unkempt yard and garden choked with overgrown grass and weeds, 
which provided a vivid contrast with the surrounding well-kept homes'. 
2.6.3. N euro-psychological studies 
A number of neuro-psychological studies have been performed in order to 
define a certain pattern of the cognitive impairment. Another question, is, 
what is the relationship between a functional alteration and the reported 
cerebral abnormalities? A selection of the most important reports will be 
discussed in chronological order highlighting the main aspects. Details can be 
found in Table 4. 
Dyken and Harper (1973) split up their population of MyD patients and found 
a difference in IQ between the separate groups depending upon the age of 
onset. In total 29 MyD patients were investigated, among whom 19 patients 
with congenital MyD (mean full scale IQ: 71), 10 patients with the adult onset 
type (mean IQ: 100) and 8 unaffected parents (mean IQ: 107). 
Woodward et al. (1982) studied the neuro-psychological features of 17 MyD 
patients choosen at random, who were attending a neuromuscular clinic and 
compared the results with 25 controls. They found moderate overall 
intellectual impairment in the patient group with a mean full scale IQ of 95 
and none in the retarded range. The mean IQ of the control group was 
significantly higher: 112. No correlation could be found between mental 
impairment and severity of muscular symptoms. 
Bird et al. (1983) included 29 patients and studied the cognitive and 
personality functions in MyD. The mean full scale IQ was 90 and 6 individuals 
were in the retarded range. All the MyD patients were grouped together and 
a control group was missing. The weakest cognitive abilities were immediate 
recall, abstraction, spatial manipulation and orientation. Overall, 32% of the 
patients had prominent personality disturbances; a figure that is not 
excessively high in a population with such physical, social and mental 
problems. 
17 
Chapter 1 
Portwood et al. (1986) performed a pilot study with 43 MyD patients in order 
to solve the relationship between cognitive dysfunction and maternal or 
parental inheritance. The mean full scale IQ was 87 for the MyD population. 
At least 3 patients had to be classified as retarded and no control group had 
been used. Psychological results were similar to the previous studies. The 
most important finding, was that there is, no significant difference in mental 
performance for maternal or paternal inheritance pattern. 
Stuss et al. (1987) gathered 19 MyD patients (12 with early onset and 7 with 
late onset) from the Childrens Hospital with a mean full scale IQ of 87 and 
compared the results with a same number of controls matched for IQ and 
education. Among the patients 2 were retarded. The leading question was 
whether MyD could be listed as a subcortical 'dementia'. 
Firstly, I would like to expatiate on subcortical dementia. This is character­
ized by a marked psychosocial incompetence associated with minimal memory 
loss and as a rule, absence of aphasia, apraxia or agnosia. Characteristic 
symptoms include forgetfulness, slowing of the thought processes, mild 
intellectual impairment, apathy, inertia, depression and the inability to 
manipulate knowledge. Difficulties in problem solving and abnormalities of 
judgement and insight may occur (Cummings et al., 1984; Dunne, 1993). 
Neuro-psychologically, the patients of Stuss performed at a low average 
level. Visual perceptual and visual constructive abilities were impaired. Stuss 
stressed that age of onset was related to poor test performance. No arguments 
could be supplied by Stuss et al. to presume a subcortical 'dementia'. 
Huber et al. (1989) examined 41 MyD patients using neuro-psychological 
procedures and MRI. The mean full scale IQ was 87 for both patients and 16 
controls. No differentiation was made between clinical subtypes. Ten patients 
had severe intellectual impairment. Problems with calculation (mini mental 
state examination), fluency, digit-span and visuo-spatial functions were the 
most pronounced. Depression was more frequent in the patient group. No 
relationship could be found between intellectual functions and neuromuscular 
deficit or sex. Furthermore, there was a correlation between maternal 
inheritance and a more severe intellectual dysfunction. Huber confirmed the 
findings of Stuss (1987) showing a relationship between an earlier onset and 
a more severe mental impairment. On MRI, focal white matter lesions and 
temporal lobe abnormalities were significantly more common in patients with 
severely disturbed intellect. 
Perniiti et al (1989) performed a controlled study with 27 patients (mean full 
scale IQ: 87), amongst whom, 4 were in the retarded range. Their aim was to 
detect a relationship between cognitive dysfunction and electrophysiological 
measures. In approximately 50% of the patients, a significant global impair­
ment of cognitive functioning was found. The event-related auditory evoked 
potentials, (50% low and 50% absent РЗОО-amplitude, whilst latency was 
normal), correlated with the intellectual impairment. 
Censori et al. (1990) studied the general neuro-psychological profile in MyD. 
They included 20 MyD patients and 20 age and education matched controls 
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in their study. IQ was not reported separately. No division into subtypes was 
accomplished. This study is complete and claims to outline a general pattern. 
In general, intellectual function has globally decreased and most test results 
have scores in the lower quadrant of normal. The cognitive dysfunction 
pattern found in this study is suggestive of a 'right hemisphere impairment': 
visuo-spatial and constructional disabilities prevail (up to 50%), often 
associated with 'frontal lobe' dysfunction (verbal fluency/Wisconsin Cart 
Sorting Test), compounded by alterations in memory and language in the 
more severe cases. 
Malloy et al. (1990) investigated the course of the disease in 20 MyD patients 
(mean full scale IQ: 85; mean age: 40 years) and compared the results with age 
and IQ matched controls. No clinical subgroups were studied. This group of 
authors concluded that the motor deficits may progress but the cognitive 
deficits are mainly developmental and rather stable. 
Franzese et al. (1991) performed an uncontrolled study with 28 MyD patients 
(mean full scale IQ: 105). This study alone, included the age of onset as a 
selection criterium. In all cases, the disease began in early adulthood or in 
adult life and the disease duration varied significantly from 2-40 years. The 
average profile showed a marked deficit on digit span subtest and milder 
deficits in arythmie, picture arrangement and block design. Only 7% of the 
patients showed low intelligence with deterioration of the perceptual-motor 
functions. 
Chang et al (1993) studied the cerebral abnormalities in MyD. In a controlled 
study (N=22), they performed psychological tests and cerebral bloodflow 
studies (quantitative MRI, 133-Xenon and SPECT). The mean full scale IQ's of 
the (early) adult onset MyD patients was 87 (SD: 18). Both visual perception 
and visual construction were significantly different from age-matched controls. 
A reduced cerebral perfusion was most severe in the frontal and temporo-
parietal association cortex and correlated with IQ and perhaps with earlier 
onset. 
Summerizing these neuro-psychological studies, some conclusions can be 
drawn. The IQ of the MyD patients in most studies was below average (IQ= 
100) and the IQ of maternally inherited disease was lower than that of 
paternally inherited disease. In most studies a differentiation for the age of 
onset was not made. The cognitive impairment is highly variable and probably 
differs per age of onset group: most severe in the congenital and early adult 
onset group and lacking in the mild (or senile) group of MyD. As the mental 
impairment may be progressive as is the muscular disorder, it is remarkable 
that the duration of the disease has been mentioned separately. This may also 
account for the wide range of IQ's (87-110) found. As most prominent 
cognitive impairment, inability to perform visuo-spatial and visuo-constructive 
tasks has been reported (Table 4). A purer pattern of mental impairment might 
have been outlined if clinically, more homogenous groups would have been 
studied and if a uniform method of testing would have been used. In 
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addition, the question remains unresolved as to whether non-retarded patients 
already have any mild cognitive deficit(s) at the onset of the disease. 
2.6.4. Additional cerebral investigations 
Nowadays, most authors consider functional and structural cerebral abnormal-
ities as a variable and disease-related feature of MyD (Harper, 1989). 
1.6.4.1. Neuro-physiological studies of the central nervous system in MyD. Diffuse 
abnormal neuronal function may be derived from the results of EEG and event 
related potential-studies. EEG recordings showed an excess of theta and delta 
wave activity and sharp focal wave discharges (Barwick et al., 1965; Op de 
Coul and Kortbeek, 1967; Lundervold, 1969). Small studies (6-27 patients), 
with regards to the auditory event related potentials (ERP) showed either 
absence or delay of peak N2 and P3, despite a correct tone-discrimination 
(Raggazoni et al., 1991). Nevertheless, the amplitude of P3 was sometimes 
reduced or absent (Perini et al., 1989). These abnormalities in auditive ERP's 
indicate global mental impairment (Perini et al., 1989). 
Anecdotal evidence can be gathered for a functional abnormality of the 
brainstem. However, the BAEP and SSEP findings, the missing late response 
(R-2) of the blink-reflex in the majority of MyD patients, supported such an 
assumption (Messina et al., 1976). 
1.6.4.2. Neuro-radiological evidence for central nervous system involvement. Some 
authors found dilatation of the (cerebral) ventricles as an explanation for the 
mental decline. Serial pneumo-encephalographic findings were indicative of 
a progressive diffuse cortical atrophy (Refsum, 1961, 1967) but were not 
accompanied by specific neuro-psychological data. Walker (1984) and Avrahmi 
(1987) confirmed the dilatation of the ventricles and cerebral atrophy on CT 
studies. However, Walker et al. (1984) were unable to reproduce the findings 
of Refsum (1967) when it became clear that ventricular size did not correlate 
either to age or mental impairment. To summarize, a progressive hydroceph-
alus is unlikely to cause the mental changes. 
Cerebral MRI showed abnormalities of up to 70% in cases of MyD. Most of 
these abnormalities are aspecific except global atrophy, ventriculomegaly, 
periventricular hyperintensity and focal white matter lesions. These bilateral 
non-specific focal white matter lesions can be characterized as high signal 
lesions in the anterior-medial temporal region (Glantz et al., 1988; Huber et al, 
1989) or fronto-(temporo)-parietal regions (Damián et al., 1993), with similar 
symptoms as in demyelinating disorders (Huber et al., 1989). The most 
important reports regarding MRI abnormalities will be outlined in the 
following paragraphs. 
Huber et al. (1989) compared the neuro-psychological and MRI findings in 
a population of 41 MyD patients (mean full scale IQ: 87, mean age 38 year, 
24% retarded). This group demonstrated that the MRI findings (focal white 
matter lesions, global atrophy and temporal lobe lesions) correlated to the 
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severity of mental dysfunction. In particular, the FWL's showed a significant 
correlation to the severity of a crude rating for intellectual status. Magnetic 
resonance findings in this study indicated that, while the focal cerebral 
atrophy was not related to severity of intellectual impairment, skull thickness, 
focal white matter degeneration and temporal lobe abnormalities were 
significantly more common in MyD patients with severely disturbed intellect. 
Damián et al. (1992) performed a transversal MRI-study on cerebral white 
matter lesions and crude neuro-psychological ratings. The authors studied 25 
patients (IQ unknown, mean age 36 years, of whom 20% were retarded) with 
a disease duration of 0-24 years. MRI findings indicated cerebral atrophy in 
the majority (81% of whom 36% were severe) and bilateral large focal white 
matter lesions (68%) in the fronto-(temporo)-parietal regions. Even excluding 
patients with mental retardation, intellectual impairment correlated to cerebral 
atrophy and focal white matter lesions. Furthermore, the occurrence of focal 
white matter lesions were more commonly seen in early onset cases with 
maternal inheritance. A remarkable finding was that 9 out of 11 patients with 
a duration of at least 10 years, showed multiple focal white matter lesions, 
whilst in the group with a duration of less than 10 years, only in 2 out of 10 
patients could such focal white matter lesions be demonstrated. An earlier 
onset and longer disease duration thus appears to be related with increasing 
number and volume of focal white matter lesions. The MRI findings provide 
an argument for slow progression of the cerebral alterations in MyD. 
In contrast, Chang et al. (1993) performed neuro-psychological tests and 
quantitative MRI investigations in 22 childhood and adult onset cases of MyD 
(full scale IQ: 87, mean age of 37 years, mean duration of disease 14 years and 
an unknown percentage of retarded patients). Except for small bright T2-signal 
areas in the regions of the inferior and medial temporal cortex, no FWL's were 
reported. These changes were interpreted as volume averaging effects of the 
adjacent cisternal spaces secondary to mild atrophy in the temporal lobes. 
Chang et al. (1993) studied the same group of 22 MyD patients, using 133-
Xenon. The patients with MyD, had significantly lower regional cerebral 
bloodflow (rCBF) (mean 38.9 + / - 7.6 ml/100 g per minute) than controls 
(mean 50.9 + / - 3.3 ml/100g per minute). The lowest values (33.2 + / - 6.5 
ml/100g per minute) were found in the temporal regions and to a lesser 
extent in the frontal regions. 
Single Photon Emission Computerized Tomography (SPECT), using 99mTc 
HMPAO, was also studied by Chang et al. (1993). The HMPAO uptake was 
abnormal in all 22 early adult and adult onset MyD patients. In twelve of 
them, a bilateral hypo-perfusion was found temporo-parietally. Sixteen 
patients showed a decreased uptake in the fronto-temporal regions. The 
patients with maternal inheritance (or early adult onset) showed a global 
hypo-perfusion and those with paternal inheritance (or adult onset), a more 
temporo-parietal and frontal hypo-perfusion. 
Fluoro-deoxy glucose (FDG) PET scan studies gave a somewhat different, 
but not contradictory view. 
22 
Review of Literature 
Fiorelli et al. (1992) studied the cerebral glucose utilization in 11 adult MyD 
patients (IQ unknown, mean age of 35 years). Concomitant brain diseases 
were ruled out by MRI, with MRI only showing minimal to moderate cortical 
atrophy. The FDG-PET scan results showed a 20% decrease of cortical glucose 
utilization and a reduction of glucose delivery to the brain. In addition, there 
was a large overlap between the metabolic rate of patients and controls. Due 
to the fact that neuro-psychological studies were omitted in that investigation, 
a link between cognitive dysfunction and PET scan data is absent. Notabally, 
some clinically symptom-free gene carriers had the highest metabolic rate of 
the entire group. A diffuse cortical glucose metabolism cannot rule out a 
subcortical origin. 
Mielke et al. (1993) studied the cognitive functions and FDG-PET scan in 3 
mentally impaired MyD patients. Two patients (age 42 and 50 years), had their 
onset in childhood and one in adulthood (age 59 years). All patients fulfilled 
the criteria of DSM-III for organic psychosyndrome but without evidence for 
'dementia'. Mielke and allies found on FDG PET, not only a diffuse cortical 
and subcortical dysfunction but also a preferential decrease in both frontal 
regions and lentiform nuclei. 
Summarizing the neuro-radiological studies several conclusions may be 
drawn. The localized MRI findings are variable but related to cognitive 
impairment. In particular, the bilateral fronto-(temporo)-parietal and anterior 
medial temporal focal white matter lesions appear to be unique for MyD and 
to correlate to the severity of mental impairment (Huber et al., 1989). 
Furthermore, the focal white matter lesions correlate to disease duration, 
indicating a progressive course (Damián et al., 1992). Other evidence for a 
frontal and subcortical abnormality is supplied by the FDG-PET scan study of 
Mielke et al. (1993). The 99mTc HMPAO SPECT- and 133-Xenon studies 
(Chang et al., 1993) correspond rather well with the (fronto) parieto-temporal 
lesions on MRI. Taken together, most neuro-radiological studies appear to 
indicate the existence of widespread and variable bilateral lesions in the 
fronto-parieto-temporal regions. 
1.6.5. Sleep disturbances 
In MyD, excessive daytime sleepiness (EDS) is a common sign (Thomasen, 
1948; Harper, 1989), despite a sleep duration of sometimes more than 10 hours 
a night (Harper, 1989). The quality of sleep may be reduced due to nocturnal 
hypoventilation. The latter is thought to be caused by a combination of a 
weakness induced obstructive (Broughton et al., 1990) and a central sleep 
apnoea syndrome (van Hilten et al., 1993; van der Meché et al., in press). For 
a relation between sleep and cognitive dysfunction see chapter 1.6.9. 
Two recent reports with regards to sleep will be described more extensively. 
Hilten et al. (1993) studied 10 patients with EDS. The main finding was a 
prolonged mean cycle duration and decreased stability of NREM/REM cycle. 
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These findings suggest that EDS in MyD, reflects a complex and widespread 
malfunction of the circadian and ultradian timing system. 
Van der Meché et al. (in press) studied 22 MyD patients. Seventeen of them 
complained about EDS, resembling 'ideopathic hypersomnolence'. A sleep 
apnoea syndrome may have contributed to only 3 out of 17 patients. 
Therefore, the authors suggested that EDS is due to a dysfunction in central 
sleep regulation and not disturbed nocturnal breathing. 
Thus, the hypersomnolence during the day must be regarded as a predomi-
nant dysfunction of the central sleep regulation with unknown localization 
(van Hilten et al., 1993; van der Meché et al., in press). The positive effects of 
Ritalin on vigilance, support the assumption of such a central component (van 
der Meché, 1986). It is speculative to localize the disturbance of central sleep 
regulation in MyD in the thalamic regions (van Hilten et al., 1993). Two 
reports support this hypothesis. First, Lugaresi (1986) described a fatal familial 
insomnia syndrome (Lugaresi et al., 1986) with primarily, involvement of 
anterior and dorsomedial thalamic nuclei; peculiarly, in the same thalamic 
areas in MyD, inclusion bodies were found by Culebras et al. (1973). 
1.6.6. Morphological studies of the central nervous system 
Older morphological studies did not reveal major cerebral abnormalities or 
have provided little detail on microscopy of the brain (Coers, 1952; Berthold, 
1958; Refsum, 1966). However, Rosman and Kalukas et al. (1966) found in all 
3 (congenital) mentally retarded patients, of whom, one had alveolar hypoven-
tilation, reduced weight of the brain, minimal changes in the gyral architecture 
and disordered cellular arrangement in the subcortical white matter. 
Culebras et al. (1973) and Wisniewski et al. (1975) reported, in 6 patients, an 
excess of eosinophilic inclusion bodies in 10-30% of the thalamic neurons 
which can also be found in less than 1% of non-diseased elderly brains. Other 
studies confirmed these findings (Pena et al., 1980; Ono et al., 1987). Ono 
(1987) also reported inclusions outside the thalamus, localized in the cerebral 
cortex, caudate nucleus and putamen. 
Neuro-fibrillairy changes, similar to those as in Alzheimer's disease, have 
been reported all over the brain in MyD, in particular in the parahippocampal 
region and remaining (para)limbic system (Sarai et al., 1969; Mitake et al., 
1987; Kuroda et al., 1988; Yoshimura et al., 1990; Kiuchi et al., 1991). The most 
important of these studies will be discussed. 
Massive neurofibrillary changes in the parahippocampus and several 
structures of the limbic system and basal forebrain nuclei were reported in 
two siblings by Kuroda (1988). 
Yoshimura et al. (1990) studied the topographical distribution of neuro-
fibrillary changes in a 61 year old adult onset patient with obvious mental 
impairment and a disease duration of more than 30 years. He found bilateral 
involvement of the parahippocampus, hippocampus, amigdaloid nucleus, 
fusiform gyrus, insula, olfactory bulb and many changes in the nucleus basalis 
of Meynert, inferior temporal gyrus, hypothalamus and brain stem and a few 
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changes in the cingulate, frontal and temporal gyn, neostriatum and 
mammillary bodies Yoshimura's study (1990) stated that the significance of 
thalamic inclusions in previous studies (see above) was overestimated 
2 6 7 Relation to the duration of disease 
A mental impairment may be the first symptom of MyD (Howeler, 1986, 
Harper, 1989) in a minority of patients The controlled transversal study of 
Malloy (1990) suggested a rather stable cognitive dysfunction, related to age, 
but not progressive, in contrast with the clinical impression Contrastingly, the 
transversal study of Damián (1992) provides evidence of progression in 
confluent bilateral white matter lesions corresponding with disease duration 
Only one clinical longitudinal study (Bird et a l , 1983) has been reported which 
mentioned no decline in mental function after a follow up of 11 and 19 years 
m five individuals with MyD 
16 8 Relation to the age of onset 
Howeler (1986) confirmed the findings of Dyken and Harper (1973), that the 
severity of the mental disorder correlates to the age of onset groups Howeler 
found mental alterations in all the congenital cases studied, in half of the early 
onset group but not in the senile onset or mild group These findings are in 
agreement with other previous studies (Thomasen, 1948, Harper, 1975) 
Maternal inheritance was also related to a more severe mental retardation, 
probably because all congenital onset patients have maternally transmitted 
disease (Harper, 1989, Huber, 1989) For the adult onset form this is uncertain 
(Franzese et al , 1991) 
Another author who studied a circumscribed adult onset group is Franzese 
(1991) He found an intellectual dysfunction in only 7% which in particular, 
consists of an abnormality in the 'digit span' subset of the WAIS, besides a 
disturbance of spatial functions and calculation 
Yoshimura (1990) studied the morphological alteration in a single 61 year 
old adult onset patient with a disease duration of more than 30 years He 
found clinical evidence for intellectual impairment and found an excess of 
Alzheimers's neurofibrillary changes scattered m the brain (see chapter 16 6) 
2 6 9 Relation to sleep disturbances 
It is known that patients with respiratory disturbances may exhibit global 
neuro-psychological deficits (Greenberg et a l , 1987) In MyD, excessive 
daytime sleepiness (EDS) is a common sign (see chapter 16 5) 
Broughton (1990) studied the relation of neuro-psychological deficits and 
sleep disorder There was no correlation in this study between cognitive deficit 
and degree of sleep fragmentation Both the neuro-psychological deficit and 
the EDS probably represent CNS lesions independent from one another 
In conclusion, the relationship of psychological dysfunction and cerebral 
abnormalities remains obscure The cluster of neuro-psychological dysfunction 
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as described by Censori et al. (1990) suggests a 'right-hemisphere' dysfunction 
but the bilateral MRI, SPECT and PET scan findings are contradictory, with 
regards to lateralization and localization. Despite no unequivocal neuro-
psychological arguments can be given for a subcortical dementia, the lack of 
initiative and carelessness is reminiscent of a diffuse subcortical involvement. 
The latter is compatible with the bilateral widespread involvement of the 
(para)limbic system (see 1.6.6). The excessive daytime sleepiness is additional 
evidence of a widespread subcortical central nervous system lesion, that 
superimposes the mental impairment. By studying further homogenous 
groups (depending on age of onset, maternal or paternal inheritance and 
severity) this discrepancy might be elucidated. 
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DISORDERS OF EYE MOVEMENT IN 
MYOTONIC DYSTROPHY 
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Eye Movement 
INTRODUCTION 
Myotonic dystrophy (MyD) is an autosomal dominant multisystem disorder 
with variable penetrance, in which dystrophic changes, apart from the 
predominant muscle involvement, are also evident in the central and 
peripheral nervous system (Jamal et al., 1986). Patients with MyD seldom 
complain of diplopia and clinical neuro-opthalmological investigation rarely 
reveals any disturbance of eye movement except for some ptosis. Electro-
oculographic (EOG) studies on disorders of eye movement in MyD have so 
far yielded conflicting interpretations as to the underlying pathophysiological 
mechanisms. Decreased maximum velocity of small and large amplitude 
saccades has been reported in limited series of patients (Baloh et al., 1975; 
Oohira et al., 1985), sometimes more pronounced for horizontal than vertical 
eye movements (Emre and Henn, 1985). Other oculomotor changes include 
hypometric saccades and disturbances of smooth pursuit (von Noorden et al., 
1964; Burian and Burns, 1967; Lessell et al., 1971). Some authors have 
suggested a central origin for the eye movement disorders (von Noorden et 
al., 1964; Burian and Burns, 1967; Lessell et al., 1971; Emre and Henn, 1985) 
while others have considered that they are related to a more peripheral 
mechanism (Junge, 1966; Oohira et al., 1985). 
We have investigated 26 MyD patients in whom we undertook routine 
neuro-ophthalmological investigation, EOG, visual evoked potential (VEP) and 
electromyographic (EMG) studies on the extraorbital muscles. VEP and EMG 
of the extraorbital muscles were examined to establish to what extent an 
afferent visual deficit and a myopathic disorder of the external ocular muscles, 
respectively, might be involved. One study (Gott et al., 1983) reported bilateral 
prechiasma tic VEP abnormalities in 17 MyD patients; no precise localization 
of the lesion was given. EMG of the external ocular muscles has revealed 
myopathic changes similar to those in the limb muscles, sometimes accompa-
nied by myotonic discharges (Davidson, 1961; Zauberman and Magora, 1969). 
The primary objective of our study was to ascertain whether a characteristic 
pattern of subclinical oculomotor disorder could be detected in patients with 
MyD. Special attention was paid to the question of central versus peripheral 
pathophysiological mechanisms. 
PATIENTS AND CONTROLS 
Patients 
Twenty-six patients with MyD, 15 males and 11 females, were studied, with 
an age range of 11-70 (mean 38) years. The duration of the clinical features, 
confirmed in all cases by EMG. A positive family history was present in all. 
None of the patients took any drugs which could influence myotonia, the EOG 
or VEPs. 
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Controls 
Normal values were obtained from healthy control subjects recruited from the 
staff of the St. Elisabeth Hospital and their relatives. There were 25 control 
subjects for the VEP studies, matched for age and sex, and 20 for EOG also 
matched for age and sex. 
METHODS 
Routine neurological examination 
This was performed with special attention to eye movements (saccades, on 
command and visually guided, smooth pursuit, myotonia), ptosis and specific 
MyD symptoms (muscle weakness, atrophy, myotonia). 
Ophthalmological investigations 
These included the measurement of visual acuity by an Oculus-Visutest 
apparatus which was expressed in decimal values, fundoscopy, extraocular 
movements and a slit lamp examination for lens opacities. 
Electro-oculography 
Eye movements were measured by d.c. electro-oculography (EOG). Non-
polarizable miniature silver chloride skin electrodes were placed on the inner 
and outer canthi of the eyes to permit separate recordings for each eye. The 
signals from the electrodes were displayed on a ink-jet writing polygraph and 
analysed quantitatively with a PDP 11 computer. Patients were seated in a 
darkened room and their heads were stabilized by an occipital support. 
Horizontal visually-guided saccades and horizontal smooth pursuit move-
ments were studied. Targets for saccades consisted of red light-emitting diodes 
fixed on a cylindrical screen. The positions were 10 degr., 20 degr. and 30 
degr. to the left and right of the primary position. Two different testing 
paradigms for saccades were used: (1) random stimulation with targets of 
variable amplitude; (2) stimulation with only the 20 degr. to the left and right 
in a predicted sequence. For random stimulation programme, only the 20 
degree steps were analysed. The rate of target alternation in the predictive 
sequence had a pause of 3 s. A filter of 0-70 Hz and a sampling frequency of 
512 Hz were used for the recording system. A complete saccade test consisted 
out of at least 20 steps of 20 degr. to both sides. The parameters studied 
included saccadic latency, maximum saccadic velocity (V max.) and amplitude. 
Smooth pursuit movement were elicited by a target moving on a dark 
background. The target was guided by a laser beam reflected by a mirror 
galvanometer. The target moved in a triangular wave fashion with excursions 
of 50 degr. (25 degr. left and right out of the midposition). The velocities 
varied from 30 to 50 degr./s. The filter range was 0-20 Hz. Smooth pursuit 
was quantitated by measuring the pursuit gain (the ratio of pursuit eye 
velocity / target velocity). Smooth pursuit gain was obtained by calculating the 
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gain, along a trajectory ranging from -15 degr. to +15 degr. from the 
midposition, between sample points with an interval of 0.02 s. The average 
gain of the velocities of 30^10-50 degr./s was determined. 
VEP recording 
VEPs were measured by a checkerboard method (Halliday, 1982) with 129 
image reversals at a rate of 1 Hz, twice to the left and twice to the right. The 
checkerboard measured 27 χ 31 cm. Each square subtended 48 min; the full 
field pattern was 10 degr. 25'. Full field luminance was 40 cd/m 2 with a back­
ground luminance of 0.05 cd/m 2 . The recordings were performed with the 
subject seated in a dimmed room, 80 cm from the screen. Each eye was tested 
twice to ensure replicability of the wave form. The latencies were determined 
for the major occipital positive peak (P100). 
Electromyography 
Needle EMG of the levator palpebrae and the external recti was performed 
with special; attention to the insertion and spontaneous activity, the amplitude 
of motor unit potentials, myotonic discharges and voluntary recruitment 
pattern. 
RESULTS 
Neurological examination and ophthalmological investigation were undertaken 
in all cases. VEPs were recorded in 26 patients (100%), EOG in 18 (69%) and 
EMG in 17 patients (65%). The disorder varied in severity, being mild in 24%, 
moderate in 16%, moderate/severe in 28% and sever in 32% (Rankin disability 
scale). Clinically evident myotonia was demonstrable in the limb muscles in 
all cases. One patient showed an external ophthalmolplegia with limitations 
of external ocular movements. Bilateral ptosis in some degree was present in 
17 cases (65%). Ophthalmological examination demonstrated impaired visual 
acuity in 18 patients (69%), Two patients had unilateral amblyopia, accompa­
nied by a strabismus of less than 5 degr.; 5 patients had a decreased vision 
below 0.3, 1 unilaterally and 4 bilaterally. Cataract was found in 17 patients 
(65%) and typical myotonic butterfly-shaped macular dystrophy in 1 case. The 
reduced visual acuity was not always related to the cataract as this sometimes 
persisted after successful cataract excision. Ocular hypotonia was not found, 
nor was the disc pallor detected. 
The results of the neurophysiological investigations are summarized in tables 
1-3. Values in excess of 2 SD were considered as abnormal. 
The P100 VEP latency was significantly prolonged in 64%, without obvious 
left-right differences, indicating a bilateral prechiasmatic abnormality. If 
corrected for a visual acuity above 0.3 the P100 was abnormal in 44%. The 
P100 latency did not correlate with age or presence of cataract; after surgery 
prolonged P100 latencies were also noted. 
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The EOG was significantly abnormal in 83% of the MD patients. The most 
striking disorder was a significant decrease of the maximum velocity of the 
visually-guided saccades (83%). The latencies of the saccades were slightly 
increased but compared with the controls this difference was not significant 
(figs 1,2). This prolongation was not significantly different between the first 
(mean latency: 242, SD 65.8), fifth (mean latency 253.6 ms, SD 74.9) and tenth 
(mean latency: 277.3 ms, SD 62.7) saccade in the predicted sequence trial. 
No significant difference of latency was observed in the random trial 
saccades of different amplitudes: mean saccadic latency, following a 10 degr. 
saccade, was 267.8 ms (SD 65.1) and following a 30 degr. saccade 267.1 ms (SD 
63.9). The amplitudes of the saccades were within normal limits (table 1). The 
latency of the PI 00 correlated significantly with the latency of the visually-
guided saccades in the MyD group (P = 0.01; R value, 0.455) (fig. 3), while in 
the control group no significant correlation could be detected. Linear regres­
sion analysis of the EOG latency/VEP latency between patients and presumed 
normals showed no significant difference (P = 0.09). The Vmax. of the visually-
guided saccades was not influenced by age, either for presumed normals or 
for MyD patients. The most striking finding was the significant (P < 0.006) 
difference in Vmax. of the visually-guided saccades between presumed 
normals (mean: 442.7 deg/s, SD 46.7) and MyD patients (mean: 309.7 degr.s, 
SD 43.2) (see fig. 2). This was independent of the testing paradigm. A 
substantial variation in amplitude of the saccades could not account for the 
decrease of Vmax. No central eye movement disorders such as dysmetria, 
nystagmus or gaze palsy were encountered. The smooth pursuit gain (the ratio 
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Fig. 2. Decreased Vmax. of the visually guided saccades of patients with MyD as compared with age-
matched controls. Note the highly significant slowing of the saccade velocity in MyD patients (P<0.006) 
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of pursuit eye velocity/target velocity) showed no significant abnormalities 
(see table 1). 
Table 1. EOG findings m patients with myotome dystrophy 
Saccades 
Latency 
Vmax. 
Mean ampi.gain 
R eye 
L eye 
Smooth pursuit 
Mean gain 
(30-50 deg.) 
Controls 
mean 
225.1 
442.7 
0 90 
0.85 
0.82 
SD 
27.7 
46 7 
0 07 
0 07 
0.14 
Patients 
mean 
252.7 
309.7 
0.91 
0 90 
0 72 
SD 
50.4 
43.2 
0.07 
0.08 
0.22 
P<0.107 
P<0.006 
P<0.131 
The results of EMG of the extra-ocular muscles are listed in table 3. No 
neurogenic abnormalities were found and the recruitment pattern on 
maximum effort was within the normal range. The duration of the action 
potentials was rather short with a relatively low voltage. Myotonic discharges 
were regularly observed. 
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Table 3. EMG of the extraocular muscles in myotonic dystrophy 
Insertion activity myotonic discharges: 35% 
Action potential characteristics LP ampl:mean: 560 ^V (N=400-1200) 
Myotonic discharges RE amplrmean: 520 /iV (N=300-1000) 
LP duration:mean: 1.8 ms (N=1-3 ms) 
RE duratiommean: 1.8 ms (N=1-3 ms) 
LP: 0% RE: 35% 
LP = levator palpebrae. RE = external rectus. N = normal values. 
DISCUSSION 
Our results indicate the presence of a significant subclinical disorder of eye 
movement in patients with MyD (table 1). The most striking finding consist 
of a decrease of Vmax. of the horizontal visually-guided saccades compared 
with normal subjects (P < 0.006, Wilcoxon test), which does not correlate with 
age (fig. 4). This finding is in agreement with reports in the literature (Baloh 
et al., 1975; Oohira et al., 1985). 
However, all other parameters for visually-guided saccades and the smooth 
pursuit movements are within normal limits, which is in contrast with most 
earlier reports in the literature (von Noorden et al., 1964; Burian and Burns, 
1967; Lessell et al., 1971). 
The latency of the visually-guided saccades is slightly increased, although 
compared with controls the difference is not statistically significant. This 
latency correlates with the latency of the P100 of the VEP (P = 0.01; R value 
0.455; fig. 3) only for the patient group but not in the controls. However, no 
statistically significant difference could be detected between the groups, 
possibly due to the limited number of patients and based on a type II error. 
The prolonged latency of the saccades thus possibly reflects an afferent visual 
disturbance as an explanation. The bilateral prolongation of the P100 latency 
of VEP (P < 0.001, Wilcoxon test), suggest a bilateral prechiasmatic deficit 
(Table 2), the localization of which is uncertain (Gott et al., 1983). 
Smooth pursuit eye movement are not significantly different from controls, 
as evidenced by the normal gain. In a number of cases a few catch-up 
saccades were seen. This phenomenon often indicates a reduced gain, but the 
smooth pursuit gain in our patient group was not significantly different form 
Table 2. VEP in myotonic di/stropln/ 
Myotonic dystrophy 
Age 11-77 yrs Mean (R/L) 111/115 ms SD 12/17 
Controls 
Age 18-60 yrs Mean (R/L) 100.8/100.9 SD 4.5/3.6 
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Fig. 4. Examples of recordings of'visually-guided saccades ofslighly affected (A) and severely affected (В) 
MyD patients, both compared with an age and sex matched control group (dotted line) Note the slow 
saccadic velocity 
age-matched controls. Apparently our findings confirm the presumption of 
Oohira et al (1985) that MyD patients have a smooth pursuit gain that is 
within normal limits, although frequently interrupted by corrective saccades. 
This does not, however, always imply a CNS disorder (Schalen, 1980; Schalen 
et al., 1982; Leigh and Zee, 1983). 
Abnormal smooth pursuit findings were the reason for previous authors 
considering the eye movement disturbances as being of central origin (von 
Noorden et al., 1964; Burian and Burns, 1967; Lessell et al., 1971). Disorders 
at different levels of the peripheral and central nervous systems have been 
described in MyD patients (Refsum et al., 1967; Lundervold et al., 1969; 
McComas et al., 1971; Ballantyne and Hansen, 1975; Panayiotopoulos and 
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Scarpalezos, 1977; Jamal et al., 1986), involving, for instance, the brainstem. 
This has been demonstrated by evoked potential studies (Thompson et al., 
1983; Bartel et al., 1984). The slow saccades, as seen in our patients, may be 
due to a disorder of the saccadic burst cells in the pontine reticular formation 
(Leigh and Zee, 1983). However, the absence of abnormalities of eye 
movement with respect to saccadic latency and amplitude and normal smooth 
pursuit gain makes this explanation unlikely (Leigh and Zee, 1983). The same 
is true for a supranuclear deficit because this also leads principally to 
abnormalities of the latency and amplitude of saccades (Schiller et al., 1980). 
An ocular motor nerve paresis is characterized by slow hypometric saccades. 
The saccades become slower as they move in the field of action of the paretic 
muscle. This has not been found in our patients. The isolated finding of a 
decreased saccadic velocity in patients with MyD is therefore in favour of a 
peripheral myopathic pathophysiological mechanism. The EMG results (see 
Table 3) for the extraocular muscles demonstrating myopathy and myotonic 
discharges in a number of patients support this conclusion. The eye movement 
disturbances indicate a "dystrophic" rather than a myotonic abnormality. In 
the predictive sequence of the saccades there was no change during the block 
of trials and there was no significant difference of saccadic latency in the at 
random trial following saccades of different amplitudes. 
The organization and structure of the extraocular muscles is quite different 
from that of other skeletal muscles in man (Miller, 1985). Different types of 
fibres are identifiable in human extraocular muscles by a variety of means, 
including light and electron microscopy (Kato, 1938; Dietert, 1965; Brandt and 
Leeson, 1966; Peachey, 1971; Bastiaensen, 1978), histochemistry (Ringel et al., 
1978; Bormioli et al., 1979; Hoogenraad et al., 1979) and by pharmacological 
and electrophysiological properties (Scott and Collins, 1973). 
According to Ringel et al. (1978), fibre types have been labelled based on 
histochemical features, as "coarse", "fine" and "granular". Coarse fibres, with 
a high myosin ATPase activity and high oxidative enzyme content, are 
predominant in the periphery of the extraocular muscles. Under the electron 
microscope these fibres show a "Felder Struktur", with large fields of 
myofibrils. The coarse fibres are supplied by many small calibre (gamma) 
nerve fibres with multiple "en grappe" nerve endings (Bastiaensen, 1978; 
Ringel et al., 1978). The fibres with a fine granular appearance (fine fibres) are 
more regularly distributed throughout the muscle and contain a moderate 
amount of myosin ATPase and oxidative enzymes. Granular fibres predom-
inate in the central parts of extraocular muscles. They show a high myosin 
ATPase activity and a low oxidative enzyme content. On electron microscopy, 
these fibres show a "Fibrillen-Struktur" with grouped myofibrils. The granular 
and fine fibres are singly innervated by large motor neurons with "en plaque" 
nerve endings (Bastiaensen, 1978; Ringel et al., 1978). 
The physiological action of the different extraocular muscle fibres correlates 
with the type of nerve endings seen by electron microscopy. The large 
(granular and fine) muscle fibres with en plaque nerve endings show fast 
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(twitch) activity as required saccades. The small (coarse) muscle fibres with 
"en grappe" nerve endings show a more tonic activity as required for smooth 
pursuit and the slow phase of nystagmus (Kato, 1938; Hess and Pilar, 1963; 
Bastiaensen, 1978; Ringel et al., 1978). The isolated decrease of Vmax. suggest 
a selective abnormality of the fibres with en plaque nerve endings. 
The decrease of Vmax. with normal saccade amplitudes is in agreement with 
the results of Baloh et al. (1975) who tested 3 patients with MyD and stated 
that the mildest form of the disease, without any visual complaint, the ocular 
motor involvement consists of slowed saccades in patients who have full 
range eye movements. Exceptionally, external ophthalmoplegia or gaze palsy 
is caused by myotonic dystrophy (Lessell et al., 1971; Miller, 1985). One 
patient in this study clinically had an external ophthalmoplegia with marked 
slowed horizontal saccades and a limited range of eye movements in all direc-
tions, generally, the preservation of full range of eye movements separates the 
MyD group from the ocular myopathies. 
Finally, there is a deficit in the afferent visual system, as shown by the VEP, 
in a large percentage of the patients, the lesion probably located prechias-
mally. The exact localization of this disorder is topic of a current study. 
Conclusions 
The results of application of EOG, VEP and EMG studies to the extra-ocular 
muscles show clearly that subclinical disorders of eye movement are 
frequently present in MyD patients. These consist of an isolated decrease of 
Vmax. of the visually-guided saccades. As other parameters of saccades and 
smooth pursuit are within normal limits, this indicates a disorder of 
myopathic origin. 
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INTRODUCTION 
Myotonic Dystrophy (MyD) is an autosomal dominant multisystem disorder 
with variable expressivity and reduced penetrance. Although generally 
regarded as a primary myopathy, MyD also affects both the central and 
peripheral nervous system (Jamal et al., 1986). Genetic counselling for affected 
individuals is usually straight forward. The risk for each offspring is 50%. On 
the other hand, absence of clinical signs and symptoms does not exclude the 
possibility that the person may be an asymptomatic carrier of the MyD gene. 
In MyD the symptoms may appear at any age from infancy to old age 
(Griggs and Woods, 1989; Harper, 1989). The great majority of gene carriers 
may be detected in young adulthood if careful clinical examination is 
combined with EMG and slitlamp examination (Bundey, 1974; Harper, 1989; 
Polgar et al., 1972). It is currently unknown which proportion of gene carriers 
escapes detection at different ages. However, apparent nonpenetrance in 
adults does occur occasionally and for this reason additional tests are required 
for accurate counselling of asymptomatic individuals at risk. 
The gene for MyD has been located on chromosome 19 through linkage with 
secretor, Lutheran and C3 (Eiberg et al., 1983) and the subsequent assignment 
of C3 to chromosome 19 (Whitehead et al., 1982). 
Although the MyD gene itself has not been identified, several closely linked 
DNA markers are now available making an indirect diagnosis possible. 
Presently, this diagnosis at the DNA level is possible in virtually all families 
with a suitable pedigree structure (Brunner et al., 1989a). Diagnostic sensitivity 
is usually over 95% and may be as high as 99% or higher if flanking markers 
are used. Such flanking markers have recently been defined (Brunner et al., 
1989b; Korneluk et al., 1989). 
Since DNA diagnosis is done by genetic linkage analysis of multiple family 
members, application of this technique may be precluded if other affected 
family members are unavailable for testing. 
Although DNA diagnosis is highly sensitive, it is as yet not suitable as a 
simple, fast, low cost screening test of family members. Furthermore it gives 
no information about the expression of the MyD gene in terms of the start and 
course of symptoms. Rarely, false positive results may occur. In a previous 
study we have used infrared light eye movement registration (EMR) to show 
that over 80% of the classical patients have a significant decrease of the 
visually guided saccades (ter Bruggen et al., 1990). In the present study we 
have used EMR to study the eye movements of 5 asymptomatic MyD gene 
carriers, identified by DNA analysis, 7 mildly affected MyD patients and 
compared them with 23 healthy controls. 
The purpose was to evaluate whether eye movement abnormalities are an 
early expression of the MyD gene and to determine the value of this 
procedure for presymptomatic detection of MyD patients. 
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PATIENTS AND CONTROLS 
The patients were divided in two groups. 
Group 1. Five asymptomatic MyD gene carriers (Rankin score 0: 2 males and 
3 females) aged between 11 and 41 years (mean: 29 years). The diagnosis of 
MyD in all patients was made by DNA linkage analysis in their families. 
Informative markers included ApoC2 (individuals 1, 2, 4 and 5) and CKMM 
(individuals 2, 3 and 4). These markers are located proximal to the MyD gene 
at 2-3 cM and 1 cM respectively. Flanking markers were used in two cases: 
RRAS (case 2) and KLK (case 5) which map at 8-10 cM distal to the MyD 
gene. Therefore, the predictive value of the DNA analysis was at least 97% in 
cases 1, 3 and 4 and well over 99% in cases 2 and 5. Clinical investigation, 
split-lamp investigation and electromyography (EMG) were performed in all 
cases. None of the gene carriers used any drug which could possibly influence 
myotonia or eye movement recordings (EMR). 
Group 2. In addition seven mildly affected (Rankin score 1) MyD patients were 
studied, varying in age between 15 and 32 years (mean: 24 years). The 
duration of clinical symptoms varied from 1 to 15 years. The diagnosis in this 
group was made by the demonstration of myotonia and/or the typical dust-
like cataract in combination with a positive family history for MyD. No drugs 
were used which are known to influence myotonia or the EMR registration. 
Controls. Twenty three healthy, age and sex matched control subjects, 
varying in age between 22 and 34 years (mean:26 years) were recruited among 
the staff and their relatives of the St. Elisabeth and Maria Hospitals Tilburg, 
the Netherlands. 
METHODS 
Neurological examination was performed twice: once by the referring neurologist 
and once by the investigating neurologist (JB). Special attention was given to 
eye movements (saccades, on command and visually guided, smooth pursuit, 
myotonic reaction), signs of muscular dystrophy and myotonia. 
Ophthalmological investigation was performed by one ophthalmologist (LB) 
and included assessment for ptosis, myotonic reaction of eye closure and 
investigation for lens opacities by slit lamp. 
DNA investigation was performed as described previously (Brunner et al., 
1989a, 1989b). Informative markers indicated the presence of the MyD gene 
with at least 97% reliability in all individuals in group 1. 
Eye movement recording (EMR). The eye movements were measured by the 
infrared light method, according to the procedure described earlier (ter 
Bruggen et al., 1990). The following eye movements were studied: visually 
guided saccades and smooth pursuit movements. The visually guided saccades 
were measured with 20 degree steps in both at random and predicted 
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sequence. The smooth pursuit eye movements were registrateci with 20, 30 and 
40 degrees/sec. target velocity. Special attention was paid to latency of the 
saccades, saccadic amplitude and maximum velocity of the saccades. The 
smooth pursuit was expressed by the gain i.e. the ratio of pursuit eye 
velocity/target velocity. 
Electromyography. All patients had previously been investigated for electrical 
myotonia by their referring neurologist. 
RESULTS 
Group 1. All five asymptomatic individuals scored optimal on the Rankin 
disability scale (Rankin score 0). No abnormalities were found on neurological 
examination. EMG investigation was normal m all these patients. Ophthal-
mological investigation demonstrated atypical lens changes in 4 individuals 
(see table 1A). The typical dustlike cataract was not seen in this group. The 
EMR results are summarized in table 1. No significant difference was found 
compared with controls (see fig. 1). 
Group 2. All 7 mildly affected patients in this group scored Rankin score 1. 
Neurological abnormalities were slight (see table 2). Ophthalmological findings 
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Fig. 1. Disorder of eye movement in myotome dystrophy The mean maximum velocities of the visually 
guided saccades is plotted for asymptomatic DNA positive myotome dystrophy individuals, mildly affected 
patients and controls (SD is graphically expressed) 
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Table 1. EMR findings in asymptomatic gene carriers (group 1) and mildly affected MyD patients 
(group 2) 
Group 1 (N = 5) 
asymptomatic 
MyD patients 
Group 2 (N = 7) 
mildly affected 
MyD patients 
Controls 
(N = 27) 
Mean SD Mean SD Mean SD 
Saccades 
Vmax 
Latency 
Amp gain 
R eye 
L eye 
Smooth pursuit 
Mean gain 
20 deg 
30deg 
40 deg 
453 
211 
0 93 
0 94 
117 
1 11 
103 
61 
22 
0 09 
0 03 
014 
015 
0 24 
305* 
246 
0 95 
0 94 
1 12 
107 
102 
38 
45 
0 03 
0 05 
012 
013 
016 
451 
223 
0 90 
0 86 
0 78 
0 86 
0 89 
41 
28 
0 07 
0 07 
013 
010 
010 
"Significance Ρ < 0 01 compared to controls by Wilcoxon test 
Table 2. Neurological and shtlamp investigation of 7 mildly affected MyD patients 
Weakness /disorder 
Facial wk 
Levator palpebra wk 
Masseter wk 
Orbicularis oris wk 
Sternocleido wk 
Shoulder girdle wk 
Pelvic girdle wk 
Prox limb muscle wk 
Dist limb muscle wk 
Myotonia limbs 
Eye lid myotonia 
Eye movement disorder 
Shtlamp invest 
6 
+ 
+ / -
+ / -
+ / -
+ / -
-
-
-
+ / -
-
-
-
dc* 
7 
+ 
+ 
+ / -
+ / -
+ / -
-
-
-
+ / -
+ 
-
-
n* 
8 
+ 
+ / -
+ / -
-
+ / -
-
-
-
+ / -
+ 
-
-
ccp* 
Patients No 
9 
-
+ / -
+ / -
-
-
-
-
-
-
+ 
-
-
dc* 
10 
-
+ / -
-
-
+ / -
-
-
-
+ / -
+ 
-
-
dc* 
11 
+ / -
-
-
-
-
-
-
-
+ / -
+ 
-
-
ccp* 
12 
+ / -
+ / -
-
-
-
-
-
-
+ / -
+ 
-
-
n* 
+ sign unequivocally present ,+/- sign present but minimal, - sign absent, dc typical dustlike 
cataract, cpp crystals in the posterior part of the lens, wk weakness, * both eyes, η normal 
were normal in 2 and atypical for MyD in another 2. The typical dustlike 
crystals were seen in 3 patients (see table 2). 
All of the patients except patient 6 showed electromyographical myotonia 
(table 2). However, this individual showed mild muscular weakness and 
typical myotonic cataract. The EMR results are summarized in table 1. The 
maximum velocity of the visually guided saccades (Vmax.) was significantly 
different compared to the Vmax. of the controls (p < 0.01, Wilcoxon test). 
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DISCUSSION 
In this study the question was addressed whether the eye movement disorder 
would be an early expression of the MyD gene. The external ocular muscles 
are commonly affected in MyD, but signs and symptoms directly attributable 
to extraocular muscle weakness such as diplopia are uncommon (Griggs and 
Woods, 1989; Harper, 1989; ter Bruggen et al., 1990). Because the infrared 
method is very sensitive for measuring eye movement disorders, subclinical 
abnormalities can be discovered. To our knowledge this is the first report 
concerning the value of precise eye movement recording for early diagnosis 
of MyD. 
Although the numbers are still small our results indicate that the extraocular 
muscles are affected frequently and early in the course of MyD (see table 2). 
The eye movement abnormality is characterized by an isolated decrease of 
Vmax. of the saccades with normal amplitudes. The EMR findings are most 
compatible with a myopathic etiology (Baloh et al., 1975; Oohira et al., 1985; 
ter Bruggen et al., 1990). The comparison of the main sequence (i.e. the 
relationship between amplitude magnitude and maximum velocity of the 
saccades) between other extraocular myopathies and MD also supports this 
assumption (Oohira et al., 1985). Accordingly light and electron-microscopical 
studies show myopathic abnormalities of the extraocular muscles in MyD (von 
Noorden and Allen, 1964; Ketelsen and Schmidt, 1972; Kuwabara and Lessell, 
1976; Isahiki et al., 1989; ter Bruggen et al., 1990). 
In the present study eye movement recordings of all patients in the 
minimally affected group showed a significant decrease in the maximum 
velocity of the saccades (ρ < 0.01, Wilcoxon test) without other oculomotor 
abnormalities. These results confirm the findings of a previous study (ter 
Bruggen et al., 1990). This indicates that eye movement disorders occur early 
in the course of the disease and perhaps even may precede the onset of 
detectable skeletal muscle weakness or myotonia. Since we did not find signs 
of disturbed eye movements in our asymptomatic group, EMR recording does 
not appear a more sensitive diagnostic tool in those cases in which neurolo­
gical examination and EMG are negative. 
So far, we have studied only a limited number of cases. Also DNA linkage 
analysis alone cannot prove that a given person is a gene carrier. Thus, not all 
individuals in the asymptomatic group may truly carry the MyD gene, even 
though their individual likehoods of being a gene carrier are high and 4 out 
of 5 showed aspecific lens changes. Because of these limitations we think that 
additional studies, aiming at preclinical diagnosis of MyD with EMR are still 
warranted. 
Exclusion of the MyD gene in an at risk individual can best be accomplished 
by a combination of careful neurological and ophthalmological examination, 
EMG recording and DNA analysis. In those cases where the DNA analysis 
suggests the presence of the MD gene in the absence of clinical symptoms, 
two approaches may be used simultaneously. Flanking DNA markers can 
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enhance the accuracy of the DNA diagnosis. Réévaluation of the clinical data 
is mandatory and additional clinical testing should be considered. In this 
setting, repeated EMG registration and EMR are possible useful options. 
The EMR abnormalities in MyD appear rather specific for this disorder (ter 
Bruggen et al., 1990). The combination of slow saccades and normal ampli-
tudes in both horizontal directions is unusual for ocular myopathies, while 
several central abnormalities with slow saccades show more extensive 
disturbances (Leigh and Zee, 1983; Stell et al., 1989). 
Since the decrease of Vmax. is found in well over 80% of the symptomatic 
MyD patients (ter Bruggen et al., 1990), this sign may be useful in the 
evaluation in patients in whom MyD is suspected but not certain. This applies 
to the isolated patient with myotonia and minimal weakness as well as to 
familial cases with distal muscle weakness but no detectable myotonia (pat. 6) 
or eye abnormalities. A recent study of 602 individuals in 88 MyD kindreds 
revealed 130 individuals (21.5%) with equivocal or unspecific signs (Mathieu 
et al., 1989). In such cases EMR should be considered. 
We conclude that eye movements are significantly and early disturbed in the 
course of MyD. Eye movement registration (EMR) detects a rather specific 
pattern of abnormalities, consisting of a decrease of Vmax without other 
abnormalities. 
EMR has so far no proven additional value for the detection of gene carriers, 
that are asymptomatic with currently accepted techniques. 
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MYOTONIC DYSTROPHY: 
THE NATURAL HISTORY OF EYE 
MOVEMENT DISORDERS 
J.P. ter Bruggen (1), C.C. Tijssen (2), L.A.K. Bastiaensen (3) 
Department of Neurology Bosch Medicentrum, 's-Hertogenbosch (1) and 
St. Elisabeth Hospital Tilburg (2), Department of 
Ophthalmology (3) St. Elisabeth Hospital Tilburg, 
the Netherlands. 
(Neuro-ophthalmology: 1993; 13: 2: 85-88) 
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INTRODUCTION 
Eye movement disorders are a common and rather early subclinical sign in 
myotonic dystrophy (MyD) (ter Bruggen et al., 1990; ter Bruggen et al., 1992). 
Diplopia is uncommon and external ophthalmoplegia even exceptional (ter 
Bruggen et al, 1990, 1992). A significant decrease of the maximum velocity of 
visually guided saccades has been reported for the classical form (ter Bruggen 
et al., 1990); a recent study indicated a derangement of smooth pursuit as most 
pronounced feature (Oohira et al., 1985). Some authors advocate a mere 
peripheral (Oohira et al., 1985; ter Bruggen et al., 1990) while others presume 
a central pathophysiological mechanism (van Noorden et al., 1964; Burian and 
Burns, 1967; Lessel et al., 1971; Bollen et al., 1992). So far no studies have been 
reported to outline the natural history. Therefore we performed a follow up 
study of eye movements in 6 patients with the classical form of MyD 6 years 
after a previous study (ter Bruggen et al., 1990). 
PATIENTS AND METHODS 
Patients 
The patients in this study are members of kindreds with classical MyD in 
accordance with published criteria (Griggs et al., 1989). All patients were 
classified as adult onset and were gathered out of a previously studied group 
in 1985-1986 (ter Bruggen et al., 1990). None of the patients had important 
other diseases, signs of a mental disorder or used any drugs which could 
influence myotonia, electro-oculography (EOG) or VEP. 
Methods 
The severity of the limb muscles was scored according to an international 
rating-scale put forward by Mathieu (Mathieu et al., 1992) and by Karnofsky 
(Karnofsky and Burchenal, 1949) and Rankin disability scales. 
Besides, the same protocol as in a previous study (ter Bruggen en et al., 
1990) was used for neurological and ophthalmological investigation. 
Furthermore eye movements (Vmax and latency of 20 degr. horizontal visually 
guided saccades and mean gain of 30-40-50 degr./sec. smooth pursuit) and 
VEP P100 latency were studied conform the previous study (ter Bruggen et al., 
1990). 
Statistics 
The differences between the two time points (1985-1986 and 1992), were 
evaluated by CIA-statistics: Wilcoxon paired ranksum test and Spearman 
correlation coefficients (Gardner and Altman, 1986). 
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RESULTS 
The most important results are listed in table 1. 
The group consists of 3 men and 3 women, with a mean age of 40.2 years 
(range 27-65). Neuromuscular involvement was as follows: 2 patients were 
rated Mathieu II (minimally affected) and the remaining 4 Mathieu III 
(moderately affected) (Griggs et al., 1989). In a period of about 6 years one 
patient got mild clinical signs of an external ocular weakness without diplopia. 
There was a clear progression of the decrease of Vmax of the visually guided 
saccades (ρ < 0.01, Wilcoxon) and VEP P100 latency prolongation (p < 0.05, 
Wilcoxon). No significant left-right differences could were observed for V max. 
As to be expected , all parameters for limb weakness showed more or less 
worsening (p < 0.01, Wilcoxon). In comparison to our previous study (ter 
Bruggen et al., 1990) no significant differences could be found for latency of 
the visually guided saccades or for the mean gain of smooth pursuit. The 
latter results did not differ from controls either (ter Bruggen et al., 1990). 
Despite the small group a significant correlation was found for Vmax and 
Mathieu (limb weakness) score (R = -0.5 Spearman, 95% CI: -0.748 to -0.112). 
Differences of disability scales did not show any significant correlations with 
the decrease of Vmax. of the saccades. 
Eye movement disorders yrs.follow up 
Vmax saccades & limb muscles weakness 
6 0 0 
4 0 0 
3 0 0 
200 
100 
0 
" ' ^ 
^ ~ ^ ^ ~ ~ _ _ ^ J - . 
4-· 
-
1 1 1 
4-
4-
i 1 
Seri» 1 —*— S a r i · 2 
serie 1 (1985), serie 2 (1992) 
Fig. 1. The relationship of decrease of the maximum velocity of the saccades and weakness of the limbs is 
depicted (Mathieu-score). Serte 1 represents the values in 1986 and serie 2 those of 1992. The drawn line 
indicates the progression rate in 6 years time in this adult onset group of MyO (slope: -0.003). 
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DISCUSSION 
One of the hallmarks of MyD is the progressive weakness and atrophy of limb 
muscles. Although extra-ocular muscles are quite different as regards 
histological structure this study demonstrates a progressive decrease of Vmax 
of the horizontal saccades, correlating with the progression of limb weakness 
(Mathieu-score). The Vmax decrease reflects myopathic changes in the extra-
ocular muscles perhaps influenced by central adaptation mechanisms (Ter 
Bruggen et al., 1990, 1992; Verhagen et al., 1992). Therefore the data support 
a progressive involvement of the extra-ocular muscles in the course of time 
(fig. 1), exceeding the normal aging (Warabi et al., 1984). 
All other eye movement parameters were normal, including smooth pursuit 
gain. Central abnormalities, based on an altered smooth pursuit gain (Bollen 
et al., 1992) could not be demonstrated in this study. Another finding was the 
progressive prolongation of VEP P100 latency (p < 0.05), exceeding the normal 
age related prolongation (Celesia and Daly, 1977). No relationship could be 
found between VEP latency and saccadic latency, in contradiction with 
previous results (ter Bruggen et al., 1990). 
In conclusion, the functional abnormality of the extra-ocular muscles is 
progressive, correlating with the severity of limb weakness. Furthermore both 
afferent (VEP) and efferent systems (EOG) deteriorate in a course indepen-
dently to one another (ter Bruggen et al., 1990). 
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1986 1992 
Rankin (1-5) 1 2 " 
Kamofsky (0-100) 90 7 0 " 
Mathieu-score (1-5) 3 4 " 
visus 0.9 0.8 
clin.extra-oc.wkn N = 0 N = 1 
slitlamp N = 1 N = 1 
normal 2 (+) 1 (++) 
ccp (+-++++) 0 1 (+++) 
pec (+-++++) 2 1 
cat. 1 1 
dense cat. 0 1 
lens extr. 
Saccades (20 deg) 
Vmax. (deg/s) 335 280" 
(SD 59.8) (SD 71.1) 
latency (ms.) 236 239 
(SD 57.9) (SD 56.3) 
Smooth pursuit 0.82 0.86 
mean gain (SD 0.14) (SD 0.27) 
(30-50 deg/s) 
VEP P100 108 118* 
latency (ms) (SD 15.8) (SD 19.5) 
Expressed values are the means of the results of the separate groups Statistics refer to Wilcoxon 
paired ranksum test. 
EOG: 
clin.extra-oc.wkn 
ccp: 
pec: 
+-++++: 
cat.: 
dense cat.: 
*. 
**. 
electro-oculography 
clinical extra-ocular weakness 
crystals cortex posterior 
polychromatic crystals or 
iridescent lucencies 
semi-quantification 
cataract 
dense cataract 
ρ < 0.05 Wilcoxon difference 1986-1992 
ρ < 0.01 Wilcoxon difference 1986-1992 
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ABNORMALITY: AN EARLY SIGN IN 
MYOTONIC DYSTROPHY? 
J.P. ter Bruggen (1), GJ. van Meel (2), A.D.A. Paridaens (2), 
C.C. Tijssen (3) and D. van Norren (2) 
Department of Neurology (1), de Wever Hospital, Heerlen, the Netherlands, 
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the Netherlands, Departement of Neurology (3), St. Elisabeth and Maria 
Hospitals, Tilburg, the Netherlands. 
(British Journal of Ophthalmology 1992; 76: 594-597) 
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INTRODUCTION 
Myotonic Dystrophy (MyD) or Curschmann-Steinert disease is an autosomal 
dominant multisystem disorder of which the gene abnormality is localized on 
chromosome 19 (Brunner et al., 1989; Harper, 1989). DNA diagnosis of MyD 
is possible with both sensitivity and specificity higher than 96% (Brunner et 
al., 1989). It shows variable gene penetrance and expressivity, and the onset 
of MyD varies from early infancy to old age (Polgar et al., 1972). An alteration 
in the intrinsic biochemical composition of the cell membrane, affecting the en-
tire body, has been proposed as the pathogenesis of MyD (Harper et al., 1989). 
Ocular abnormalities associated with MyD are cataract, hypotonia and 
chorio-retinal changes. Several authors reported the considerable electroretinal 
alterations in MyD patients, even before fundal changes and other expression 
of the abnormal gene (Junge, 1966; Burian and Burns, 1967; Stanescu and 
Wawernia, 1970; Stanescu and Michiels, 1975; Kirkham and Coupland, 1981; 
Gott et al., 1983; Creel et al., 1985; Harper et al., 1989; Sandrini et al., 1986; 
Pinto et al., 1987; Kerty and Ganes, 1989; ter Bruggen et al., 1990). A common 
finding was the reduction of the b-wave amplitude in ERG, both in scotopic 
and photopic conditions (Junge, 1966; Burian and Burns, 1967; Stanescu and 
Wawernia, 1970; Stanescu and Michiels, 1975; Kirkham and Coupland, 1981; 
Gott et al., 1983; Creel et al., 1985; Sandrini et al., 1986; Pinto et al., 1987). VEP 
recording in MyD repeatedly showed prolongation of latency or decrease of 
amplitude (Pinto et al., 1987). They recorded PERG and pVEP simultaneously 
and found abnormalities that occured independently of one another. The 
authors also found subnormal EOG Arden indices. They suggested that the 
pathological process may affect both the retina and post-retinal intrinsic visual 
pathways. 
Both clinical (Junge, 1966; Burian and Burns, 1967) and histopathological 
(Manschot, 1968; Burian and Burns, 1966; Burns, 1969; Houber and Babel, 1970; 
Betten et al., 1971; Ginsberg et al., 1978; Hayasaka et al., 1984; Sarks et al., 
1985) evidence of photoreceptor and other neuroretinal abnormalities has been 
reported in progressive stages of MyD. The purpose of this study was to 
investigate the early expression of retinal abnormalities in MyD, including 
those of foveal photoreceptors. We have used retinal densitometry to examine 
the macular photoreceptors of eyes of a group of minimally affected MyD 
patients. To our knowledge this technique has never been utilized in Myotonic 
Dystrophy. 
MATERIAL AND METHODS 
Subjects 
Twelve patients, 8 females and 4 males, were examined. 
Informed consent was given by all patients. They all either had a positive 
family history for MyD and myotonia, or a clinical diagnosis of MyD, 
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confirmed by DNA investigation (Laboratory of Clinical Genetics, Radboud 
Hospital, Nijmegen, the Netherlands). All patients were submitted to 
neurological and ophthalmological examination, including testing of visual 
acuity, fundoscopy, slit-lamp examination and tonometry (Goldmann 
applanation tonometer). Inclusion criteria for the study were a visual acuity 
of at least 0.8 after correction and no or minimal lens abnormalities (sporadic 
polychromatic cristals or white dots) and a Karnofsky index exceeding 80. An 
age matched group of 12 healthy subjects was used as control. 
Investigations 
Densitometry 
The density of foveal cone pigments was measured with the Utrecht 
densitometer which has been described in detail by van Norren and van der 
Kraats (van Norren and van der Kraats, 1989). 
Briefly, the light reflection at the fundus is determined at a range of wave 
lengths through the visual spectrum. The light needed for this measurements 
is so dim that influence on the visual pigments is minimal. The spot of light/ 
(30-W halogen lamp) at the fundus is restricted to 2.8 degrees in this 
measurement. Reflections of the fundal lights are collected by a photo-
multiplier in photon-counting mode and processed by a computer. Bleaching 
is possible with a separate light path which provides a retinal illumination of 
5.6 log Td. The change in reflection from the retina of a healthy person before 
and after bleaching determines the "two-way density". The pupils of all 
subjects were dilated with tropicamide. A bar made of dental impression 
compound, and two temple pads were used for immobilization of the head. 
The fundus camera was adjusted to obtain the highest possible reflection as 
measured by the photomultiplier. Subjects fixated cross-hairs centered with the 
stimulus field. The fovea was bleached for 2 minutes. After switching off the 
bleaching light, the regeneration of cone pigment was followed until the 
density trace had reached a stable level. Then the bleaching light was switched 
on again for 2 minutes. The density trace should than return to the fully 
bleached condition, permitting the reliability of the measurements to be 
checked. The changes in retinal transmittance between fully dark adapted and 
fully bleached states of the retina are related to the photopigment density of 
the test area. 
Basically, two values can be extracted from the data: the density difference 
and the time constant of pigment regeneration. The density difference is the 
change in the logarithm of the measuring light reflectance to the reference 
light reflectance, from fully bleached to fully adapted states. The time constant 
of pigment regeneration can be estimated from the initial 180 sec. of 
adaptation following extinction of the bleaching light. 
In this study we only present the data obtained at 554 nm, being the peak 
of the absorption-spectrum. Peripheral measurements, investigating the rods 
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take considerably longer, since the adopser regenerates slow. In our subjects 
occasionally denture fitting problems and lack of concentration - common 
signs of MyD - interfered with the measurements. 
VEP and ERG 
Pattern visual evoked potentials (VEP) and electroretinography (ERG) 
measurements were made with a laboratory built system for clinical 
electrophysiology of vision (Van Norren and van der Kraats, 1984). ERG was 
performed in both scotopic and photopic conditions, using corneal electrodes 
and three different white light stimulus intensities. VEP recording was done 
under standard conditions, using 11', 46' and 92' settings in the black-and-
white checkerboard reversal pattern. 
Anomaloscope 
Colour matching was investigated with a Nagel type I anomaloscope by a 
standard technique (Pojorny, 1979). 
RESULTS 
The ages of the patients ranged from 12 to 39 years (mean: 26 yrs) and the 
general disability rated by Karnofsky index (25) varied from 80 to 100 (mean: 
90). The duration of clinical disease varied from 0 to 408 months (mean: 71 
mths). 
A summary of the main ophthalmological results is displayed in table 1. Slit-
lamp examination revealed minimal lens opacities in four patients (30%) and 
characteristic polychromatic crystals in three patients (25%), whilst in five 
patients (42%) no abnormalities were detected. Fundoscopy did not show 
morphological changes of the retina in any of the patients. The visual acuity 
varied from 1.2 to 0.8 (mean: 0.9). Anomaloscopy showed no protan or deutan 
defects. Seven out of nine patients had low intra-ocular pressures bilaterally, 
whilst two patients had low-normal pressures (mean: 12.7 ± 2.3) (normal 
values: 15.5 ± 2.5) (Goldman and Schmidt, 1957). 
In 4 out of 23 eyes (17%) the scotopic ERG showed a significant decrease of 
the a-wave amplitude and in only 1/23 eyes (4%) a significant decrease of the 
b-wave. An increase in implicit time was noticed in 10/23 eyes (43%) for the 
scotopic a-wave and 3/23 (12%) for the scotopic b-wave. In photopic 
conditions 8/23 eyes (35%) showed a decrease of the a-wave amplitude and 
in 7/23 eyes (30%) a decrease of the b-wave amplitude. An increase in implicit 
time was recorded in 2/23 (8%) eyes for the photopic a-wave and in 4/23 
(16%) for the photopic b-wave. 
Pattern VEP recording with 11' pattern reversal blocks showed a significant 
prolongation of the PlOO-latency in 4 patients (30%). In 5 eyes (42%) a decrease 
of the VEP amplitude was noted. No significant hemispheric asymmetry was 
seen. In 2 eyes (16%) both VEP amplitude and latency were abnormal. Only 
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five eyes (42%) had normal VEP data. There was no clear correlation between 
VEP and ERG data. 
Foveal densitometric measurements showed in 6 patients (50%) a significant 
decrease of the two-way density. The mean density of all patients tested (0.29 
+ / - 0.09) was significantly lower than the mean of the age-matched control 
group (0.38 + / - 0.12). The time constants of pigment regeneration of the 
patients (mean: 66 + / - 6 sec) were in the normal range (mean: 69 + / - 8 sec). 
Both peripheral retinal densitometry and ERG in patient 1 and 5 showed no 
abnormalities, but foveal densitometry was significantly abnormal in both 
cases. In patient 3 the peripheral densitometric measurement was low: 0.13 
(normal: 0.18 + / - 0.04) (table 1). 
The Arden-index, of the EOG was subnormal in 6/12 eyes (mean: 181% + / -
15.7, range: 161-193). 
Myotonia was noted in 7 patients (58%). Ptosis was absent in 6 patients 
(50%), minimal in one (8%), moderate in 3 patients (25%), and severe in the 
remaining 2 patients (16%). Weakness of the limb muscles was found in 3 
patients (25%), varying from minimal to moderate. 
DISCUSSION 
Foveal densitometry demonstrated subclinical abnormalities of foveal 
photoreceptors in 50% of our patients with minimal (early) expression of the 
MyD gene (table 1). Even in a 12 year old asymptomatic DNA-positive 
individual (pt.ll) a strikingly abnormal value was noticed. The reduced two-
way density may be caused by loss or dysfunction of photoreceptors or by a 
reduced effective optical density of foveal cones due to shortened outer 
segments. Other causes include active or chronic serous leakage of subretinal 
fluid with photoreceptor disorientation and abnormally high stray light levels 
secondary to lenticular opacities. The latter is unlikely because lens opacities 
in our patients were neglidgable. Serous leakage of subretinal fluid can be 
excluded by normal fundoscopy findings. The results of the normal pigment 
regeneration times excludes serous leakage because this phenomenon is 
usually associated with increased pigment regeneration times (van Meel et al., 
1986). Normal findings with the Nagel anomaloscope, which would be most 
sensitive to cone pigment density changes occuring in individual cones, such 
as shortened outer segments (Alpern, 1979), make such alterations less 
probable. Therefore, we argue in favour of loss or dysfunction of photorecep-
tors to explain the reduced densitometric values. 
Additionally, the peripheral retina of three cases was examined using retinal 
densitometry. Whilst in all three patients the foveal densitometry findings 
were abnormal, in two out of three the peripheral two-way densities were 
normal. Although the number of investigated eyes is limited, these findings 
may indicate predominant involvement of the macular area in early stages of 
MyD. The predictive power for densitometry for family-members of patients 
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Fig. 1. The amplitudes of the a wave of the photopic ERG are plotted against the values of foveal 
densitometry The best fitting line has a R-value ofO 57 (Spearman's rank corr ) and a Ρ = 002 (Wikoxon 
rank sum test) to reject the nul-optwn 
with MyD is very high (odds ratio: 6, 95% CI: 0.728 - 277 CIA statistics) 
compared with the total of all performed ophthalmological tests (odds ratio: 
10, 95% CI: 1.42 - 442). 
In contrast with previous authors (see introduction), who reported reduced 
amplitudes of the scotopic b-wave as the most frequent ERG abnormality, our 
study showed a significant predominance of photopic ERG a- and b-wave 
abnormalities. The latter is not due to a sample error. Compared with the 
study of Pinto (1987) a difference of proportions is significantly different 
(difference of confidence interval: 0.560, 99% CI: 0.151 - 2.58, CIA statistics). 
Furthermore, the photopic ERG a-wave amplitude showed a significant 
(Wilcoxon: ρ = 0.02) correlation with the foveal densitometric values. The 
decrease of amplitude of 11' p-VEP shows a trend for correlation with foveal 
densitometric findings (Wilcoxon, 0.05 < ρ < 0.10). These findings also points 
at subclinical (macular) cone changes in early onset of MyD. Only in a 
minority of this selected patient group, a decrease of the b-wave of the 
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scotopic ERG could be detected (table 1). Presumably, the scotopic b-wave 
abnormality seems a late manifestation (Sarks et al., 1985). Several authors 
described a decrease of the scotopic b-wave (Faber, 1969; Miller and Dowling, 
1970), which may be associated with a disturbance in retinal Mueller cells. 
Another report (Pinto et al., 1987) suggested involvement of ganglion cells. 
Retinal pigment epithelial changes have been clinically Qunge, 1966; Burian 
and Burns, 1967; Babel and Tsacopoulos, 1970) and histologically observed 
(15-18). Whether the photoreceptor and other neuroretinal (Mueller and 
ganglion cells) alterations are primary or secondary to changes in the retinal 
pigment epithelium (RPE), remains a matter of discussion. Sarks (1985) argues 
in favour of the principal pathological changes to occur at the level of the RPE, 
based on the minimal fallout of photoreceptors, despite relatively good vision 
and slightly affected electrophysiological tests. Whilst, in those cases the RPE 
was grossly irregular and hypertrophic, with distorted villi, containing - in 
particular under the fovea - large amounts of (melano)lipofuscin (Sarks et al., 
1985). If the EOG is abnormal, a much larger area than the foveal (receptors) 
must be affected (see above). It is intriguing to speculate that in MyD some 
as yet unknown metabolic disturbance of the RPE cells may result in 
dysfunction and subsequent variable atrophy of photo-receptors. 
Where does this leave us with the retinal pathophysiology? 
The difficulty could He in the voltage generating mechanisms of the slow 
oscillations at the basal membrane, the concentration of the 'light peak 
substance (l.p.s.)' at the level of the photoreceptors or the transmittance of the 
message across the apical membrane through the RPE cytoplasm to the basal 
membrane. Less likely hypotheses, we cannot exclude, are a delay or a block 
in the messenger system or a defective voltage generation system of RPE and 
photoreceptors, similar to the one demonstrated in the muscle- and erythro-
cyte membranes. Nevertheless, the 'l.p.s.' concentration change-abnormality 
at the level of the photoreceptors (Gallmore etal., 1988) might explain both 
ERG, EOG and densitometry findings. Therefore, we postulate an abnormality 
in a Na, Ca:K dependent exchanger in the outer segments to be the primary 
defect, taking in account knowledge of membrane pathophysiology. The 
mRNA of the MyD gene encodes a protein kinase polypeptide, which is 
known to modulate the activity of excitable cells by phosphorylation of ion-
channels (Brook et al., 1992; Hunter, 1991). The (muscle) membrane has a 
decreased resting potential, with a value close to the threshold for activation 
of Na+ channels and the presence of specific (apamin-sensitive) Ca++-
activated K+ channels (Schmidt-Antromarchi et al., 1985; Ruedel et al., 1989). 
Besides, the Na+-K+-ATP-ase activity is decreased and the voltage dependent 
Ca++ channels are active under conditions in which they are normally inactive 
(Benders et al., 1990). Therefore, instead of 3 moles of Na+ ion exchange for 
2 moles of K+ ion in control cells, a 2 Na+ for 2 K+ ion exchange occured in 
MyD cells (Hull and Roses, 1976). Altered inward sodium transport and 
extracellular leaking of potassium is involved in the generation of action 
potentials or regulation of resting potentials (Desnuelle et al., 1982; Dowling 
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et al., 1987; Wevers et al., 1990; Kuwabara et al., 1991). The defective 
regulation of ion transport could initiate or contribute to abnormal cellular 
functions in MyD (Wevers et al., 1990). Remarkably, in more advanced disease 
the Mueller glial cell becomes affected. In particular this cell, with a high 
resting potential, appears to be most sensitive to potassium changes at 
physiological levels compared with neurons (Dowling, 1987). We hope that 
future studies may obtain additional information on the locality and 
mechanisms of the retinal dysfunction in MyD. 
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INTRODUCTION 
It is well-known that myotonic dystrophy (MyD) is a progressive autosomal 
dominant multisystem disorder (see Kuhn and Fiehn, 1981 and Miller, 1985 
for review). The associated gene defect, i.e. an unstable DNA segment in 
affected subjects, has been recently identified within the region of the MyD 
locus on chromosome 19 (Aslanidis et al., 1992). Neurophysiologic studies on 
MyD have produced evidence for peripheral and central involvement. 
Evidence for peripheral involvement has come from studies employing electro-
myography (EMG) (Davidson, 1961; Lessel et al., 1971; Caccia et al., 1972; 
Panayiotopoulos et al., 1977; Oohira et al., 1985; Jamal et al., 1986; ter Bruggen 
et al., 1990), somatosensory-evoked potentials (SSEPs) (Barrel et al., 1984), 
visual-evoked potentials (VEPs) (Gott et al., 1983; Sandrini et al 1987; ter 
Bruggen et al., 1990) and audiometry (Kuhn and Ey, 1966; Wright et al., 1988). 
Evidence for central involvement has come from studies employing brain-stem 
auditory-evoked potentials (BAEPs) (Thompson et al., 1983), SSEPs (Thompson 
et al., 1983; Bartel et al., 1984; Ganes and Kerty, 1988), VEPs (Sandrini et al., 
1986) and electro-oculography (EOG) (von Noorden et al., 1964; Emre and 
Henn, 1985). 
Evidence for a combination of peripheral and central abnormalities was 
found for the somatosensory system (Bartel et al., 1984) and the visual system 
(Sandrini et al., 1986). The present study was undertaken to find out whether 
the oculomotor, auditory and vestibular systems also exhibit a combination of 
peripheral and central dysfunctions in MyD patients, when studied with 
suitable methods. 
PATIENTS AND METHODS 
Our study population comprised 13 patients with MyD (see Table 1) (8 men 
and 5 women, aged 18-57 years, median age 39 years). The group included a 
father and two sons (Nrs. 12, 2 and 3) and a father and a daughter (Nrs. 11 
and 1). All of the patients met the criteria for MyD according to Griggs and 
Woods (1989). General physical, neurologic and ophthalmologic examinations 
had been performed previously. Special attention was given to eye movement 
disturbances, muscle weakness, atrophy and myotonia. Visual acuity was 
measured. A slit lamp examination for lens opacities and funduscopy were 
performed. A routine otolaryngologic examination was performed on the day 
of testing. Examination results will be mentioned only where relevant. The 
assessment of the severity of MyD was based on both the Karnofsky index 
(Karnofsky and Burchenal, 1949) and the value of the MRC (Medical Research 
Council scale, 1943) sum score of 11 limb muscles (see Table 1). 
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Oculomotor system 
Eye movements were recorded with d.c. EOG. The filter settings were 30 Hz 
low-pass for all the tests except for the saccade velocity test, for which 100 Hz 
was used. Calibration of eye movement was made before each test by having 
the patient look in alternation at two light dots 10° on either side of the 
primary position. The resulting (20°) saccades were analyzed as reported 
previously (Huygen, 1983), in this case using a 125 Hz sampling rate (both 
monocular horizontal leads) and an overall filter characteristic (from input to 
output including the numerical methods of smoothing and differentiation) 
with 3, 6, 12 and 18 dB points at 11, 15, 21 and 25 Hz, respectively. The 
primary saccades which had been best performed, i.e. were followed by only 
a small correction saccade if any, were selected for analysis; testing was 
continued until at least 4 representative saccades in each horizontal direction 
had been collected. Eyelid or other movement artefacts were avoided, if 
possible, by inspecting a vertical lead on the EOG and recorded close-up video 
pictures of the patient's eyes. The 5% lower confidence limit derived from 
measurements in 17 normal subjects (11 men, 6 women, aged 14-85 years) was 
280°/s for the peak velocity; the upper 5% confidence limit for saccade 
duration was 100 ms. Smooth pursuit (SP) was tested using a light dot moving 
in a circular fashion24 (radius 10°, peak velocities in horizontal and vertical 
directions 20°/s). Optokinetic nystagmus (OKN) responses were elicited with 
shadow stripes (7.5° width and separation), projected onto a hemicylindrical 
screen in front of the patient, which covered 100 χ 50° of the visual field. The 
stimulus velocities used were 40 and 60° /s, the lower 5% confidence limit of 
response velocity was 20°/s. Gaze positions were tested to see whether there 
was any gaze nystagmus (in the light, the patient fixating a target at about 30° 
to 40° lateral displacement). 
Auditory system 
Pure tone audiograms (PTAs) were measured with an Interacoustics AC5 
audiometer to determine the hearing threshold (in dB hearing level, HL 
measured according to ISO 825325). We employed the method of ISO 7029 
(1984) to calculate a P95 (95th percentile) threshold value for presbyacusis for 
each patient at each frequency, relating to the patient's age and sex. This 
method is almost equivalent to that of Robinson and Sutton (Robinson and 
Sutton, 1979) who presented a full account of this method. Only a hearing loss 
greater than the P95 value relating to presbyacusis will be called significant 
below. Tympanograms and contra- and ipsilateral acoustic middle-ear muscle 
reflexes were elicited and recorded with an Amplaid 720 tympanometer and 
x-y recorder. 
BAEPs were obtained with a Medelec Sensor AS10/ER94a system linked to 
a PC. Silver-silverchloride cup electrodes were attached to the skin of the 
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forehead and both mastoids. The wrist served as the ground electrode. Skin 
potentials were amplified differentially with 20 or 50 ^V input sensitivity and 
artefact rejection level. Filters were set at 100 Hz high-pass (cut-off 12 
dB/octave down) and 6000 Hz low-pass (cut-off 6 dB/octave down). 
Monaural click stimuli (100 цэ rectangular pulses) were delivered through 
Telephonies TDH-49P shielded earphones. The stimulus rate was 15 Hz; click 
intensity was 70, 80 or 90 dB HL. A masking white noise of 35, 45 or 55 dB 
HL intensity, respectively, was delivered to the contralateral ear. The final 
waveforms were obtained from either 2 χ 2048,4 χ 2048 or 6 χ 2048 (averaged) 
responses to stimuli of alternating polarity, which were sampled within a time 
window of 20 ms, using a 512 address memory. Time-related data pertaining 
to the component waves (for each click intensity) were tested on any 
abnormalities by applying 95% sex-related confidence limits which had been 
established with this equipment in our laboratory. 
Vestibular system 
Vestibular tests were conducted with the patient in the dark with the eyes 
open. It was checked whether there was any spontaneous nystagmus. Velocity 
step (VS) tests were performed with a Tönnies rotatory chair. After 0.8°/s2 
acceleration and a period of 90°/s constant velocity long enough to let the 
perro ta tory nystagmus response subside, the chair was stopped with 200°/s2 
deceleration. The postrotatory nystagmus response was analysed with a 
computer method (Huygen, 1979,1985; Theunissen et al., 1989), which utilized 
the parameter slow phase velocity (SPV) and yielded the following response 
parameters to characterize the vestibulo-ocular reflex (VOR): initial velocity (V, 
90% confidence limits 30-65°/s), time constant (T, 11-26 s) and "Gesamt-
amplitude" or cumulative eye displacement (G = VT, 485-1135°) (Theunissen 
et al. 1989). 
Statistical tests 
Individual values were compared to the above-mentioned normal values. 
Differences in the relative frequencies of any feature were tested in a 2 χ 2 
contingency table using Fisher's exact probability test; the F value (cf. Ρ value) 
is specified only for significant differences (i.e. F < 0.05). Correlations between 
variables were analyzed after calculating correlation coefficients and first-order 
partial-correlation coefficients, provided the variables involved had (approx­
imately) normal distributions and, in combination, showed linear and 
homogeneous bivariate relationships (as judged from scatterdiagrams). 
Correlations involving wave delay (BAEP) variables with their odd mixtures 
of zero and nonzero values (see Table 1) were evaluated by using Fisher's 
(distribution-free) exact probability test. 
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RESULTS 
In general 
All of the 13 patients showed abnormalities on at least one of the examina-
tions. It was striking that 6 out of the 7 patients who were 39 years of age or 
older, i.e. the group of clinically generally more severely affected patients, 
showed one or more severe abnormalities, whereas none of the 6 younger 
patients showed such severe abnormalities. The difference is significant 
(F = 0.020) and provides evidence for increasing penetrance of abnormalities 
with increasing age. Part of the relevant patient data is shown in Table 1. 
Oculomotor system 
No gaze nystagmus was found in any of the patients. Two patients (Nrs. 11 
and 13) had divergent strabism and convergence paralysis, one (Nr. 8) could 
not move his eyes by more than approximately 15° from the primary position. 
Limitation of convergence was found in 3 patients (Nrs. 1, 4 and 7). Other 
oculomotor abnormalities were not observed. 
Saccades 
Saccadic slowing was found in 10 out of the 13 patients and was moderate 
(peak velocity 225-270°/s) in 7 and severe (peak velocity 145-180°/s; duration 
150-210 ms) in 3 patients. The latter 3 patients (Nrs. 8, 11 and 13 in Table 1) 
were among the oldest patients and those who showed the longest duration 
of disease (> 25 years) and were in the low ranges of both the Karnofsky index 
(60-70) and the MRC score (41-46). Interestingly, the 3 patients with normal 
saccades (Nrs. 9,10,12) were of about the same age as the patients with severe 
slowing but had a shorter duration of disease (< 25 years) and (most of them) 
higher clinical scores. It was remarkable that all of the patients who showed 
peak saccade velocities of below 265°/s had some type of clinically apparent 
limitation of eye movement: convergence paralysis with divergent strabism or 
limited excursion (Nrs. 8,11 and 13) was linked to peak velocities in the range 
of 145-225°/s and limitation of convergence (Nrs. 1, 4 and 7) was linked to 
velocities in the range of 225-260°/s. Table 2 shows significant correlations of 
saccade peak velocity with duration of disease, Karnofsky index, MRC score 
and visual acuity. Partial-correlation analysis indicated that only the 
correlation with the Karnofsky index was resistant against controlling for any 
other relevant variable. The correlations with duration of disease and visual 
acuity are likely to be spurious, because they vanished when controlling for 
either of the clinical scores, which procedure attempts to "correct for" the 
patient's clinical condition. 
OKN and SP responses 
OKN responses were normal in all of the patients, both in horizontal and 
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Table 2. Correlation coefficients for the variables with normal distributions and linear homogeneous 
bwanate relationships 
Age 
Duration 
Karnofsky 
index 
MRC score 
Visual acuity 
Peak velocity 
PTA (8 kHz) 
Right 
Left 
Age 
1 
.63]} 
-.571 ] 
-.43 
-.68 1 ] 
-.31 
.81 
.74 
Duration 
1 
-.69)) 
-.82 
-.75]| 
-.59)]] 
.56)] 
.62)]) 
Karnofsky 
index 
1 
.54 
.761 
.73 
-.76 
-.59)1] 
MRC 
score 
1 
.711] 
.681] 
-.22 
-.36 
Visual 
acuity 
1 
•75]] 
-.57)1] 
-.66)1] 
Saccade 
velocity 
1 
-28] 
-.38 
PTA (8 kHz) 
Right Left 
1 
.77) 1 
Significant values (13 data points, г = ±.55 for Ρ = 05) in bold print), Partial-correlation coefficient 
not significant when controlling for age; I, for duration, ], for Karnofsky index; ], for MRC score; 
], Partial-correlation coefficient significant when controlling for Karnofsky index 
vertical directions. Smooth pursuit responses were normal in all the patients 
except for two (Nrs. 11,13) who showed many saccades but also occasional 
smooth hémicycles of sinusoidal response (cf. réf. 8). These two latter patients 
had the lowest visual acuity (0.3-0.5). They were the same as the two above-
mentioned patients with divergent strabism and convergence paralysis. 
Auditory system 
PTAs 
A significant sensorineural high-tone hearing loss, most prominent at 8 kHz 
(30-85 dB, see Table 1) was found in 7 patients (Nrs. 4,6-11). All of these cases 
showed descending audiometer curves beginning at 1 kHz or 2 kHz, their 
hearing loss becoming prominent only at the highest frequencies and leaving 
the speech frequencies almost unaffected. A significant hearing loss at 4 kHz 
is indicated in Table 1 for 3 additional patients (Nrs. 2, 3 and 12). In patient 
Nr. 3, the maximum hearing loss was found at 2 kHz (20-25 dB) bilaterally. 
Patient Nr. 2 had a significant bilateral loss (15 dB) only at 4 kHz. Patient Nr. 
12 had a most prominent loss at 4 kHz bilaterally which was ascribed to 
heavy noise exposure. We did not attribute the hearing loss observed in 
patients Nrs. 2, 3 and 12 to MyD. The (significant) hearing loss at 8 kHz was 
bilateral and symmetrical within 20 dB in most cases. In one case (Nr. 4) it 
was unilateral and in another case (Nr. 8) there was a difference of 50 dB 
between left and right. In the younger age group (< 39 years), 33% (2 out of 
6) of the patients showed a substantial hearing loss (at 8 kHz) as opposed to 
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71% (5 out of 7) in the older age group (39 years and older); the difference is 
not significant. The (significant) hearing loss, however, was more severe in the 
older age group (30-85 dB at 8 KHz) than in the younger age group (30-35 dB 
at 8 kHz). 
Table 2 shows significant correlations of high-tone hearing loss with age, 
duration of disease, Karnofsky index and visual acuity. Only the correlation 
with age was resistant against a partial-correlation analysis. The other 
correlations are likely to be spurious, perhaps except for the one with the 
Karnowsky index, i.e. for one side only. 
Tympanometry and acoustic reflexes 
Normal tympanic membrane mobility was found in all of the 11 patients 
measured (assessment had been omitted in Nrs. 2 and 3) except for one (Nr. 
12) in whom mobility was bilaterally reduced, so we could not measure his 
acoustic reflexes. The reflexes were normal in all the other patients measured. 
BAEPs 
Some absolute wave delay of the total I-V complex was found in 4 of the 
patients (Nrs. 6,7,8 and 11) with a significant high-tone hearing loss at 8 kHz 
(range 0.1-0.38 ms), which was attributed to their hearing loss. It was also 
found in 5 patients (Nrs. 1,2,5,12 and 13) without such a hearing loss (range 
0.09-0.19 ms). This type of delay will not be further considered below. A 
significant interwave delay (IWD) was found in 9 patients (Nrs. 1,2,4,5,7,8, 
10-12, see Table 1). Such a delay was found in the I-V interval alone in 6 cases 
and in both the I-V and the I—III intervals in 3 cases. 
All of the 5 women and 4 out of the 8 men had abnormal I-V IWD; the 
difference is not significant. Four patients (Nrs. 1,4,8 and 12) had a unilateral 
I-V IWD; this was associated with a significant hearing loss at 8 kHz in 3 of 
them, which was only present or most prominent on the same side in 2 of 
these patients (Nrs. 4,8), the third (Nr. 1) showed normal hearing on both 
sides. Only one patient (Nr. 3), who had the shortest duration of disease (2 
years), had both normal PTAs at 8 kHz and normal BAEPs. The three other 
patients with a similar short duration (3 years) (Nrs. 2, 7 and 10) all showed 
bilateral IWD; the two oldest also had significant hearing loss at 8 kHz. Three 
patients (Nrs. 6,9,13) had normal BAEPs with bilateral high-tone hearing loss; 
in one of them (Nr. 13), the hearing loss could be ascribed to presbyacusis. All 
of the 5 patients (Nrs. 2,5,7,10,11) with bilateral significant I-V IWD had a 
significant bilateral high-tone hearing loss, except for the two youngest of 
these (Nrs. 2 and 5) who had a significant IWD (I-V) but normal PTAs at 8 
kHz (for their age). For the patient group as a whole, IWD findings were not 
correlated with PTA findings. The BAEP findings were not clearly correlated 
with age: both normal and abnormal results were obtained from patients of 
various ages; the greater IWDs, however, tended to occur at a higher age. 
There was no significant correlation between the BAEP findings and the 
duration of disease, or the clinical scores. 
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Vestibular system 
None of the patients showed spontaneous nystagmus (eyes open in the dark). 
An abnormal VOR was found in 6 patients. Three patients (Nrs. 2,4,7) showed 
hyperreflexia characterized by a significantly high gain (V, 68-79°/s; G, 
1166-1420°). One of them (Nr. 2) had a mild chronic bronchitis. Patient Nr. 10 
had a similar bronchitis but a normal VOR. 
Hyporeflexia in both nystagmus directions characterized by a significantly 
short VOR time constant (T 4-9 s) was found in 3 patients (Nrs. 9, 11, 13). In 
each of these patients, the short time constants were associated with a high-
tone hearing loss (45-60 dB at 8 kHz), although in one of them (Nr. 13) the 
hearing loss was not significantly higher than the upper confidence limit for 
his age (57 years). A significant IWD (0.54-0.65 ms) was found in only one 
case (Nr. 11). Two of these patients (Nrs. 11, 13) had severe saccadic slowing. 
DISCUSSION 
Oculomotor system 
Saccades 
The high incidence of saccadic slowing (77%) agrees with the 86% reported by 
Oohira et al. (1985) and the 83% recently reported in a different group of 
patients by Ter Bruggen et al. (1990), who used slightly different methods. The 
latter authors found severe slowing in 2 out of 18 patients evaluated with 
EOG. With the introduction of the saccade velocity test, Baloh et al. (1975) 
described 3 patients with MyD who showed severe slowing. We found only 
a slight reduction in peak velocity in 7 patients (54%), whereas in the report 
by Ter Bruggen et al. (1990) 72% was indicated. Just as in the latter report, we 
found that saccadic slowing can be detected in MD patients of any age. It 
must be emphasized that slowing was apparent on visual inspection only in 
the 3 most severe cases. The present study therefore confirms the previous 
observation that a moderate reduction in saccade peak velocity is an important 
subclinical finding in MyD. The present 3 cases with the most severe saccadic 
slowing were found among the older, more severely affected patients, just as 
the 2 cases previously reported on by Ter Bruggen et al. (1990). All of the 6 
patients with the slowest saccades (peak velocities in the range of 145-260°/s) 
had some type of clinically apparent limitation of eye movement (it should be 
noted that the saccade test covered excursions of only ±10° from the primary 
position, which all of the patients were able to perform). No eye movement 
abnormality whatsoever had been apparent upon visual inspection in the other 
4 cases with significant saccadic slowing (peak velocities in the range of 
265-270°/s). So it may be that limitation of eye movement is an indication of 
(more severe) saccadic slowing, but it is also clear that (moderate) saccadic 
slowing was a subclinical finding in at least 4 of the cases. 
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Saccade peak velocity correlated significantly with the clinical scores 
(especially the Karnofsky index). Presumably, this has caused a spurious 
correlation with visual acuity because the latter variable also correlated with 
the clinical scores. The fact that reduced visual acuity and reduced peak 
velocity tended to co-exist in the clinically more severe cases accounted for the 
significant correlation. The observation that the correlation vanishes when 
controlling for the effects of the clinical condition, indicates that a causal 
relationship is unlikely (this also applies to the above-stipulated correlation 
between high-tone hearing loss and visual acuity, which we included as a 
more obvious example of a spurious correlation). In a current study on 
patients with Usher's syndrome, who also have reduced visual acuity, we did 
not find any saccadic slowing sofar (n = 29). 
Two possible explanations might apply to the phenomenon of saccadic 
slowing in MyD. One is based on a dysfunction on the central (pre)motor level 
and the other on a dysfunction on the level of the extra-ocular muscles. Emre 
and Henn (1985) have argued that a peripheral mechanism cannot offer an 
explanation for the dissociation between rapid and slow eye movements or the 
dissociation they observed between horizontal and vertical saccades. They 
consider the rostral pole of the paramedian pontine reticular formation (PPRF) 
to be a likely candidate for a bilateral lesion which might explain such types 
of dissociation. Ter Bruggen et al. (1990) favour a peripheral (myopathic) 
pathophysiologic mechanism. They suggest a selective abnormality of the 
peripheral large muscle fibres with "en piacque" nerve endings (labelled as 
"granular" and "fine" based on histochemic features) which show a fast 
(twitch) activity as required for saccades. This would be combined with the 
relative preservation of the small muscle fibres (with a "coarse" microscopic 
aspect) with "en grappe" nerve endings, which show more tonic activity, as 
is required for smooth pursuit and the slow phase of nystagmus (Ringel et al., 
1978). 
It would appear that a selective abnormality of phasic extra-ocular muscle 
activity would result in a pulse-step mismatch of a peripheral nature. If this 
is so, why did we not observe any sign of such a mismatch, i.e. a hypometric 
saccade followed by a postsaccadic drift (called "glissade" by Weber and 
Daroff (1972) "from the position initially given by an inadequate pulse to the 
gaze angle specified by the step" (Abel et al., 1978). Presumably, such a 
mismatch - by analogy with peripheral abducens (Kommerell et al., 1976) or 
oculomotor nerve weakness (Abel et al., 1978) - can be overcome by a central 
plastic adaptation of the pulse of saccadic innervation. Abel et al. (1978) 
showed that the adaptive adjustment of saccadic amplitude depended on 
changing saccade duration. Optican et al. (1982) could also correlate adaptive 
changes in saccadic innervation to abnormal extra-ocular muscle forces. Given 
the observation that during a normal saccade, the antagonist relaxes 
completely (Robinson, 1975) and that it is in the nature of MyD that relaxation 
can be impaired by myotonia, as was also demonstrated in extra-ocular 
muscles (Davidson 1961; Lessel et al., 1971; Oohira et al., 1985; ter Bruggen et 
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al., 1990) it may well be that abnormal muscle forces are involved. Such 
abnormal forces could be the cause of initially undershooting saccades and the 
ensuing adaptive changes in saccadic innervation, if they occur, might consist 
of an increase in the height of the saccadic pulse - as much as possible - and 
an increase in the duration of the saccadic pulse which, despite the decrease 
in velocity (due to peripheral restraining muscle forces), takes the eye to the 
intended gaze angle. 
OKN and SP responses 
OKN responses were normal in all of the patients, including the two who 
showed many saccades in their SP response. We are therefore inclined to 
attribute the poor SP response to their poor visual acuity (0.3-0.5); remarkably, 
they also had convergence paralysis and divergent strabism. Normal SP 
responses have also been reported by others (Junge, 1966; Oohira et al., 1985; 
ter Bruggen et al., 1990). Contrary to this, the report by Von Noorden et al. 
(1964) stated that horizontal SP responses were defective in all of their 10 
patients with MyD. It appears to us, however, that in at least one of their 
recordings, depicted in their figure 8, which they called "a representative 
sample for the entire group", some smooth parts of the response can be found 
at each of the frequencies (peak velocities 20-45°/s). In view of the fact that 
most patients with MD have reduced vision due to cataract and retinal 
abnormalities (Miller, 1985; Burian and Burns, 1967), we would not be inclined 
to accept a deficit in visual following responses, unless it showed up in both 
the SP and the OKN responses. OKN responses were not reported on by Von 
Noorden et al. (1964). The only previously published OKN responses in MyD 
concerned one patient reported on by Emre and Henn (1985). His horizontal 
eye movement responses were not calibrated, because he could not perform 
any horizontal saccades but, nevertheless, he showed the presence of SP and 
OKN responses. The latter were more lively in vertical directions, where he 
had preservation of saccades. The findings suggest that the horizontal OKN 
gain was too low. The horizontal SP response looked fairly smooth, but we 
cannot infer the absence of saccades from that observation, because the 
horizontal saccades were so severely impaired. 
Auditory system 
PTAs 
The present findings were very similar to those reported previously by Kuhn 
and Ey (1966). The effect of age was also similar, but in our smaller sample we 
found no significant increase in the number of individuals showing a 
significant hearing loss at a higher age. However, the hearing loss (at 8 kHz) 
was most severe in the older age group and the correlation with age was 
significant (and did not vanish by partialing out any relevant variable). We 
did not find, nor did Kuhn and Ey (1966), any major involvement of the 
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speech frequencies such as that reported by Wright et al. (1988). In view of the 
total wave delay (of the I-V complex) found in the BAEPs in some of the 
present cases, or even the presence of fully normal BAEPs in others, we have 
no other explanation for the high-tone hearing loss than involvement of the 
cochlea and/or the cochlear nerve. There was some indication of a significant 
correlation between high-tone hearing loss and the Karnofsky index, however, 
the significance was lost for the left side after partialing out age, duration or 
MRC score. 
Tympanometry and acoustic reflexes 
We found only one case with reduced tympanic membrane mobility, whereas 
Wright et al. (1988) reported abnormal mobility in 8 out of their 25 cases. In 
the report by Kuhn and Ey (1966) the suggestion can be found that in MyD 
the cochlea might be more vulnerable to damage caused by noise exposure. 
We cannot exclude that possibility, but our demonstration of normal acoustic 
reflexes at least shows that such an effect, if it exists, cannot be due to a defect 
in that noise-protection mechanism. 
BAEPs 
The proportion of our patients with BAEPs showing significant IWD (69%) 
was higher than that reported by Thompson et al. (1983), i.e. 53%. The IWD 
findings themselves were fairly similar, although we did not find cases with 
isolated I—III IWD, as reported by the latter authors. Wright et al. (1988) had 
difficulty in evaluating IWD in 2 cases caused by a predominant influence of 
a major peripheral hearing loss; they found normal values in 2 patients and 
a bilaterally delayed wave V in one. Just as Thompson et al., 1983, we had no 
special problems related to peripheral hearing loss and attributed the total 
wave delay found in a number of patients to the high-tone cochlear loss 
shown in the PTAs. In some patients with significant high-tone hearing loss, 
it even appeared that their BAEPs were completely normal. In the patient 
group with IWD reported on by Thompson et al.(1983), there was a signif-
icantly low number of women. In our group, all of the 5 women had IWD and 
only 4 out of the 8 men. 
The IWD, which was also present in some of our patients with normal PTAs 
and, more in general, was not correlated with PTA findings, can only be 
interpreted in favour of a central, i.e. brain stem (auditory) dysfunction. Other 
studies have also indicated central conduction abnormalities of other evoked 
potentials in MyD, such as median nerve SSEPs (Thompson et al., 1983; Bartel 
et al., 1984; Ganes and Kerty, 1988) and pattern VEPs (Gott et al., 1983; 
Sandrini et al., 1986; Ganes and Kerty, 1988; Pinto et al., 1987; ter Bruggen et 
al., 1990). The present study did not indicate any useful correlation between 
BAEP findings and clinical scores. 
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Vestibular system 
It is tempting to speculate about the finding of vestibular hyperreflexia in 
MyD, because, in principle, this is a central abnormality, which has been 
reported in vestibulo-cerebellar dysfunction (Baloh et al., 1975), multiple 
sclerosis (Huygen, 1983), the hyperventilation syndrome (Theunissen et al., 
1986) and idiopathic spasmodic torticollis (Huygen et al., 1989). It can be 
suggested, for example, as in the latter report, that patients with MyD have 
limited head movements and, therefore, develop an enhanced VOR. First, 
however, it must be concluded that in the present series the relative frequency 
of hyperreflexia is not significantly higher than could have been expected on 
the basis of false positivity (see ref. 31 for a statistical discussion). Second, one 
of our patients also had mild chronic bronchitis and our clinical experience 
indicates that such patients fairly often show vestibular hyperreflexia. 
The feature of vestibular hyporeflexia with short time constants was not 
found in a significant number of patients in our study, either, but nevertheless 
it merits special attention. The first patient (Nr. 9) with vestibular hyporeflexia 
had a pronounced bilateral high-tone hearing loss and completely normal 
BAEPs (even without a total wave delay). A labyrinthine deficit which 
involves both the cochlear and the vestibular parts, is a possible explanation. 
Such a possibility cannot be excluded in the second patient with hyporeflexia 
(Nr. 11), who also had a significant bilateral high-tone hearing loss and IWD 
but, in addition, had severe saccadic slowing. However, the former two 
abnormalities often came together in the present group of patients, whereas 
vestibular hyporeflexia occurred only in a minority. The third patient with 
hyporeflexia (Nr. 13) had a high-tone hearing loss which was not abnormal for 
his age, normal BAEPs and also severe saccadic slowing. In the second and 
the third patients, there are two possible explanations for their hyporeflexia: 
a dysfunction of the semicircular canals or the ampullary nerves, or a central 
deficit. In the latter case, similar to our previously reported findings on 
multiple sclerosis, it might be that the hyporeflexia is associated with, or 
secondary to, a central oculomotor dysfunction of, for example, the saccadic 
system (Huygen et al., 1990). It can be shown that the latter two (among the 
3 oldest, i.e. age 45-57 years) patients combined two relatively infrequent 
features, i.e. vestibular hyporeflexia (P = 3/13) and severe saccadic slowing 
(P = 3/13). The number of cases which can be expected to have this specific 
combination in a sample of size 3 is: 3(3/13)(3/13) = 0.16; according to Poisson 
tables, a frequency of 2 is significant (P = 0.012). This implies that it might not 
be a coincidental finding that 2 out of the 3 oldest patients (with the longest 
duration of disease) had developed a clinical picture which combined 
vestibular hyporeflexia with severe saccadic slowing. If these two abnormal 
features are indeed linked, we may assume, by analogy with multiple sclerosis 
(Huygen et al., 1990), that they share a common central causative factor. 
Another calculation showed that the combination of several abnormalities 
might also be associated with an increase of penetrance with age. If we take 
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the chance for each abnormality in the older age group from a lower limit at 
39 years, which is the youngest age at which any of these abnormalities was 
found, the number of cases that can be expected to have both abnormalities 
is 7(3/7)(3/7) = 1.29, thus a frequency of 2 is not significant (P = 0.37). 
In summary, it is clear that with application of the above-mentioned tests, 
(subclinical) peripheral and/or central disturbances of the oculomotor, 
auditory and vestibular systems can be detected in MyD patients. 
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INTRODUCTION 
Myotonic dystrophy (MyD) has the highest overall prevalence and incidence 
of inherited muscular dystrophies in the general population of Western 
Europe (incidence: 1/8000) (Emery, 1991). Upper gastrointestinal (GI) motility 
disturbances are frequent (up to 80%) and cause considerable morbidity 
(Eckhart et al., 1986; Harper, 1989). Pharyngeal peristalsis has been reported 
to be of low amplitude with diminished upper oesophageal pressure and 
normal sphincter relaxation (Swick et al., 1981; Eckhart et al., 1986). Gastric 
emptying (Horowitz et al., 1987a,b) and small intestine motility may be also 
disturbed (Nowak et al., 1984). This may lead to delayed oesophageal 
emptying for solids and liquids (Eckhart et al., 1986; Horowitz et al., 1987a,b). 
The basic mechanism of dysphagia is a combination of myotonia (Bosma and 
Brodie, 1969) and weakness of the striated and smooth muscles (Eckhart et al., 
1986). The influence of the latter is of minor importance for dysphagia 
(Eckhart et al., 1986). 
Sudden aspiration followed by pneumonia is a hazardous complication of 
MyD, which may occur anywhere in the progressive course of the disease 
(Harper, 1989). A correlation between GI symptoms and severity of limb 
muscle weakness is lacking (Swick et al., 1981; Horowitz et al., 1987a). 
Therefore, there remains a need to identify and follow patients who are at 
greatest risk for dysphagia or aspiration and thus in need of extensive studies 
of swallowing function. 
PATIENTS AND METHODS 
Patients 
Twenty-six MyD patients and 28 age matched healthy volunteers were 
investigated according a standard protocol. Only cooperative patients with the 
'classical' (adult onset) form of MyD without prominent mental dysfunction 
or severe proximal weakness were included. 
Methods 
A standardized questionnaire for swallowing (Horowitz et al., 1987a), a bulbar 
rating scale (BRS, Appel et al., 1987) and a slightly modified (150 cc versus 50 
or 90 cc) quantitative swallowing test (ST) were used in all individuals 
(Gordon et al., 1987; DePipo et al., 1992). Patients were asked to drink 150 cc 
(5-oz) water from a cup without interruption (standard teacup; 20 degr.C.). 
The duration to empty the cup was measured with a handhold stopwatch. All 
tests were performed twice by two separate investigators and the shortest time 
was noted. Coughing within 1 minute after swallowing or a postswallow wet-
hoarse voice quality were regarded as signs of aspiration. ST was defined 
abnormal if its value exceeds the mean and two times the standard deviation 
of the controls. The severity of muscular symptoms was graded according to 
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an international rating scale for MyD reported by Mathieu (1992): grade I 
means clinically asymptomatic but characteristic changes on EMG or typical 
lens crystals, grade II minimal distal limb involvement, grade III moderate 
distal limb involvement, grade IV proximal weakness as well and grade V 
wheelchair-bound or severe proximal weakness. Due to the fact that in MyD 
(peri)oral weakness coexists with pharyngeal dysfunction (Harper, 1989), we 
measured the perioral function in order to prevent false positive results for 
swallowing function. In this instance we used the 'snout-index' (Jansen et al., 
1990): perioral weakness was expressed as the procentual decrease from the 
intercommisural distance (ICD) in rest and after repeated 'snouting', measured 
after a warming up to prevent myotonia (Jansen et al., 1990). The quotient of 
perioral function (mean Snout-index) of MyD patients and controls may act 
as a factor for the influence of the (peri)oral phase. 
Statistical analysis 
SAS and CIA statistic computer-programs were used. For correlations, 
Pearsson's correlation coefficient and for group differences, Wilcoxon unpaired 
ranksum test were chosen. 
RESULTS 
The major results are summarized in table 1. The group of MyD patients 
counted 9 females and 17 males (mean age: 35 yrs, SD: 8.7), while the control 
group had 11 females and 17 males (mean age 32 yrs, SD: 7). Only 3 patients 
were aware of mild swallowing difficulties. Using the questionnaire 4 more 
patients revealed mild dysphagia complaints. The duration of swallowing was 
significantly prolonged in 65% of the MyD patients (17/26, see fig. 1). 
Furthermore the values of mean ST were significantly different between MyD 
patient group and the controls (Wilcoxon, ρ < 0.01). 
Perioral weakness was of minor importance for the duration of ST. This has 
to be concluded by a persistent differences of the mean ST duration before 
and after correction for perioral weakness (see methods) (Wilcoxon, ρ < 0.01). 
The duration of swallowing is related to the severity of the weakness of the 
limb muscles. Two arguments support this. First, the ST duration (R: 0.44) 
correlates with the Mathieu score, which expresses the severity of limb muscle 
involvement (p < 0.05, Wilcoxon). Secondly, the ST duration increases 
significantly (Wilcoxon, ρ < 0.05) from nearly asymptomatic patients 
(Mathieu I) to severely involved patients (Mathieu IV) (differences of the 
means: -4.6 (95%CI: -7.8 to -1.36). 
The results of the questionnaire are unrelated to the ST results, although the 
mean ST (10.8, SD: 1.8) for 7 patients with swallowing difficulties but without 
aspiration showed a trend to be prolonged. The test is rather safe, finding only 
once signs of aspiration in a patient with an extremely prolonged ST: 21 sec. 
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Table 1. Results of clinical investigations 
MyD patients controls 
number 
Mathieu score I 
II 
III 
IV 
swall. complaints* 
BRS abnormal 
ST abnormal 
Mean ST: Mathieu 
Snout abnormal 
Mean 'Snout' (SD) 
I 
II 
III 
IV 
26 
5 
4 
12 
5 
7/26 
4/26 
17/26 
8.7* SD 2.9 
10.0 SD 4.7 
11.4 SD 4.4 
13.3* SD 1.2 
16/26 
20.5% SD 8.0 
NS 
NS 
** 
** 
+* 
** 
28 
4.6 SD 1.8 
1/28 
32% SD 6.0 
M I-IV: 
#: 
BRS: 
ST. 
MeanSTM.II/III/IV: 
NS· 
Snout: 
Mathieu score, indicating a rating scale for limb muscle involvement 
dysphagia according questionnaire 
bulbar rating scale (Apple, 1985) 
investigated swallowing test 
ST results Mathieu II vs III vs IV 
Ρ < 0.01 (Wilcoxon ranksum test) 
0.01 < Ρ < 0.05 
not significant 
parameter for perioral dysfunction 
duration in seconds to drink 150cc 
contr. MyD patients 
Fig. 1. Graphical presentation of the mean duration of swallowing (ST) m patients with myotonic 
dystrophy and controls. M I-IV refers to a neuromuscular disability rating-scale specific for MyD patients, 
developed by Mathieu et al (1992). 
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DISCUSSION 
Our observations show that even in minimal and moderate phases of adult 
onset MyD the duration of swallowing, measured by the ST test is prolonged. 
This causes only in a minority swallowing difficulties and seldom aspiration. 
In agreement with previous reports (Jerusalem et al., 1985; Cook and Glass, 
1987; Gordon et al., 1987; DePipo et al., 1992), ST acts as an assessment for 
dysphagia. Although one must assume some co-influence of (peri)oral 
weakness in MyD besides pharyngeal / oesophageal dysfunction, this alone 
cannot completely explain the current ST findings. For MyD, ST mainly 
depends on swallowing function, however the current test does not discrim-
inate between oral, pharyngeal and oesophageal phases. 
What is the value of screening for swallowing with a bedside test like ST in 
MyD? Firstly, a severely prolonged duration of ST (duration > 14 seconds) 
justifies more extensive gastro-intestinal investigations. Further studies are 
required to assess at what duration of ST, aspiration may occur. Secondly, 
repeated measurements may monitor the natural history of swallowing 
difficulties and document the increase of dysphagia of an index patient. 
The current swallowing test (ST) bears some advantages. First of all it is a 
wellknown quantitative test, able to reflect minor changes. The used ST is easy 
and safe to perform, nearly without side effects: only in 1 of 26 patients (4%) 
aspiration was noticed. In addition the test was found rather discriminative 
from healthy controls (sensitivity: 0.65; specificity: 0.75) for a functional test 
in a minimally and moderately affected group. Although experience is mainly 
gathered for motor neuron diseases (Jerusalem et al., 1985), Guillain Barré 
syndrome (Cook and Glass, 1987) and cerebro-vascular diseases (Gordon et al., 
1987; DePipo et al., 1992), this study revealed its usefulness in a slowly 
progressive disorder like MyD as well. 
For cerebrovascular events DePipo (1992) used a similar test with 90 ml of 
water (with videofluoroscopic barium swallow examination as golden 
standard) and found a sensitivity to predict aspiration in 76-94% with false 
negative results in 10%. The specificity to predict aspiration was rather low: 
26-30% in the former study. False positive results were due to other coexisting 
oral or pharyngeal swallowing abnormalities. In our study we tried to 
minimalize this by using a correction factor for (peri)oral weakness. 
To summarize, in accordance with previous reports (Swick et al., 1981; 
Horowitz et al., 1987a,b) we confirm that upper pharyngeal motor dysfunction 
in MyD is highly variable and may occur in absence of swallowing com-
plaints. In contrast to the former reports, but rather in agreement with clinical 
experience, this is the first study to suggest that swallowing dysfunction 
probably gets worse during the successive phases of MyD. Because MyD is 
highly variable, a true progression in previous swallowing studies may be 
discarded. By selection of only the adult onset group of MyD patients and 
using a quantitative method we are able to explain this point of controversy. 
In this study as well, other options for severity of dysphagia like question-
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naires or rating scales are insufficient for follow up (Horowitz et al., 1987a). 
Furthermore, our study demonstrates that the ST is sensitive enough to 
monitor the course or to be used as screening tool for further swallowing 
examination. Future studies are suggested to evaluate the merits of ST as a 
bedside screening tool for identifying MyD patients at risk for aspiration. How 
long is the ST in MyD patients with clinical signs of dysphagia or first time 
aspiration and what is the correlation with definitely abnormal Barium 
studies? Is there any influence of posture on this type of functional swal-
lowing testing? At last, how powerful is the current ST to monitor medical 
inventions? 
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INTRODUCTION 
Myotonic dystrophy (MyD) is an autosomal dominantly inherited multisystem 
disease, which is characterized by progressive muscular weakness, atrophy 
and myotonia. Facial-bulbar muscle weakness is characteristic for adult-onset 
MyD, which can result in a peripheral disorder of speech-motor execution, in 
particular flaccid dysarthria [Darley et al., 1975]. The available clinical 
descriptions of speech in MyD patients [Weinberg et al., 1968; Griggs et al., 
1989] are qualitative and therefore insufficient to assess a possible concomitant: 
a more central disorder of speech-motor programming - apraxia of speech. 
In the present study we selected mildly affected, early-adult and adult onset 
MyD-patients. The patients had no intellectual impairment and no known 
neuropsychological dysfunction. The question was: Given the fact that there 
is muscular involvement, to what extent does this affect the speech-motor 
function? If only dysarthric signs are observed, this suggests that the disease 
is restricted to speech-motor execution. If apraxic signs are also observed, this 
is evidence for the additional involvement of speech-motor programming. 
In order to determine whether MyD speech contains apraxic characteristics 
and to specify the type of dysarthria further, a set of speech- and oral-motor 
tasks was administered to assess the integrity of speech-motor programming 
and speech-motor execution on a quantitative level. 
SUBJECTS AND METHODS 
Subjects 
The experimental group consisted of 15 patients with early-adult and adult 
onset MyD. The patients were asked to participate during a consultation at the 
Department of Neurology, University Hospital Nijmegen. The following 
selection criteria were applied. The patients were members of kindreds with 
classical myotonic dystrophy in accordance with the published criteria [Griggs 
et al., 1989], and were classified as adult or early adult onset with a mild or 
moderate severity of neuromuscular disability [Harper, 1989]. The diagnosis 
of MyD was made by DNA linkage analysis in their families [Brunner et al, 
1989a], and positive (myotonic) EMG and/or split-lamp test [Griggs et al., 
1989; Brunner et al., 1989a]. Other inclusion criteria were: Muscular Disability 
Rating Scale score of 3 or less [Mathieu et al., 1992]; and normal hearing. The 
patients had no intellectual impairment according to anamnestic information; 
this was confirmed by neuropsychological assessment (mean IQ: 107.6). The 
group consisted of 8 female and 7 male subjects with a mean age of 36.2 years 
(sd=8.6 yrs.). The duration of the disease ranged from 0;3 years (0 years, 3 
months) to 30;0 years with a mean of 11;0 years (sd=8;4 yrs.). 
For each MyD subject, a control subject was selected and matched with 
respect to age, sex and educational level. The control subjects reported a 
history free of speech- or hearing-related problems. Informed consent was 
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Table 1. Subject characteristics of the experimental (MyD) and the control group 
Exp, 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
. Gr. 
Ag£ 
27 
30 
36 
22 
38 
42 
49 
52 
26 
28 
32 
32 
37 
41 
43 
(MyD) 
; S 
F 
F 
F 
F 
F 
F 
F 
F 
M 
M 
M 
M 
M 
M 
M 
El 
2 
1 
3 
1 
3 
1 
1 
1 
2 
2 
3 
3 
3 
2 
1 
Severity 
Inh Dur 
Ρ 
Ρ 
Ρ 
M 
M 
M 
Ρ 
M 
Ρ 
M 
Ρ 
Ρ 
Ρ 
M 
M 
13,0 
14,0 
21,1 
2,8 
5,0 
5,0 
10,0 
7,0 
5,6 
0,3 
6,6 
10,0 
18,11 
30,0 
18,0 
MDRS 
3 
3 
3 
3 
3 
3 
2 
2 
3 
2 
3 
3 
3 
2 
3 
SI 
23 
14 
16 
33 
18 
-
-
-
-
15 
15 
-
12 
28 
-
M 
Y 
N 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
N 
Y 
Y 
Y 
Y 
Y 
Control Group 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Age 
27 
30 
36 
23 
38 
43 
40 
57 
26 
31 
31 
34 
38 
35 
40 
S 
F 
F 
F 
F 
F 
F 
F 
F 
M 
M 
M 
M 
M 
M 
M 
El 
2 
1 
3 
1 
3 
1 
1 
1 
2 
2 
3 
3 
3 
2 
1 
Note S sex F=female, M=male 
El Educational level l=lower, 2=intermediate, 3=higher education 
Inh inheritance P=paternal, M=matemal 
Dur duration m years,months 
MDRS Muscular Disability Rating Scale [Mathieu et a l , 1992] 
SI snout index (perioral weakness indicator [Jansen et a l , 1990]) 
Μ myotonic EMG limbs (Y = positive, Ν = negative) 
obtained from both the experimental and control subjects. In Table 1 the 
subject characteristics are summarized. 
In a brief interview at the beginning of the speech-motor assessment session, 
eight of the experimental group patients reported initiation problems in their 
speech, which were reported to disappear after motoric warming-up. In three 
patients reduced intelligibility and increased speech exertion were reported as 
the first signs of fatigue. No effects of psychological condition, other than 
fatigue, were reported. 
To obtain an initial characterization of the subjects' speech, the interviewing 
speech pathologist evaluated fragments of spontaneous speech produced 
during the interview. The speech of ten patients was judged as unremarkable. 
Five patients showed slight signs of imprecise articulation. Overall, the pa­
tients were perfectly intelligible and the speech signs were judged to be mild. 
Procedure 
The patients were administered a neurological examination and a number of 
speech and oral motor tasks. Two of the speech and oral motor tasks were 
intended to assess integrity of motor execution and two of the tasks were 
intended to assess motor programming. Maximum Sound Prolongation and 
Maximum Repetition Rate for monosyllabic sequences were used to measure 
motor execution or dysarthria Maximum Repetition Rate of multisyllabic 
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sequences and Pseudoword Imitation were used to measure motor program-
ming or apraxia of speech. 
For the Maximum Sound Prolongation task, the subjects were requested to 
sustain the speech sounds / a / , / z / , / s / , and /f/ for as long as possible. After 
instruction they were given three trials and the best of these was used for 
analysis. Performance on the Maximum Sound Prolongation task depends on 
the respiratory mechanism and on the integrity of the phonatory and 
articulatory mechanisms [Kent et al., 1987; Wit et al., 1993]. Thus, prolongation 
differences between the voiced /a, z/ and voiceless /s , f/ sounds, - and the 
s/z ratio in particular - are of diagnostic significance for laryngeal problems 
[Eckel and Boone , 1981; Mueller et al., 1991]. Prolongation of /f/ predom-
inantly tests the lips, and prolongation of /z, s/ predominantly test the tongue 
tip [Kent et al., 1987; wit et al., 1993]. 
For the Maximum Repetition Rate of monosyllabic sequences the subjects were 
asked to repeat the following sequences as fast as possible: "papa.." (phonetic 
notation: /pApA/ ) and "fafa.." (/fAfA/) to test the lips and the jaw; "tata.." 
( / tAtA/) and "sasa.." ( /sAsA/) to test the tongue tip; and "kaka.." ( /kAkA/) 
and "xaxa.." (/xAxA/) to test the tongue body. The subjects were given 
several trials, and the best of these was selected for analysis. A reduced 
repetition rate in monosyllabic sequences points to motor execution problems 
and has been found to characterize several types of dysarthria [Fletcher, 1972; 
Darley et al., 1975; Kent and Rosenbeck, 1982; Wit et al., 1993; Wit et al., in 
press]. Such reduced repetition has not been found to characterize apraxia of 
speech [Kent and Rosenbeck, 1982]. 
For the Maximum Repetition Rate of multisyllabic sequences the subjects were 
asked to repeat the sequences "patakapataka.." and "fasaxafasaxa.." as fast as 
possible. A reduced repetition rate in multisyllabic sequences relative to the 
monosyllabic sequences is often used as a criterion for the selection of apraxic 
subjects [Aram and Horowitz, 1983; Dewey et al., 1988] and points to a motor 
programming dysfunction. 
The Pseudoword Imitation task consisted of 27 pseudowords. The successive 
consonants within each pseudoword were highly similar, which is known to 
elicit speech errors in subjects with apraxia of speech [Thoonen and Maasen, 
1992; Maasen and Thoonen, 1993]. 
Data Analysis 
Acoustic analysis. To obtain a Maximum Sound Prolongation score, the dura-
tions of the three trials per sound were measured directly from the audiotape 
using a stopwatch. After selection of the longest trial, this trial was then 
measured twice again. The total Maximum Sound Prolongation was calculated 
by averaging the mean durations for the / a / , / z / , / s / , and /f/ sounds. 
The Maximum Repetition Rate of monosyllabic sequences was measured 
in a semi-automatic way using a digitized signal. Syllable durations and 
consonant durations were determined according to the procedure of Ziegler 
et al. [1988]. In addition, a consonant ratio was calculated by dividing the 
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duration of the consonant by the total syllable duration. 
The multisyllabic sequences "pataka.." and "fasaxa.." were analyzed more 
globally: The total duration of the utterance was divided by the number of 
syllables. 
Pseudoword imitations were phonetically transcribed and analyzed with the 
LIPP phonetic analysis software [LIPP, 1991]. The following calculations were 
then made: (1) the frequency and percentage of substitutions; (2) the frequency 
and percentage of omissions; and (3) the percentage retention for place-of-
articulation, manner-of-articulation, and voicing [Klich et al., 1979; Maasen et 
al., 1991; Maasen and Thoonen, 1993]. 
Statistical analysis. Analyses of variance were performed on the MSP and MRR 
measurements. Factors in the analysis were: Group (MyD, Control subjects), 
Sound (/a/, /z/, /s/, /il), and for the monosyllabic sequences: Place-of-
articulation (labial: /p, f/, alveolar: /t, s/ and velar: /k, x/), and Manner-of-
articulation (Plosive: /p, t, k/, Fricative: /f, s, x/ sequences). The multisyllabic 
durations were analyzed separately against the mean monosyllabic durations. 
All effects were tested against the interaction with subjects, which was 
considered a random factor, thereby minimizing type 1 error and maximizing 
generalizability [Winer et al., 1991]. 
RESULTS 
Maximum Sound Prolongation 
The MyD group performed poorer than the Control group on the Maximum 
Sound Prolongation task (factor Group: F(l,28) = 4.20, ρ < 0.05) as can be seen 
in Table 2. Both groups showed fairly equal durations for /a/, /z/, and /s/, 
but shorter durations for /f/ (factor Sound: F(3,84) = 5.33, ρ < 0.01). The 
interaction between Group and Sound was not significant (F < 1.0). 
Maximum Repetition Rate 
The MyD group also performed significantly poorer than the control group on 
the Maximum Repetition Rate for monosyllabic sequences (factor Group: 
F(l,28) = 5.29, ρ < 0.05), as can be seen in Figure 1. The pattern of relative 
syllable durations (plosive sequences faster than fricative sequences) was 
identical for both groups. In order to disentangle the contribution of the 
duration of the consonant and the vowel, the consonant ratio was calculated: 
the duration of the consonant (plosive or fricative) was divided by the total 
duration of the syllable. The MyD subjects produced relatively longer 
consonants (larger ratios) in the plosive sequences than in the fricative 
sequences (ratios 0.48 and 0.46, respectively), compared to the control subjects 
(ratios 0.42 and 0.44); this interaction was significant (F(l,27) = 4.23, ρ < 0.05). 
The latter effect is strongest in the sequences with labial place-of-articulation 
("papa.., fafa.."; ρ < 0.05). 
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Table 2. Mean and standard errors (italics) of Maximum Prolongations of la, z,f, si produced by the 15 
MyD and 15 Control subjects 
/a/ 
/z/ 
/s/ 
/f/ 
Overall 
MyD 
21.3 
19 7** 
20 8** 
14.5** 
19.1** 
2.54 
2.69 
1.97 
2.73 
2.54 
Controls 
26.5 
28.8 
32.4 
22.6 
27.6 
2.7S 
3.54 
4.59 
5.44 
4.20 
Note: Significance level of difference between MyD and Controls-
* ρ < 0 05 
** ρ < 0.01 
The MyD subjects produced the multisyllabic sequences, as the monosyllabic 
sequences, significantly slower than the control subjects (factor Group: F(l,28) 
= 5.58, ρ < 0.05; see Figure 1). More importantly, both the MyD and the 
control subjects produced the multisyllabic sequences slightly but significantly 
faster than the monosyllabic ones (F(l,28) = 6.14), ρ < 0.05); the relative 
durations of mono- and multi-syllabic sequences is similar across groups. 
Pseudoword Imitation 
Results of the pseudoword imitation task are presented in Table 3; no 
omissions were produced by either group. The very slight differences between 
the MyD and control groups with respect to percentage substitutions, and 
percentages retention of place- and manner-of-articulation, and voicing were 
not significant. 
Correlations between subject characteristics, MyD-severity indices and speech 
measures 
Correlations between the MyD-subject characteristics age, sex, educational 
level and age of onset, and the severity ratings MDRS, SI and M (see Table 1), 
did not prove significant even at the .05 level. As regards the relation between 
subject characteristics and severity ratings on the one hand, and speech 
measures on the other, only the correlation between sex and maximum 
repetition rate of the multisyllabic sequence "pataka.." (r = 0.609, ρ < 0.05) was 
Table 3. Results of pseudoword imitation task for MyD and control group Presented are· number and 
percentages of substitutions, and percentages retention of place-of-articulation, manner-of-arttculation and 
voicing; standard errors in italics 
MyD Control Group 
# substitutions 4.07 72 3.27 .96 
% substitutions 5 02 .89 4.03 1 19 
retention of place % 97.3 48 96.9 98 
retention of manner % 98.3 57 98.7 72 
retention of voicing % 98.6 .39 99.0 44 
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Syllable duration (me) 
250 
200 
150 
100 
50 
PI:mon-trl Fr:mon-trl PI:mon-trl Fr:mon-trl 
MyD (n = 15) Controls (n = 15) 
Fig. 1. Mean syllable durations (connected by drawn lines) and standard deviations of the mono- and tri­
syllabic plosive and fricative sequences, for the MyD and Control group. 
significant; females were slower than males. However, significant correlations 
were found between the subjective speech assessment by the interviewing 
speech pathologist and the objective speech measures maximum repetition rate 
of monosyllabic velar sequences "kakaka.., xaxaxa.." (r = 0.524, ρ < 0.05) as 
well as multisyllabic fricative sequence "fasaxa.." (r = 0.614, γ < 0.05); the five 
patients with signs of imprecise articulation were slower. 
DISCUSSION 
Clinical descriptions of mildly affected, early-adult and adult onset MyD 
patients indicate qualitative speech abnormalities but provide little other 
information as to the exact nature of the problem. In the present study a 
quantitative assessment of MyD symptoms was therefore undertaken. The 
question was whether or not the speech of MyD patients contains apraxic 
characteristics. In order to answer this question, the difference in Maximum 
Repetition Rate for multisyllabic and monosyllabic sequences was determined. 
Previous studies [Maasen et al., 1991; Wit et al., 1993] have shown an overall 
slowing of both monosyllabic and multisyllabic sequences in dysarthric 
patients and a slowing of multisyllabic sequences relative to monosyllabic 
sequences in apraxic patients. The MyD patients in the present study clearly 
showed a dysarthric profile. That is, the monosyllabic sequences were 
produced significantly slower by the MyD subjects than by the control 
subjects, while both of the subject groups produced the multisyllabic 
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sequences slightly faster than the monosyllabic sequences. This suggests that 
the MyD speech abnormalities may be limited to motor execution. 
Further evidence against the involvement of higher motor programming 
processes comes from the speech errors produced in the pseudoword imitation 
task. Only very slight and nonsignificant differences between the MyD 
patients and control subjects were found. No significant differences were 
found in the substitution rates or in the retention percentages for place-of-
articulation, manner-of-articulation, and voicing information. 
A secondary aim of the present study was to establish more firmly the 
nature of the dysarthria in a group of mildly affected MyD patients. Maximum 
Sound Prolongation and Maximum Repetition Rate yielded an overall poorer 
score for the MyD patients when compared to control subjects. Shorter 
stretches of speech and slowed speech strongly indicate flaccid dysarthria [1]. 
Moreover, performance on some of the maximum repetition rate sequences 
correlated significantly with the judgement 'imprecise articulation' of the 
speech language pathologist. 
Two further specifications of the dysarthria are in order. 
First, identical profiles were found on the Maximum Sound Prolongation and 
Maximum Repetition Rate duration measures, which suggests that the muscle 
weakness observed in the MyD subjects is not restricted to a particular 
articulatory organ. 
Second, the consonant ratios for the labial Maximum Repetition Rate sequences 
were the shortest for the control subjects and among the longest for the MyD 
subjects. Such high consonant ratios reflect problems with rapid alternating 
movement of the lips (and jaw). Furthermore, in contrast to the control 
subjects, the MyD subjects produced systematically higher consonant ratios in 
the plosive sequences than in the fricative sequences. In plosive sequences a 
complete occlusion of the vocal tract is made, which requires more muscle 
activity than in fricative sequences, where incomplete occlusion suffices 
[Harris et al., 1985]. The relatively high consonant ratios indicate overshoot 
rather than undershoot in the production of plosives by the MyD subjects. 
Taken together, the results suggest the effects of myotonia: the inability to 
relax in particular the lips, where the increase of the consonant ratio is most 
prominently present. The absence of significant correlations between motoric 
severity ratings, which reflect weakness in particular, and speech measures 
further supports this interpretation. 
To summarize: A procedure to quantitatively assess the integrity of speech 
motor execution and speech motor programming was applied to a group of 
mildly affected, early-adult and adult onset MyD patients. From the absence 
of apraxic signs, it can be concluded that there is no involvement of speech 
motor programming. The observed speech motor execution signs point to flaccid 
dysarthria. Relative differences between MyD and control subjects can 
tentatively be interpreted as the result of myotonia, particularly in the perioral 
musculature. 
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With the quantitative assessment procedure used in this study, one of the 
signs of MyD in an early phase can be detected. Moreover, an objective 
instrument is available to evaluate the results of therapy, that might be 
developed in the near future. 
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INTRODUCTION 
Myotonic dystrophy (MyD) is an autosomal dominant multisystem disease 
with a variable clinical expression. The primary genetic defect is an increased 
number of cytosine-thymidine-guanine (CTG) trinucleotide repeats in the 3' 
untranslated sequence of a gene, located at the ql3.3 band of chromosome 19 
(Aslanidis et al., 1992; Buxton et al., 1992; Harley et al., 1992). Expansion of the 
CTG repeat correlates with early onset and severity of MyD (Buxton et al., 
1992; Brook et al., 1992). The principal symptoms are myotonia, slowly 
progressive weakness and atrophy (Harper, 1989), but, since MyD is a 
multisystem disease and the genetic deficit is present in every cell, symptoms 
and signs arise in several tissues and organs (Moxley, 1992). Cognitive 
impairment is common in MyD and is often the most disabling component of 
the disease. Most studies in MyD showed mild to severe intellectual deficits 
(Woodward et al., 1982; Bird et al.,1983; Portwood et al., 1986; Perini et al., 
1989; Walker et al.,1984; Malloy et al., 1990; Censori et al., 1990; Ragazzoni et 
al., 1991; Chang et al., 1993), but some did not (Brumback, 1987; Franzese et 
al., 1991). The diversity of these findings depends largely on the composition 
of the group of patients under study (Stuss et al., 1987; Huber et al., 1989), but 
also on the way in which cognitive functioning was assessed. Accordingly, if 
one intends to investigate cognitive functioning in MyD, it is necessary to 
study homogeneous groups. Furthermore, some studies only assess global 
intelligence, some studies also measure more subtle cognitive functions of 
which impairment may occur in absence of diffuse intellectual deterioration. 
Despite a normal IQ profile, Chang et al., (1993) did not find any completely 
normal SPECT in a homogeneous subgroup of MyD patients with parental 
inheritance and with early adult and adult onset. Thus, it is not at all 
excluded, that these patients might have shown discrete cognitive dysfunctions 
in a more detailed neuropsychological assessment. As far as we know, the 
study of Franzese et al. (1991) is the only one which investigated a homogene-
ous group of patients, but with a very restricted test battery, and there are no 
studies, which investigated cognitive functioning in a homogeneous group of 
MyD patients as well as with a broad spectrum of neuropsychological tests. 
The aim of the present study was to investigate whether normal intelligent 
MyD patients with early adult and adult onset show subtle cognitive 
dysfunction. We compared a homogeneous group of mildly disabled patients 
without mental retardation and with early adult and adult onset MyD and a 
group of matched control subjects (CS) on a range of neuropsychological tests 
and motor tasks of increasing complexity, which required correspondingly 
more cognitive control. With respect to the motor tasks: if MyD impairs 
cognitive control of motor performance, patients suffering from MyD will 
show a greater drop in performance from simple to complex motor tasks, than 
CS. 
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MATERIALS AND METHODS 
Subjects 
The patients included in this study are members of kindreds with classical 
myotonic dystrophy according to the diagnostic criteria of Griggs and Wood 
(1989). All patients had an early adult and adult onset, that is an onset 
between the ages of eleven and forty-five years in terms of the criteria of Koch 
et al. (1991). Patients with non-MyD symptoms, with sleep apnoea (Broughton 
et al., 1990), or using drugs, that might interfere with test performance, were 
also excluded. Patients with an IQ < 80, impaired vision or hearing and a 
Karnofsky disability-score < 70 (Karnofsky, 1949) were also excluded from this 
study. We used two rating scales to assess muscular disability: the Muscular 
Disability Rating Scale (MDRS) (Mathieu et al.,1992) and the scale of the 
Medical Research Council (MRC) (1982). Eventually, twenty-four patients 
participated in this study. All gave informed consent. We added 2 patients 
with a diagnosis of MyD on the basis of DNA linkage studies and positive 
pedigree structure (Brunner et al., 1989). Thus, the total group consisted of 26 
patients. Seven patients had maternal, and fourteen had paternal inheritance. 
In five patients inheritance was unknown. All patients scored below the cut-
off score of the Zung depression scale (Zung, 1965). A sample of 24 healthy 
control subjects (CS), matched for age, IQ and educational level, was obtained 
from relatives and hospital employees. Table 1 summarizes some demographic 
and clinical data. 
Table 1. Demographic and clinical characteristics of patients suffering from myotonic dystrophy (MyD) 
and control subjects 
MyD 
26 
13/13 
35.6 (10.3) 
10.2 (3.8) 
107.6 (18.3) 
24 8 (8.9) 
121.1 (102.5) 
7 (26%) 
14 (54%) 
5 (19%) 
83.8 (9.4) 
51 (5.2) 
2 9 (0.6) 
18 (70%) 
CS 
24 
9/15 
38.3 (10.3) 
9.5 (3.4) 
110 9(15.1) 
MRC Medical Research Council scale 
MDRS: Muscular Disability Rating Scale 
Number 
Ratio male/female 
Age 
Educational level (yrs) 
WAIS-IQ 
Age at onset 
Duration (months) 
Maternal inheritance 
Paternal inheritance 
Inheritance unknown 
Karnofsky score 
MRC sum score 
MDRS 
Dysarthria 
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Methods 
We selected neuropsychological tests which assess a broad spectrum of 
cognitive functions, such as memory, maintaining set, visuospatial scanning, 
fluency and executive function, besides global intelligence. Impaired executive 
functions are extensively documented in frontal lobe dysfunction, but also in 
diseases with subcortical degeneration (Albert, 1978), such as Parkinson's 
disease (Cools et al., 1984; Taylor et al., 1986; Cummings, 1988), Huntington's 
disease (Caine and Fisher, 1985; Starkstein et al., 1988; Bamford et al., 1989), 
supranuclear palsy (Milberg and Albert, 1989) and multiple system atrophy 
(Robbins et al., 1992). 
To assess intelligence we made a valid and reliable selection of four subtests 
from the revised Wechsler Adult Intelligence Scale (WAIS-R): vocabulary and 
similarities, measuring verbal intelligence, and picture completion and block 
design, measuring visuoperceptual intelligence (Cyr and Brooker, 1984). 
Memory was assessed by means of the California Verbal Learning Test (Delis 
et al., 1987). We selected the CVLT, because this test not only provides a 
measure of the amount of information that a subject is able to remember, but 
also a multi-factor framework for quantifying his learning strategies. The 
CVLT is composed of two shopping lists, each containing 16 common items 
bought in stores. The 16 items on each list are presented in random order. 
Each item belongs to one of four semantic categories embedded in the test (i.e. 
clothing, tools, fruit and spices). The first list was read aloud by the experi­
menter for a total of five trials. Test protocols were scored using the IBM-PC 
California Verbal Learning Test scoring program (Fridlund and Delis, 1987). 
Score was the total number of words recalled over the five trials. The semantic 
and serial cluster ratio reflected the semantic, respectively serial clustering 
tendency, both being learning strategies. It was obtained by dividing the 
observed cluster score (i.e. the total number of semantically clustered words) 
by the cluster score expected by chance. A decrease of semantic clustering 
(Taylor et al., 1990; Buytenhuijs et al., 1994) and an increase of serial clustering 
(Buytenhuijs et al., 1994) are established in Parkinson's disease, and might 
therefore be linked with subcortical dysfunction. We included a variety of tests 
measuring executive functions (Lezak, 1983). The Stroop Colour Word Test 
involves the ability to inhibit a well-rehearsed response in favour of a counter­
intuitive one (Jensen and Rohwer, 1966). The test consists of three cards. The 
subject had to read words, each designating one out of four colours (red, blue, 
yellow and green), printed in black ink on card A, then name the colour of 
coloured bars, printed on card B, and finally, name the colour of the ink, in 
which words designating a different colour were printed (card C). For 
example, when the word 'green' is printed in red ink, the correct response is 
'red'. Score was the time in seconds needed by a subject for each card. The 
score of interference was calculated by subtracting the score of card В from 
that of card C, thus extracting speed of performance. The Trail Making Test 
(TMT) consists of the sections A and В (Reitan, 1958). Initially, in section A the 
numbers 1-25, randomly distributed on a sheet of paper, had to be connected 
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in order with a pencil line as quickly as possible. In section B, the numbers 
1-13 and the letters A-L (again randomly distributed) had to be connected in 
order using an alternating number-letter sequence. The score was the time 
difference between section A and В (B-Α). This removed the effect of motor 
speed from performance. The Verbal Fluency tests (VFT) required the subjects 
to enumerate as many animals as possible during one minute. The score was 
the number of items generated. The Wisconsin Card Sorting Test (Berg, 1948) 
is a categorization test. In this test the subject began to sort on the basis of trial 
and error according to a criterion that was only known to the experimenter. 
A false response was corrected by the experimenter. After a fixed number of 
correct responses the experimenter changed the criterion twice without 
informing the subject. In order to exclude biasing differences in speed of 
information processing there were no time constraints. Performance was 
reflected in the number of categories the subject discovered (Bowen, 1976), and 
the total number of trials he needed (Van Spaendonck et al., 1993). 
We presented a range of motor tasks to be performed by each hand 
separately (Perret et al. 1970; Cools et al., 1984). For these tests, keyboards 
were constructed with four push-buttons. Measurement of pushes was 
computerized. Before starting the motor tasks the patients were asked to 
clench their hands as often as they needed to get rid of stiffness. Motor ability 
was assessed in a number of tasks of increasing complexity. The first was 
classical diadochokinesis of each hand separately. The other tasks were finger 
tapping tasks of increasing complexity. In the first three tasks, the subjects had 
to press one push-button with the index finger as fast as possible for a period 
of 5 s. Then they had to press all push-buttons with the index finger. Next, 
they had to place the four fingers on the buttons and to push the buttons in 
a random sequence for 10 s. In the following series complexity with respect 
to response planning and motor programming increased (Schmidt, 1982 and 
1988; Mulder, 1991). The subjects had to press the push-buttons in a fixed 
sequence of increasing complexity, firstly, index finger - middle finger - ring 
finger - little finger; next, index finger - ring finger - middle finger - little 
finger; and finally, they had to shift from the first and simple sequence to the 
second and more complex one. The latter task enables us to differentiate 
between response planning and motor programming: if performance of MyD 
patients is significantly poorer than that of CS in the shifting condition, but 
not in the two prior conditions, then it seems plausible there is an impairment 
in the non-output specific planning, i.e. on the level of response planning, 
rather than in the output specific motor programming. The following scores 
were computed: the total number of pushes in each task; the total number of 
correct successive pushes in the shifting task (a push was counted as correct 
when it was preceded or followed by the correct push as defined in the 
sequence). 
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RESULTS 
Table 2 summarizes means, standard deviations and t tests of the neuro­
psychological test scores. The groups of patients and CS were matched for 
intelligence. 
Table 2. Means and standard deviations of neuropsychological test scores 
level of significance is associated with t values 
CVLT 
first shopping list 
immediate recall 
semantic ratio 
second shopping list 
immediate recall 
first shopping list 
short term 
free recall 
short term 
cued recall 
long term 
free recall 
long term 
cued recall 
Stroop A 
Stroop В 
Stroop С 
Stroop С-В 
ТМТ А 
ТМТВ 
ТМТВ-А 
Verbal fluency 
WCST sum categories 
WCST sum trials 
Mean 
57 64 
195 
814 
1190 
13 27 
1318 
13 45 
49 48 
64 64 
115 48 
50 80 
38 92 
93 50 
54 00 
19 54 
3 73 
22 00 
MyD 
(n = 26) 
sd 
10 52 
0 74 
2 60 
310 
2 91 
2 86 
2 63 
10 03 
1156 
2148 
13 40 
1718 
37 60 
22 61 
4 63 
0 45 
13 93 
Mean 
60 06 
218 
7 61 
12 98 
13 94 
13 78 
14 06 
42 88 
54 79 
90 58 
35 79 
32 86 
77 43 
44 57 
2213 
3 79 
2121 
CS 
(η = 24) 
sd 
8 68 
0 72 
2 30 
2 27 
1 77 
2 07 
177 
813 
10 08 
19 70 
12 63 
14 91 
35 90 
26 08 
5 47 
5 47 
13 61 
significance 
oft 
Ρ 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
<05 
<005 
<0001 
<0005 
ns 
ns 
ns 
ns 
ns 
ns 
Globally, the Myd patients did perform as well as the CS on all tests. With 
respect to the CVLT we also tested whether the learning performance of the 
MyD and that of CS differed over the five trials. A MANOVA test revealed 
that there was no group χ trial interaction: F = 1.33 (ns). There were no 
significant differences between the groups with respect to the semantic and 
serial cluster ratios. Thus, we did not find any indication of cognitive 
impairment, with the exception of the Stroop Colour Word Test. Even after 
correction for speed of performance by subtracting time of performance of the 
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simple Card В from that of the complex card C, the scores of the MyD patients 
remained significantly higher than those of CS 
Table 3 summarizes means, standard deviations and t tests of the motor 
scores 
Table 3. Means and standard deviations of motor scores level of significance is associated with t values 
diadochokinesis DH 
diadochokinesis NDH 
Tapping tasks 
index one button DH 
index one button NDH 
index four buttons DH 
index four buttons ND 
free sequence DH 
free sequence NDH 
1-2-3-4 DH 
1-2-3-4 NDH 
1-3-2-4 DH 
1-3-2^1 NDH 
Shifting tasks 
1-2-3-4 DH total 
1-2-3-4 NDH total 
1-2-3^1 DH correct 
1-2-3^ NDH correct 
1-3-2^1 DH total 
1-3-2-4 NDH total 
1-3-2-4 DH correct 
1-3-2-4 NDH correct 
Mean 
118 
10 9 
219 
19 8 
9 1 
8 7 
24 6 
23 2 
219 
213 
175 
178 
20 6 
215 
18 8 
19 3 
176 
16 6 
14 6 
12 8 
MyD 
(n = 26) 
sd 
4 6 
4 8 
6 3 
5 6 
3 5 
3 8 
9 1 
79 
79 
8 0 
6 7 
8 4 
77 
7 3 
8 6 
6 3 
79 
79 
71 
79 
Mean 
16 7 
16 0 
25 5 
23 9 
126 
12 4 
37 5 
29 7 
29 3 
271 
19 4 
18 5 
27 0 
26 1 
20 7 
19 8 
19 5 
18 5 
15 3 
13 0 
CS 
(η = 24) 
sd 
2 7 
3 1 
4 0 
3 4 
6 0 
5 0 
201 
10 2 
9 7 
8 6 
7 9 
8 2 
8 2 
8 3 
9 2 
9 1 
76 
9 0 
6 5 
9 0 
significance 
oft 
Ρ 
<0005 
<0005 
<05 
<01 
<05 
<01 
<05 
<05 
<01 
<05 
ns 
ns 
<05 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
DH dominant hand 
NDH non-dominant hand 
total total number of pushes 
correct number of correct pushes 
MyD patients showed a significantly poorer performance on simple tasks. 
However, the difference between the groups decreased on more complex 
tasks, that required increasingly cognitive control. In the most complex task, 
i.e. the shifting task, the difference between MyD patients and CS has 
disappeared. 
Since we were interested in the relationship between the measures, which 
differentiated between the groups, we calculated the correlations (Pearson's 
r) between the motor scores and the scores of the Stroop Colour Word Test in 
both groups. 
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Table 4. Correlations between scores of motor tests and Stroop performance· level of significance is 
associated with Pearson's r 
Stroop card 
diadochokinesis DH 
diadochokinesis NDH 
Tapping tasks: 
index one button DH 
index one button NDH 
index four buttons DH 
index four buttons NDH 
free sequence DH 
free sequence NDH 
1-2-3-4 DH 
1-2-3^1 NDH 
1-3-2-4 DH 
1-3-2-1 NDH 
Shifting tasks: 
1-2-3-4 DH total 
1-2-3-1 NDH total 
1-2-3-4 DH correct 
1-2-3-4 NDH correct 
1-3-2^1 DH total 
1-3-2-1 NDH total 
1-3-2-1 DH correct 
1-3-2-1 NDH correct 
DH: dominant hand 
NDH: non-dominant hand 
* ρ < .05 ** ρ < .01 # ρ < 
A 
- 2 1 
- 2 5 
-.15 
-.16 
.03 
-.01 
.01 
-.04 
.11 
.01 
-.06 
-.10 
-.01 
-.09 
- 0 5 
.09 
- 1 1 
-.09 
-.27 
-.16 
.005 
MyD 
(η = 26) 
В 
03 
22 
-.28 
-.26 
-.24 
- 2 2 
-.27 
-.33 
-.28 
-.28 
-.43* 
-.47* 
-.42 
-.47* 
-.42 
-.35 
-.47* 
-.45* 
-.54** 
-.48* 
total: 
С 
-.02 
.25 
-.45* 
-.41 
-.42 
-.38 
-.33 
-.42 
- 3 4 
-.38 
-.50* 
-.57** 
-.49* 
-.49* 
-.51* 
-.44* 
-.57** 
-.58** 
-.58** 
-63# 
A 
.01 
-.08 
-.28 
-.32 
-.22 
-.23 
.29 
.10 
- 4 1 
-.36 
-.29 
-.28 
-.36 
-.33 
-.22 
-.14 
-.32 
-.35 
-.21 
-.52* 
CS 
(η = 24) 
В 
.05 
.10 
-.25 
-.30 
-.29 
-.21 
.10 
-.09 
-.35 
-.27 
-.25 
- 2 6 
-.27 
-.25 
-.18 
-.12 
-.33 
-.35 
-.24 
-.49* 
: total number of pushes 
correct: number of correct pushes 
С 
-.15 
.08 
- 0 2 
-.07 
-.31 
-.21 
-.13 
-.12 
-.36 
-.26 
-.22 
-.26 
-.28 
-.21 
-.02 
.02 
-.34 
-.36 
-.12 
-.45 
There was no relationship between the scores of the motor tasks and the 
simple card A in either group. Only in the MyD patients some scores of 
complex motor tasks correlated with card B, and all scores with card С 
DISCUSSION 
The purpose of the present study was to investigate whether patients with 
early adult and adult onset MyD show subtle cognitive dysfunction despite 
a normal intelligence. For this reason, we excluded all MyD patients with 
mental retardation. This enabled us to examine whether a homogeneous group 
of MyD patients with only mild disability, as reflected by the Karnofsky scores 
and the muscular rating scales, shows a more discrete pattern of cognitive 
impairment. We compared these patients with a group of CS, matched for age, 
intelligence and educational level, on a range of neuropsychological tests, 
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measuring a broad spectrum of functions: memory (CVLT), attention (Stroop), 
visuospatial scanning (TMT), verbal fluency and cognitive shifting (WCST). As 
already indicated in the introduction, we selected these tests, because 
performance of these tests is impaired not only in patients with cortical 
dysfunction, but also in patients with subcortical dysfunction. 
The MyD patients and CS did not differ in performance on these tests, with 
the exception of the Stroop Colour Word Test. Our results are not in 
accordance with studies, which did not exclude patients with infantile and 
juvenile MyD (Woodward et al., 1982; Bird et al.,1983; Portwood et al., 1986; 
Huber et al., 1989; Perini et al., 1989; Walker et al.,1984; Malloy et al., 1990; 
Censori et al, 1990; Ragazzoni et al, 1991), but are fully in agreement with the 
study of Franzese et al. (1991), as far as we know the only study that involved 
only early adult and adult onset patients. In the latter study, fully normal IQ-
scores are reported. With regard to the Stroop Colour Word Test, MyD 
patients gained significantly poorer scores on all cards. Nevertheless, they 
scored better than the patients in the study of Broughton (1990). Our patients 
also scored better than the MyD patients and CS in the study of Stuss et al. 
(1987), but the CS in that study, who were matched with MyD patients for 
intelligence, showed a dull normal mean IQ (WAIS-R) = 87.1. However, the 
subgroup of late onset MyD patients in that study produced only slightly 
poorer scores than our patients. Apparently, the distinct findings are due to 
the composition of the groups under study. The results of the present study 
emphasize the necessity to have homogeneous groups. Some authors 
(Brumback, 1987; Malloy et al., 1990) found visuospatial and constructional 
disabilities, suggesting greater right hemisphere dysfunction in MyD, but this 
hypothesis is not supported by the finding in the same studies and in ours, 
that there are no significant differences in tapping performance between the 
right and left hand. In a heterogeneous group of 22 MyD patients, Chang et 
al. (1993) found significant correlations between right hemisphere perfusion 
and visuospatial skills (Hooper Test, Visual Reproduction), but also between 
left temporo-parietal perfusion and Performance-IQ, a measure which also 
reflects visuospatial skills. Thus, an exclusive relationship between right 
hemisphere dysfunction and visuospatial or constructional impairments in 
MyD is uncertain. An overall reduction of speed itself might also account for 
poorer performance of MyD patients in visuospatial tasks. Therefore, we 
recommend correcting neuropsychological task performance of MyD patients 
for both speed and intelligence: the visuospatial and constructional disabilities, 
that are established in the studies mentioned above, might not stand such a 
correction. Many studies (Bird et al., 1983; Portwood et al., 1986; Huber et al., 
1989; Censori et al., 1990; Koch et al., 1992; Chang et al., 1993) revealed more 
cognitive impairment in patients with maternal inheritance than in patients 
with paternal inheritance. In the present study, patients with maternal 
inheritance (n = 7) showed a poorer performance overall than the patients with 
paternal inheritance (n = 14), but the difference was only significant in the 
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immediate recall of the second shopping list of the CVLT. The lack of 
significance might be due to sample sizes. 
The selective poor performance of MyD patients with respect to the Stroop 
Colour Word Test is not easy to interpret. This test is based on a conflicting 
response paradigm (Dyer, 1973): the first and most automatic response is 
reading words (Card A), the second response is simple, but less automated: 
naming colours (card B). Finally, in Card С the subject is required to suppress 
the automatic response (reading words) in favour of the less automated 
response (naming colours). Since our MyD patients produced poorer scores on 
all cards, a retardation of information processing is plausible. Our MyD 
patients were also slower than CS in the TMT, but this difference did not 
reach significance. Since the Stroop performance of MyD patients worsened, 
as the complexity of the task increased, they appear to be sensitive to response 
interference. However, our data also allow a different interpretation. In the 
majority of our MyD patients (see Table 1), dysarthria was already clinically 
established during normal speaking. Because of this - MyD coupled -
dysarthria (see also Harper, 1989), speaking aloud and as fast as possible, is 
a more effort demanding task for MyD patients than for CS, which is reflected 
in the significant lower scores on cards A and B. Therefore, it seems plausible, 
that in the case of MyD patients, simultaneously speaking fast and reading the 
difficult card С required a dual task performance. Previous research has 
shown that performance of the Stroop Colour Word Test significantly affects 
the performance of a concurrent motor task, viz. control of balance after lower 
limb amputation in normal subjects (Geurts et al., 1991). Further research will 
be needed, involving a test of the Stroop paradigm, but without an appeal to 
fluently speaking. Anyhow, in our view the lower performance of the Stroop 
Colour Word Test does not necessarily imply a central cognitive deficit, but 
may also be due to a peripheral defect. The significant difference in Stroop 
performance between the two groups clearly does not interfere with any other 
cognitive function under study, simply because there are no other differences. 
To summarize, these findings indicate that MyD patients of normal intelli­
gence with early adult and adult onset show any or no cognitive impair­
ment. We also presented a number of motor tasks of increasing complexity, 
which required correspondingly more cognitive control. The scores of all 
motor tasks showed very low correlations with any disease variable or rating 
scale. This last finding is not surprising, since both the MRC-scale and MDRS 
assess muscular weakness, a disease characteristic, which played a minor part 
in our motor tasks. The MyD patients produced significantly poorer scores 
than the CS on simple tasks. The difference between the groups reached the 
highest significance in diadochokinesis, being the most automatic one in our 
series. The difference between the groups disappeared in tasks in which 
performance depends less on speed of motor execution, but more on response 
planning and motor programming, i.e. cognitive control. It was only in the 
simple sequence (index - middle finger - ring finger - little finger), that MyD 
patients scored significantly worse than CS. In the complex sequence (index 
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- ring finger - middle finger - little finger) the scores of MyD patients were 
no longer significantly different from those of CS. A plausible explanation for 
this finding is that the simple sequence approximates an automatic one. Since 
we did not find any significant correlation between the Stroop scores and 
simple motor performance, the significant group differences in simple motor 
tasks cannot be attributed to the significant differences in Stroop performance 
between the groups. Complex motor sequence performance is known to 
deteriorate in diseases with central programming deficits, such as Parkinson's 
disease (Cools et al. 1984; Benecke et al. 1987; Harrington and Haaland, 1991). 
Our results indicate that the cognitive control of motor performance is not 
impaired in MyD. Our findings lead us to conclude that MyD patients with 
mild symptoms, normal intelligence, and early adult and adult onset do not 
show cognitive dysfunction. In turn, this indicates that in this group of 
patients there is no evidence of brain dysfunction, such in spite of an 
ubiquitous genetic deficit. 
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GENERAL DISCUSSION 
In this thesis a number of quantitative functional assessments are presented 
that refer to different aspects of organ involvement of MyD. Seventy-five 
adult-onset patients were included in the current study. In the following 
paragraphs, the results of neuro-ophthalmologic, neuro-otologic, bulbar and 
neuro-psychologic symptoms and signs will be summarized. Subsequently, the 
main findings will be discussed in relation to the literature on systemic 
involvement in MyD and on the current views on genetics. 
Neuro-ophthalmology 
With regards to the visual system, the functions of the extra-ocular muscles 
(chapter 2.1-2.3), retina (chapter 2.4) and optical nerves have been studied 
(chapters 2.1, 2.3 and 2.4) as well as visuospatial functions (see chapter 5, 
neuro-psychology). 
Eye movements. In 31 patients, without pronounced mental involvement, the 
pattern of eye movements was studied. In total, 26 patients had their onset in 
adult life with only one patient complaining of diplopia. The main eye-move-
ment disorder in the classical form of MyD is an isolated sub-clinical decrease 
of maximum velocity (Vmax.) of the horizontal visually guided saccades. The 
slowing of the saccades is a rather early and progressive sign, that correlates 
weakly with the severity of the neuromuscular deficit (Mathieu-score). The 
pathophysiological mechanism is based mainly on myopathy of the extra-
ocular muscles. The group of Bollen et al. (1992) disagreed and suggested, in 
accordance with temporal MRI findings, a central abnormality as the cause of 
eye-movement disturbances due to the more pronounced smooth pursuit gain 
decrease. 
Perhaps, the different patient selection by Bollen et al., i.e. congenital cases 
with hypersomnolence, may be a better explanation than heterogenicity. How-
ever, we would add that secondary, 'central' adaptation mechanisms, may also 
play a role in oculomotor function as demonstrated in our study of neuro-
otological signs. 
Retinopathy. In chapter 2.4, the functional abnormalities of the retina were 
described for a group of 12 MyD patients among whom, 8 were of mild 
severity and 4 were asymptomatic gene carriers. In total, 7 out of 8 were 
classified as adult onset. In contrast to all previous studies, we found the 
cones, the foveal photoreceptors and the RPE (retinal pigment epithelium) to 
be more commonly affected than the rods in this minimally affected group. 
Thus, retinopathy is an 'early phenomenon' with an unknown but progressive 
course (Yoshihiro et al., 1993). We assume that a diffuse degeneration of the 
rods and other retinal layers occurs only in later phases of the disease. None 
of the retinal findings showed a correlation with the neuromuscular deficit 
(scores converted to the Mathieu-score). 
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Optical nerves. Chapter 2.1-2.3 and 2.4 deal with the optical nerve functions 
in MyD. The subclinical changes were studied by pattern VEP (pVEP) in 44 
patients, of whom 40 were classified as adult onset. The pattern for an adult 
onset group can be characterized by a bilaterally prolonged PI 00 latency and 
diminished amplitude. The former results correspond with previous studies 
(Gott et al., 1983, Kerty and Ganes, 1989). The pVEP changes are probably a 
rather 'early' phenomenon (Gott et al., 1983) with a progressive course, that 
correlated with the latency of the visually guided saccades and slightly with 
the neuromuscular deficit (Mathieu-score). 
We found in a group (N=12) of mainly adult onset MyD patients, a trend 
between P100 latency and foveal two-way-densitometry findings (chapter 2.4). 
Therefore, we assume a bilateral optical nerve degeneration, secondary to the 
above described retinal processes. This is in accordance with the opinion of 
Junge (1966), whilst Kerty and Ganes (1989) proclaimed an altered processing 
within the visual cortex as an explanation for the VEP changes. This is 
unlikely for the group studied, due to the intact colour vision and normal MRI 
findings of the occipital cortex (Damián et al., 1992). 
Neuro-otology 
In chapter 3 the results of oculomotor, auditory and vestibular tests have been 
described for an adult onset group of 13 MyD patients. Twelve of them were 
classified as adult onset. None of the patients complained about vertigo. Our 
observations showed sensorineural high tone loss, frequent abnormal VOR 
(vestibulo-ocular reflex) as well as central abnormalities in the acoustic 
pathways (prolongation of BAEP I-V interwave delay). Our results are in 
agreement with previous authors (Kuhn and Ey, 1966; Wright et al., 1988). 
The hearing loss in the 'classical group' has its onset in adult life and the 
course is definitely progressive and slightly related to neuromuscular deficit 
(scores converted to Mathieu-score). 
Bulbar dysfunction 
Swallowing. In chapter 4.1 we studied the function of swallowing in 26 adult 
onset MyD patients. The duration of swallowing was significantly prolonged 
in the MyD patients. Even in the early phase of the disease, difficulties with 
swallowing may occur which are unrelated to the complaints of dysphagia 
(Horowitz, 1987a,b), while the course appears to be progressive (this study). 
The swallowing disorder in this study correlated slightly with the severity of 
limb muscle weakness (Mathieu-score). Our results correspond with another 
single published quantitative study using a videofluoroscopic technique that 
reports a prolonged pharyngeal transit time (Johnson et al., 1993). In the early 
phase, myotonia is held responsible for dysphagia (Bosma and Brodie, 1968), 
while in the later phase the myopathy of striated muscles in the upper 
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pharynx are supposed to predominate in the swallowing disorder (Eckhart et 
al., 1986). 
Speech. In chapter 4.2 we investigated the function of speech in 15 mildly 
affected adult onset MyD patients using a quantitative computerized speech 
analysis. A flaccid dysarthria with absence of dyspraxia is a noticeable feature. 
The speech disorder is undoubtedly an 'early' onset phenomenon, with a pro-
gressive course (Thomasen, 1948; Harper, 1989), unrelated, in this study, to the 
neuromuscular deficit (Mathieu-score; chapter 4.2). 
The speech in the adult onset MyD group can be characterized by a poor 
sound prolongation and a reduced repetition rate which together, lead to 
shorter stretches of speech and slowed speech. Apart from the predominant 
flaccid dysarthria, we also presume that myotonic phenomena, particularly in 
the (peri)oral muscles, influenced the speech disorder in our group. 
Neuro-psychology 
In chapter 5, we investigated the cognitive and motor functions in a group of 
26 normal intelligent adult and early adult onset MyD patients with mild 
symptoms. In the investigated group, the only abnormal findings were present 
in a test for selective attention (Stroop Colour Word Test, SCWT) and for hand 
motor execution. Although SCWT scores correlated with motoric test scores, 
no significant correlation was found between test scores and clinical scores of 
hypersomnolence, inheritance pattern or neuromuscular deficit (Mathieu-
score). However, a correlation trend was found between SCWT results and 
maternal inheritance. 
On its own, a SCWT alteration is an aspecific finding which might be related 
to defective selective attention or a more general information processing 
capacity. It is argued that poor SCWT performance is not strictly due to 
cerebral involvement. Rather, it may be the result of the higher demands 
which this task puts on the MyD subjects as a result of poorer speech motor 
function. The abnormal SCWT finding does not contradict the studies of Stuss 
(1987) and Broughton (1990). 
However, the visuo-spatial and visuo-constructive tasks were within the 
normal range in our study. In other neuro-psychological studies this was the 
most common finding with regards to MyD (Censori et al., 1990). The relation-
ship between visuo-spatial and visuo-constructive dysfunction and the 
bilateral fronto-parieto-temporal localization of neuroradiological and mor-
phological findings is curious or perhaps spurious. The prevailing view of the 
neuro-psychological studies is that they reflect an unknown and subtle 
developmental abnormality of the cerebrum, chiefly involving the non-
dominant hemisphere functions. This occurs more often in MyD patients with 
an earlier onset than in patients with adult onset. Alternatively, a more likely 
interpretation of the cognitive impairment pattern might be due to hetero-
genous group composition in previous studies. Another option is to consider 
the disturbances of the visuo-spatial and constructional functions as a non-spe-
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cific phenomenon due to bilateral cerebral involvement (Lezak, 1983), e.g. 
caused by widespread neurofibrillary changes (Yoshimura, 1990). Moreover, 
Franzese (1991) found in his adult onset group, that only in the group with 
low intelligence (7%), were there alterations of the visuospatial functions. 
In conclusion, our results are not in agreement with other neuropsychologi-
cal studies. So far, for the cognitive dysfunction in the adult onset group there 
is no unanimity and the results are insufficiently reproducible. Presumably, 
most groups studied have been inhomogeneous and are consequently incom-
parable with one another. This issue might be solved by studying cognitive 
function, using a few carefully selected tests in larger numbers of adult onset 
patients with a short and a longer duration of the disease. 
What are the implications of the current views in genetics on clinical signs 
and symptoms of MyD? 
The impact of genetics in MyD will be subdivided into practical consequences 
and the acquired insight with regards to MyD basic mechanisms. Furthermore, 
we will discuss the clinical variability of the disease. 
First, the practical consequences. Nowadays, DNA analysis is the golden 
standard for diagnosis. No diagnostic gain is to be expected from clinical stu-
dies as the accuracy of DNA analysis is almost 100% now, (Wieringa, 1994 
a.o.). After performing a neurological investigation, an EMG and a slitlamp 
examination, the minority, (approximately 8%) of MyD patients remain un-
detected (Brunner et al., 1991). Therefore, only EMG and slitlamp examination 
remain useful diagnostic tools, whilst in fact tonometry should be listed as 
well, due to its high specificity (Ashizawa et al., 1992). However, sporadic and 
'aspecific' (white dots) lens inclusions are not often reasons for diagnostic 
confusion and unnecessary genetic studies (Brunner et al., 1991; Ashizawa et 
al., 1992). 
Slitlamp examination should be employed carefully and should be carried 
out by an experienced ophthalmologist (Ashizawa et al., 1992). 
DNA analysis has to be performed at least in 1 person in an affected family. 
Certainly, the diagnosis of MyD in asymptomatic family members or in cases 
where there is doubt, has to be confirmed or excluded by DNA techniques. 
Based on knowledge derived from genetic studies, the clinical subdivision in 
the age of onset groups makes sense due to the broad correlation with (CTG)n 
repeat length. Nowadays, the consequences of the somatic variability in 
(CTG)n amplification for various tissues within the same patient, remain 
obscure. Therefore, for predicting the prognosis and future severity of the 
disease, the possibilities of DNA methods are still limited. One exception is 
that all patients with a mild form (CTG repeat excess 100-120) usually have 
cataracts as the sole symptom. 
Secondly, the concept of a dynamic (CTG)n repeat, highlighted some 
longstanding and incompletely understood features of MyD. The principle of 
114 
General Discussion and Epilogue 
anticipation, (an earlier occurrence in later generations), can be explained in 
this way. In adult onset patients, the (CTG)n repeat length in sperm does not 
allow further prolongation than 1000 (Lavedan et al., 1993; Mulley et al., 1993; 
Brunner thesis, 1993). The exclusive maternal inheritance of congenital 
dystrophy cases is probably due to negative selection during the spermato-
genesis (Brunner, thesis, 1993). 
Recent investigations also raise new questions with regards to the variability 
of systemic involvement of patients belonging to the same disease type and 
finding accumulating evidence for a variable (CTG)n excess in separate tissues 
within a MyD patient. 
Concerning the enormous clinical variability, some incomplete correlations 
with the genetic abnormality can be outlined: an earlier age of onset and a 
greater severity, broadly correlates with a (CTG)n repeat excess (Harley et al., 
1993). Therefore, a clinical subdivision in the age of onset groups has been used 
in the analysis of genotype/phenotype relationships. However, the overlap in 
(CTG)n excess shows that other influences should be taken into account. For 
example, the extent of myotonin-proteinkinase (MT-PK) mRNA also showed 
a correlation with the severity of the limb muscle weakness (Pizzuti et al., 
1993). 
The majority of the genotype-phenotype correlative studies, refer to the 
severity of limb muscle weakness. However, the correlation between DNA 
expansions and clinical severity is also valid when single symptoms are analyzed 
in patients with MyD. Novelli et al. (1993) measured the (CTG)n expansion in 
107 MyD patients using an arbitrary clinical scale for scoring different parame-
ters such as muscle hypotonia, myotonia, cardiac manifestations, ocular 
findings and mental status. As was to be expected, the strongest correlation 
was found between (CTG)n repeat and muscle involvement (myotonia< atro-
phy< severe weakness). The presence of overt mental retardation and some 
ocular findings also slightly correlated with the CTG repeat length. 
Because half of the genome is needed to specify the manifold brain function, 
it is not surprising that mental impairment is a consistent component of 
expansion disorders (Wieringa, 1994). 
To date, we must conclude that genotype-phenotype correlation is complex 
and determined by many factors (Brunner, 1993a,b; Cobo, 1993; Wieringa, 
1994). As described in this thesis, the dynamic mutation responsible for MyD 
must have different effects on several tissues. One of the attractive alternatives 
is a different genetic abnormality per organ system, also termed somatic 
mosaisims or - heterogeneity. This assumption receives increasing support from 
recent studies. 
A different (CTG)n repeat length is found in sperm and leucocytes (Janssen 
et al., in press), in muscle cells and leucocytes (Anvret et al., 1993; Ashizawa 
et al., 1993; Thornton et al., 1994) and in several tissues of an adult onset MyD 
patient (Janssen et al., 1994). Consequently, a genetic heterogeneity may also 
be suggested in the several organ systems in the adult onset group with mild 
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severity, as investigated in this thesis. 
Nevertheless, as long as knowledge with regards to the cellular effects of the 
(CTG)n expansion remains limited, the question of variable expressivity, (type 
of symptoms, severity and course), will remain unanswered. 
Main conclusions from this thesis 
1. An isolated and progressive slowing of maximum velocity (Vmax.) of the 
visually guided saccades is the predominant eye movement disorder. 
Myopathy of the extra-ocular muscles is most likely to be the underlying 
pathophysiological mechanism. 
2. In the 'early' phase of adult onset MyD, a dysfunction of cones and 
photoreceptors occurs first, while subsequently a diffuse degeneration 
arises. 
3. It is suggested that the neuropathy of the optical nerves is secondary to the 
retinal processes. 
4. Both peripheral and central neuro-otological abnormalities occur in MyD. 
The sensorineural hearing loss and other neuro-otological deficits in MyD 
are progressive. 
5. A disturbance of swallowing in the adult onset form of MyD is progres-
sive. The dysphagia is only faintly related to the severity of limb muscle 
weakness, indicating a different pattern of involvement. 
6. The dysarthric speech in mild phases of adult onset MyD can be charac-
terized as 'flaccid dysarthria', with normal speech programming. Further-
more, myotonia in the perioral muscles has an influence on the speech 
motor execution. 
7. The noticeable feature of cognitive dysfunction in adult onset MyD with 
mild severity, is supposed to be a prolonged duration on Stroop Colour 
Word Test with normal visuospatial- and constructive functions. 
8. In the adult onset group with mild severity, bulbar and distal limb muscles 
and the eye are more frequently involved than the neuro-otological system 
and cerebrum. 
9. Variability of clinical features is a hallmark of MyD. A marked reduction 
in clinical variability can be generated by including age of onset, degree of 
severity (Mathieu-score) and by using quantitative methods. 
10. A specific tissue vulnerability has to be assumed for the adult onset form 
of mild severity. The highly variable or absent correlations of different 
kinds of organ involvement with the score for neuromuscular deficit 
(Mathieu), and thus indirectly (CTG)n excess, may support such an as-
sumption. 
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EPILOGUE 
Our study results indicate that MyD quantitative clinical investigations may 
be essential to discover expression of organ involvement, to assess its severity 
and to outline its course. Many questions remain unsolved with regards to the 
variable expressivity, (variation in severity, type of organ involvement and 
course). 
Since we have to deal with mozaisism and unknown cellular effects of the 
(CTG)n excess, the expressivity should in fact be re-examined for each organ 
system in genetically well defined groups of patients. For example, the visual 
system is an excellent clinical human model for expression related issues, 
suitable for all kinds of quantitative measurements. Likewise, the com-
puterized speech analysis and oculomotor studies presented in this thesis are 
candidates for such studies. 
In order to reduce variability in clinical studies, we suggest studying organ 
specific signs in homogenous groups, (e.g. same age of onset and severity) and 
using uniform validated quantitative methods. 
The main issue to be defined, is how to assess clinically the extent and course 
of the disease. In this respect, simple functional but quantitative tests such as 
the described perioral tests or swallowing tests may be valuable tools for 
follow up. Furthermore, it is not clear which clinical methods are most 
appropriate to discover the minimal changes, either for genotype-phenotype 
correlation studies or for evaluation of future (gene)-therapy or pharmacologi-
cal modulation. 
Given our present knowledge, for each age of onset clinical subgroup with 
a certain severity, a compilation of studies should be established in order to 
create an overall picture of the variable expressivity of organ-system invol-
vement. 
In the future, the role of the myotonin-proteinkinase gene products and 
protein phosphorylation processes in mediating the correct protein-protein 
interactions is expected to be resolved, which may finally result in a proper 
insight into clinical variability and possible therapeutic opportunities. In 
advance of this, many basic and (quantitative) clinical investigations will be 
necessary for well defined groups of MyD patients, before we really 
understand how the MyD gene and the variable clinical signs are connected. 
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Summary & Samenvatting 
SUMMARY 
This thesis presents the results of a serie of clinical studies about the adult 
onset or 'classical form' of myotonic dystrophy (MyD). After a global 
introduction about MyD, the aim and outline of the studies have been descri-
bed, followed by own studies regarding neuro-ophthalmology, neuro-otology, 
bulbar dysfunction and neuropsychology. 
First, in chapter 1 a selective review of literature has been given, confined to 
the topics of the several studies. 
In chapter 2.1 the horizontal saccades and smooth pursuit eye movements were 
studied in 26 patients with myotonic dystrophy. Clinical neuro-ophthalmologi-
cal investigations in 1 patient revealed an inability to achieve a full range of 
eye movements. Electro-oculography showed a significant decrease of the 
maximum velocity of the visually-guided saccades in 83% of the patients. 
Smooth pursuit eye movements were not significantly different from age-
matched controls. Visual evoked potential (VEP) latencies (P100) were 
significantly prolonged compared with controls in 64% of the patients. The 
saccadic latency of the visually-guided saccades was correlated with the 
prolonged VEP latencies, indicating that lesions in the primary visual 
pathways probably contribute to the oculomotor dysfunction. The isolated 
decrease of the maximum velocity of the saccades in combination with EMG 
findings favours a peripheral (dystrophic) pathophysiological mechanism. 
Chapter 2.2 deals with eye movement recording (EMR) performed in 5 
asymptomatic myotonic dystrophy (MyD) gene carriers, 7 mildly affected 
MyD patients and 23 age and sex matched healthy controls. The purpose of 
the study was to evaluate whether eye movement abnormalities are an early 
expression of the MyD gene and to determine the value of this procedure for 
detection of otherwise asymptomatic gene carriers. EMR did not reveal any 
abnormalities in the asymptomatic group, but in the mildly affected group 
showed significantly (p<0.01) decreased maximum velocities of the saccades, 
compared to controls. The results indicate that EMR may add in the detection 
of mildly affected MyD patients. However, the use of EMR in preclinical 
diagnosis of putative MyD gene carriers has no additional value. 
Chapter 2.3 A 6 year follow-up study of eye movements was performed in 6 
patients with myotonic dystrophy (MyD). In agreement with previous studies 
the major finding was a symmetrical decrease of maximum velocity of the 
visually guided saccades (Vmax) with normal latency of the saccades and 
normal smooth pursuit gain. Deterioration of Vmax (p<0.01), weakness of the 
limbs (p<0.01) and VEP P100 latency (P<0.05) were significant. We conclude 
that the oculomotor disturbance in MyD is definitely progressive, correlating 
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with progression of weakness of the limbs (p<0.05). The pattern is in 
agreement with a predominantly peripheral pathophysiological mechanism. 
In chapter 2.4 twelve subjects with minimal expression of the myotonic dys-
trophy (MyD) gene were studies and investigated by retinal densitometry, a 
technique which has been used to study the properties of photopigments in 
the living eye and to detect photoreceptor abnormalities. Other investigations 
included slit-lamp examination, fundoscopy, raleigh matches with the 
anomaloscope, tonometry, and neurological examination, including electro-
retinography (ERG) and pattern visual evoked potentials recording (pVEP). 
Foveal densitometry demonstrated reduced values of the macular photopig-
ment density difference with normal photopigment kinetics in early phases of 
the disease, even in asymptomatic individuals. The densitometric values 
correlated with decreased amplitudes of the photopic ERG a-wave. These 
findings may be explained by loss or dysfunction of the outer segments of 
foveal receptors. It is yet unknown whether or not these changes are 
secondary to other observed neuro-retinal abnormalities in MyD. The most 
likely explanation might be an abnormality of the Na, Ca:K exchanger at the 
level of the outer segments of the photoreceptors whether or not in com-
bination with a dysfunction of voltage generation systems, involving both 
photoreceptors and RPE. 
In chapter 3 auditory and vestibular tests and oculomotor, were described 
which were performed in 13 patients with myotonic dystrophy (MyD). All of 
the 13 patients showed one or more abnormalities. There was a significant 
increase in the penetrance of separate abnormalities with age. Saccadic slowing 
was found in 10 patients, in severe form in 3. Seven patients had a sensori-
neural high-tone hearing loss (30-85 dB at 8Hz), which was in excess of that 
expected for their age, that could be attributed to MyD. Brain stem auditory-
evoked potentials showed a significant interwave delay of the I-V interval 
(0.35-0.7 ms). An abnormal vestibulo-ocular reflex was found in 6 patients; 3 
had vestibular hyperreflexia with increased gain and 3 hyporeflexia with short 
time constants. This study confirms that in MyD, sensory system involvement 
can be found both on a peripheral and a central level. 
Chapter 4.1 stressed the importance of a bedside test for swallowing. The 
objective of the study was to assess the merits of a quantitative bedside test 
for screening and follow up of swallowing function in myotonic dystrophy 
(MyD). The design was as follows: 26 MyD patients with adult onset and 28 
age matched controls were investigated as follows: a questionnaire for 
swallowing disturbances, a bulbar and neuromuscular rating scale and a 5-oz 
swallowing test, which was performed twice. The main result was that a 5-oz 
water swallowing test (ST) identified 65% (17/26) of the MyD patients to have 
a prolonged swallowing time. Even in moderate MyD, swallowing dysfunction 
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may occur. In agreement with previous studies no correlation with clinical 
dysphagia was found, while in the current study the disturbance in swal-
lowing was positively correlated with the severity of the limb muscle 
weakness (Mathieu-score). In sum, the 5-oz water swallowing test seems a 
sensitive screening tool (65%) for identifying those MyD patients in need of 
more extensive GI studies, or to monitor the course of the disease. 
In chapter 4.2 computerized analysis of standardized speech tests were 
reported. To a group of 15 mildly affected, early-adult and adult onset MyD-
patients a set of speech- and oral-motor tasks was administered in order to 
specify on a quantitative level the type of dysarthria, and to assess whether 
their speech-motor system contains apraxic characteristics. As compared to 
matched control subjects, the MyD patients showed no signs of apraxia of 
speech, but clearly exhibited a dysarthric profile. It can be concluded that in 
the speech-motor system of mildly affected MyD patients there is no 
involvement of speech motor programming. The observed speech motor execu-
tion signs point to flaccid dysarthria and myotonia, particularly in the perioral 
musculature. 
Brain involvement in early and adult onset patients is topic of chapter 5. Many 
studies have revealed intellectual deficits in myotonic dystrophy. However, 
the groups of patients in these studies were heterogeneous with respect to 
intelligence, and severity and onset of disease. The present study was 
undertaken to investigate whether patients with early adult and adult myo-
tonic dystrophy show subtle cognitive deficits despite a normal intelligence. 
We compared 26 normal intelligent MyD patients with mild symptoms and 
early adult and adult onset myotonic dystrophy to 25 matched control subjects 
on a range of neuropsychological tests and a number of motor tasks of 
increasing complexity, which required increasingly cognitive control. We 
found hardly any evidence of cognitive dysfunction in our group of myotonic 
dystrophy patients with early adult and adult onset. The groups did not differ 
as far as the neuropsychological tests were concerned, with the exception of 
the Stroop Colour Word Test. With respect to motor performance, the 
myotonic dystrophy patients were poorer scorers on simple and automatic 
motor tasks than control subjects, but the difference decreased and eventually 
disappeared as the complexity of the tasks increased and required correspond-
ingly more cognitive control. 
Chapter 6 contains a general discussion about the results of investigations, the 
summaries and epilogue. 
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SAMENVATTING 
In dit proefschrift worden na een globale introductie over het ziektebeeld 
myotone dystrophy (MyD), de vraagstelling en het doel van de klinische 
studies uiteengezet. Achtereenvolgens worden de eigen klinische studies 
besproken, welke betrekking hebben of neuro-ophthalmologie, neuro-otologie, 
bulbaire dysfunctie en neuropsychologie. 
Alvorens de eigen studies te bespreken, vindt men in hoofdstuk 1 een 
toegespitst overzicht van de relevante literatuur. 
In hoofdstuk 2.1 worden de resultaten beschreven van een onderzoek naar de 
visueel geleide horizontale saccaden en langzame volgbeweging van de oog-
bewegingen van 26 patiënten lijdende aan dystrofische myotonie. In totaal 
behoorden 23 tot de 'adult onset' groep. Klinisch onderzoek van de oculomo-
toriek bracht bij 1 patiënt een beperking van de oogmotiliteit aan het licht. 
Electro-oculografisch onderzoek liet echter een significante afname zien van 
de maximum snelheid der saccaden (Vmax.) bij 83% der patiënten. Langzame 
volgbewegingen verschilden niet ten opzichte van de controles met een 
overeenkomstige leeftijd. Visuele 'evoked potential' (VEP) studies lieten een 
verlengde latentietijd der P100 zien bij 64% van de patiënten. De latentie van 
de visueel geleide saccaden bleek te correleren met de latentie van de P100 
van de VEP. Op grond hiervan mag men een lesie veronderstellen van het 
afferente optisch systeem, welke ook tot uitdrukking komt bij de oogmotoriek. 
De Vmax. afname zonder overige oogmotoriek-afwijkingen pleit, zeker als we 
de EMG bevindingen van de externe oogspieren in ogenschouw nemen, voor 
een perifere oorzaak als verklaring voor de subklinische oogbewegingsstoor-
nissen. 
In hoofdstuk 2.2 wordt nagegaan in hoeverre oogbewegingsregistaties kunnen 
bijdragen aan vroegdiagnostiek. Daarom werd bij 5 asymptomatische DNA 
positieve gendragers en 7 licht tot matig aangedane MyD patiënten een 
oogbewegingsregistratie vervaardigd. 
Alle patiënten op een na behoorden tot de 'adult onset' groep. De resultaten 
werden vergeleken met 23 controles, welke overeenkwamen qua geslacht en 
leeftijd. De resultaten van de gendragers waren niet afwijkend t.o.v. de 
controle groep, terwijl de licht en matig aangedane patiënten wel een sig-
nificant verschil bleken te vertonen (p<0.01). Hieruit valt te concluderen dat 
oogbewegingsregistaties van nut kunnen zijn bij het opsporen licht aangedane 
dystrofische myotonie patiënten, maar voor opsporing van asymptomatische 
gendragers blijkt er geen aanvullende waarde te bestaan. 
In hoofdstuk 2.3 wordt een vervolgstudie beschreven bij 6 patiënten behorend 
tot de 'adult onset' vorm van MyD. Een onderzoek naar oogparameters, ske-
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letspierzwakte en een uitvoerig oogbewegingsonderzoek (identiek aan het 
onderzoek als beschreven in hoofdstuk 2.1) werd herhaald na 6 jaar. De 
maximum snelheid der saccaden (Vmax) bleek significant te zijn afgenomen, 
terwijl de langzame volgbewegingen onveranderd bleken te zijn. De 
achteruitgang van de Vmax. bleek significant te correleren met de resultaten 
van de ledemaatspieren (Mathieu-rating-scale). Dit veronderstelt eveneens een 
perifere genese als oorzaak van de afgenomen snelheid der saccaden. 
Hoofdstuk 2.4 behandelt de · retinale afwijkingen van patiënten met een 
minimale expressie van het gen voor dystrophische myotome. De twaalf 
geselecteerde patiënten behoorden op een na allen tot de 'adult onset' vorm 
van dystrophische myotonie. Zij werden neurologisch, oogheelkundig 
onderzocht. Vervolgens werd bij elk van hen een foveale densitometrie ver-
vaardigd, een techniek om de eigenschappen van photopigment in het oog te 
bestuderen, teneinde afwijkingen van de functie der photoreceptoren te 
ontdekken. Tevens werd in het onderzoek betrokken een spleetlamp 
onderzoek, anomaloscoop (kleurenzien) test, oogboldruk metingen, electro-
retinogram (ERG) en een visueel 'evoked potential' (VEP). Bij het bidirec-
tionele foveale densitometrie onderzoek bleek in 50% er sprake van afwijkin-
gen van de functie der photoreceptoren ten opzichte van controles. De 
afwijkende bevindingen der foveale densitometrie bleken te correleren met de 
fotopische a-golf afname van het ERG. Dit ondersteunde onze hypothese van 
teloor gaan of functie-stoornis van de foveale photoreceptoren. De meest voor 
de hand liggende verklaring lijkt een stoornis in de Na, Ca:K 'exchanger' op 
het niveau van de buitenste segmenten van de photoreceptoren, al dan niet in 
combinatie met een stoornis van de 'voltage generating systems', welke 
stoornis uiteindelijk zowel de photoreceptoren als het retinale pigment 
epitheel kan aantasten. 
In hoofdstuk 3 wordt ingegaan op auditieve, vestibulaire en oculomotoriek-
testen. De vraag is in hoeverre perifeer- en centraal bepaalde mechanismen 
verantwoordelijk zijn voor de afwijkingen op neuro-otologische terrein. Bij 13 
myotone dystrophie patiënten, waarvan 12 'adult onset', werden de boven-
beschreven testen uitgevoerd. Alle patiënten bleken bij een of meerdere testen 
afwijkingen te vertonen. Met het vorderen der leeftijd bleken de afwijkingen 
toe te nemen. Bij 10 patiënten werd een vertraging der visuele saccaden 
gevonden, in ernstige mate bij 3. Zeven patiënten bleken een perceptief hoge 
tonen verlies te hebben in de orde van 35-80 dB bij 8Hz. De 'brainstem evoked 
potentials (BAEP)' lieten een verlengd interval tussen top I en V zien. In totaal 
6 patiënten bleken afwijkingen te hebben wat betreft de vestibulo-oculaire 
reflex, 3 vertoonden vestibulaire hyperreflexie met toegenomen 'gain', terwijl 
er bij de overige 3 patiënten juist hyporeflexie werd gevonden. Deze studie 
bevestigt dat in dystrophische myotonie dus zowel centraal als perifeer afwij-
kingen worden gevonden in het sensore neuro-otologische systeem. 
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In hoofdstuk 4.1 komen slikstoornissen aan de orde bij dystrophische myotonie 
(MyD). Met behulp van een simpele en quantitatieve sliktest werden 26 'adult 
onset' MyD patiënten en 28 controles onderzocht volgens een vast protocol. 
Bij alle patiënten werd een vragenlijst afgenomen t.a.v. slikklachten en werd 
de ernst vastgelegd middels een bulbaire- en neuromusculaire rating scale. 
Ook werd de duur bepaald hoe snel men 150 cc H20 kon slikken (ST). Hieruit 
bleek dat de tijd benodigd voor het slikken frequent verlengd was (17/26, 
65%). Zelfs in deze matig aangedane groep patiënten komen blijkbaar al 
slikstoornissen voor. In overeenstemming met voorgaande onderzoekingen 
werd er geen verband aangetoond met de klachten van het slikken en de duur 
van het slikken. In de huidige studie werd voor het eerst een correlatie 
aangetoond tussen objectief meetbare functionele slikstoornis (ST) en ernst der 
spierzwakte. Concluderend, mag men stellen dat de besproken ST een 
tamelijke sensitief (65%) instrument is voor het opsporen van patiënten met 
functionele slikstoornisen of om die patiënten te selecteren waarbij aanvullend 
slikonderzoek aan te bevelen is. Tevens kan het natuurlijk beloop van de 
slikstoornis op deze manier in kaart worden gebracht. 
In hoofdstuk 4.2 is bij 15 'adult onset' MyD patiënten middels een computer-
analyse de spraak en (peri)orale musculatuur onderzocht, teneinde het type 
dysarthrie nader te onderzoeken en om na te gaan of er sprake is van een 
programmeringsstoornis der spraak (dyspraxie). Ten opzichte van controles, 
bleek er geen dyspraxie aantoonbaar. Dientengevolge mag men concluderen 
dat er bij weinig aangedane adult onset patiënten de programmering der 
spraak normaal is. De waargenomen stoornis van de spraak pleit voor een 
slappe (bulbaire) dysarthrie, waarbij in het bijzonder de myotonie in de 
periorale spieren een belangrijke rol lijkt te spelen. 
Hoofdstuk 5 betreft een onderzoek naar cognitieve stoornissen bij een licht tot 
matig aangedane groep MyD patiënten, welke allen tot de 'adult onset of 
vroeg adulte' type behoren. Uit veel studies blijkt dat er een intellectuele 
dysfunctie in het kader van MyD moet worden verondersteld. De bestudeerde 
groepen patiënten zijn echter vrijwel altijd heterogeen wat betreft intelligentie, 
ernst of tijdstip van begin der ziekte. De onderhavige studie had ten doel om 
na te gaan of er subtiele afwijkingen op cognitief terrein konden worden waar-
genomen bij 26 patiënten met een 'adulte' of 'vroeg adulte vorm' van MyD. 
In totaal werden 26 patiënten met een normaal IQ bereid gevonden om deel 
te nemen aan deze studie. De bevindingen werden afgezet tegen die van 25 
vergelijkbare controles. Met uitzondering de Stroop Colour Word Test (SCWT) 
werden er geen significante neuropsychologische afwijkingen gevonden ten 
opzichte van een controle groep met overeenkomstige leeftijd, geslacht, 
opleiding en IQ. Ook na correctie voor motoriek bleef de SCWT afwijkend. 
Wel scoorden de MyD patiënten doorgaans slechter op simpele taken der 
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handmotoriek. Dit verschil ten opzichte van controles verdween opmerkelijk 
genoeg bij de complexere handmotoriek opdrachten. 
In hoofdstuk 6 komt de algemene discussie aan de orde naast de samenvattin-
gen van de klinische studies. In het slotwoord worden de lijnen naar 
toekomstig klinisch onderzoek aangestipt. 
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Klinisch onderzoek kan slechts in samenwerking geschieden, waarbij 
multidisciplinaire bundeling van kennis en energie het draagvlak vormen voor 
het tot stand komen van wetenschappelijke werk. De afgelopen jaren heb ik 
dat zeker ondervonden. De talrijke mede-auteurs, afkomstig uit diverse centra, 
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definitieve vorm werd verkregen dankzij de inbreng van Prof. Dr. F.J.M. 
Gabreëls en Dr. C.J. Höweler en vele anderen, welke de noodzakelijke 
bouwstenen hebben aangereikt. 
Dr. A.A.W. Op de Coul heeft mij niet alleen opgeleid in de klinische 
neurologie maar heeft mij bovendien geïnspireerd om wetenschappelijke 
activiteiten te ontplooien. 
Prof. Dr. F.J.M. Gabreëls ben ik erkentelijk voor diens regulerende invloed, de 
leerzame avond-sessies en bezielende begeleiding, welke ik ondervonden heb 
gedurende het schrijven van dit proefschrift. 
De belangstelling voor de neuro-ophthalmologie heb ik te danken aan Dr. C.C. 
Tijssen, door wiens stimulerende invloed, beknoptheid en kernachtige stijl 
menig onderzoek succesvol afgerond kon worden. 
Dr. C.J. Höweler, was van onschatbare waarde voor de incorporatie van de 
bevindingen in een huidige multisysteem-hypothese, met in achtneming van 
relativering en oog voor een historisch perspectief. 
Dr. B.A.M. Maassen dank ik voor zijn begeleiding en innoverende ideeën bij 
het onderzoek naar dysarthrie. 
Alleen dankzij de multi-disciplinaire inbreng van mede-onderzoekers, is een 
veelkleurig ziektebeeld als myotone dystrophie te onderzoeken. Andere 
collega's welke ik persoonlijk wil noemen: 
De oogartsen Dr. L.A.K. Bastiaensen en Dr. G.J. van Meel gaven mij inzicht in 
de functie van extra-oculaire spieren en retina pathofysiologie. De hoogge-
leerde Dr. D. van Norren was immer een vraagbaak bij de interpretatie van 
de photoreceptor-afwijkingen en fundamentele retina-processen. De hulp van 
Dr. A.D.A. (Dion) Paridaens, oogarts in opleiding en paranymf, was 
onmisbaar voor het retina- en aangezichts-spier-onderzoek. 
Een aantal neurologen heeft mij verder terzijde gestaan: 
Dr. C. Jansen, was als grondlegger van de 'periorale spierfunctie-meting', 
intensief betrokken bij het onderzoek naar bulbaire dysfunctie. Dr. W.I.M. 
Verhagen, verrichtte geavanceerde neuro-otologische onderzoeken. Waarde-
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volle ideeën en steun kreeg ik van Drs. J.B.M, van de Biezenbos en wijlen Dr. 
E.M.G. Joosten. 
Dr. H.G. Brunner, klinisch geneticus, heeft mij op het spoor gezet van 
onderzoek naar de vroeg-expressie van MyD gen en was mijn gids in het 
labyrinth der genetica. 
De neuro-psychologen Drs. K.P.M, van Spaendonck en Drs. E.W.A. Joosten-
Weyn Banningh vormden de creatieve leidraad in het onderzoek naar de 
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De data werden verwerkt door de statistici Dr. H. Freriks, T. de Haan en G. 
Gielen. Mevr. J. Postma en Dr. R. Walstra wil ik danken voor hun taalkundige 
correcties aangaande het Engels. 
De verschillende deelaspecten der studies werden becommentarieerd door tal 
van collega's in binnen- en buitenland. Mijn dank gaat uit naar hen allen, doch 
in het bijzonder wil ik Prof. dr. A. Bird, Moorfield Eye Hospital Londen 
noemen. 
Verder dank ik al mijn collega's en vrienden welke de afgelopen jaren met mij 
meeleefden. Speciaal wil ik bedanken Drs. P. J. M. G. (Peter) Eggen, orthopaed 
en paranymf; en mijn twee maten in het Bosch Medicentrum, locatie Willem 
Alexander Ziekenhuis en Carolus/Liduina Ziekenhuis: Dr. W.G. Buist en Dr. 
J.P.C. Peperkamp, voor hun niet aflatende steun in de eindfase van dit 
proefschrift. 
Ook mijn ouders en schoonouders wil ik danken voor hun morele steun. 
Tot slot ben ik veel dank verschuldigd aan de patiënten, hun families en de 
Vereniging Spierziekten Nederland. Hun medewerking was een noodzakelijke 
voorwaarde voor het welslagen van dit project. 
Hanneke, jij hebt altijd pal achter mij gestaan en met nooit aflatende energie 
mij immer gesteund; ja, met recht heb je de phoenix laten herrijzen! Daarnaast 
waren Floris-Jan en Feline mijn onmisbare relativerende peilers. 
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De auteur van dit proefschrift werd op 11 december 1954 geboren te Meppel. 
Na het behalen van het eindiploma gymnasium beta in 1973 ging hij 
geneeskunde studeren aan de Universiteit te Groningen. Tijdens zijn studie 
was hij als student-assistent werkzaam op de afdeling Immunologie. In 1979 
en 1980 werden respectievelijk het doctoraal examen, ECFMG en artsexamen 
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Zijn opleiding tot neuroloog vond plaats van 1982 tot 1986 in het St. Elisabeth 
Ziekenhuis te Tilburg (opleider Dr. A.A.W. Op de Coul). De aantekening 
klinische neurofysiologie werd behaald in het St. Antonius Ziekenhuis te 
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Jan Pieter ter Bruggen 
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I 
Ook in het DNA tijdperk is selectief gekozen aanvullende diagnostiek bij MyD 
geen overbodige luxe (dit proefschrift). 
II 
De retina is naast de spier een potentieel membraan-model voor K+ homeo-
stasis bij MyD (dit proefschrift). 
III 
Spraak- en oogbewegings-analyse dient een belangrijker plaats te verkrijgen 
bij het onderzoek naar vroeg-expressie van het MyD gen (dit proefschrift). 
IV 
Quantitatieve functionele testen aangaande slikstoornissen en periorale 
spierzwakte zijn geschikt als parameter voor follow up bij MyD (dit 
proefschrift). 
V 
Twee condities zijn nodig om aan iets betekenis te ontlenen: het moet simpel 
zijn en herhaalbaar (The way of transformation, K.G. Durkheim, 1988) 
VI 
'Alle medici in dienstverband, zou veel structurele problemen in de gezond-
heidszorg oplossen', (Het medisch universum, W.F. Hermans, 1954) maar de 
regelgeving en de lengte der wachtlijsten zullen vermoedelijk eerder toe dan 
afnemen, zodat de poging van de Commissie Biesheuvel toch als 'schipperen' 
dient te worden afgedaan. 
VII 
Bekwaamheid en grootheid dient men niet te meten aan het succes maar aan 
de deugdzaamheid (Oráculo manual y arte de prudentia, B. Gradan, 1647). 
Vili 
Het vergaren van kennis is geen aaneenrijgen van nieuwe feiten, maar in het 
licht der voortdurend veranderende inzichten, een door inspiratie verkregen 
groeiend besef van eenheid achter de veelheid van actuele hypothesen (vrij 
naar: Heracleitos, 504 BC). 
IX 
Hoogwaardige wetenschap bedrijven en succes oogsten biedt geen garantie 
dat de geldstroom wordt gecontinueerd. Dit pleit voor wetenschapsbeoefening 
vanuit een pragmatisch nevenberoep (Ethica, Spinoza, 1677). 
X 
De wetenschap dient als amusement te worden bedreven, maar kan door 
contingentie en serependiteit tot grootse ontdekkingen leiden (The Origin of 
Species, C. Darwin, 1859). 
XI 
Medische expertise blijkt niet zozeer te berusten op superieure redenatie, 
vaardigheid en pathofysiologische inzichten, maar weet hebben van het 
'archetype' van de ziekte en concrete gevallen (A cognitive perspective, 
Schmidt, 1990). 
XII 
Drie maal per week lichaamsbeweging bevordert de gezondheid en verlengt 
de levensverwachting (G. Fletcher, Circulation 1990; 82; 2286-322). Vandaar 
dat vragen naar lichaamsbeweging in wezen bij elk routine arts-patiënt contact 
aan de orde zou moeten komen. 
XIII 
'Veel is mooi en groot is prachtig', maar men moet veel gestudeerd hebben om 
weinig echt te weten (De 'waarde-ring', Maarten Toonder, 1971). 
XIV 
Een grotere woon-werk afstand biedt voordelen wat betreft mogelijkheden tot 
bezinning op wetenschappelijke problemen. 
XV 
Capaciteit is niet de grootste verworvenheid van de menselijke geest maar 
flexibiliteit (Ever since Darwin, S.J. Gould, 1977). Het zal dus ongetwijfeld lang 
duren eer kunstmatige intelligentie het domein van het brein verovert. 
XVI 
Het moet ons Nederlanders met een grote nautische historie toch als muziek 
in de oren klinken, dat enorme galjoenen het telkens weer afleggen tegen de 
kleine, wendbare en slagvaardige vaartuigen. Waarom dan te streven naar 
steeds grotere fusie-ziekenhuizen? Een bilocatie model zou dan toch te 
prefereren zijn boven een moloch van een ziekenhuis. 
XVII 
De ontrafeling van de mysterieuze relatie tussen genotype en fenotype van de 
ziekte myotone dystrophic is nog immer een 'brug te ver'. 



